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Heterocycles play an important role in many biological processes and are 
widespread among natural products. Oxazole-containing natural products possess a 
broad range of bioactivities and are of great interest in the pharmaceutical and 
agrochemical industries. Herein, the biosynthetic routes to the oxazole-containing 
phthoxazolins and the bis(benzoxaozle) AJI9561, were investigated. 
            Phthoxazolins A-D are a group of oxazole trienes produced by a polyketide 
synthase-nonribosomal peptide synthetase (PKS-NRPS) pathway in Streptomyces 
sp. KO-7888 and Streptomyces sp. OM-5714. The phthoxazolin pathway was used 
as a model to study 5-oxazole and primary amide formation in PKS-NRPS pathways. 
An unusually large gene cluster for phthoxazolin biosynthesis was identified from the 
complete genome sequence of the producer strains and various gene deletions were 
performed to define the minimal gene cluster. PhoxP was proposed to encode an 
ATP-dependent cyclodehydratase for 5-oxazole formation on an enzyme-bound N-
formylglycylacyl-intermediate, and its deletion abolished phthoxazolin production. In 
vitro reconstitution of the early steps of phthoxazolin biosynthesis was attempted to 
validate the role of PhoxP, but was unsuccessful. Furthermore, Orf3515, a putative 
flavin-dependent monooxygenase coded by a remote gene, was proposed to 
hydroxylate glycine-extended polyketide-peptide chain(s) at the α-position to yield 
phthoxazolins with the primary amide moiety.  
On the other hand, an in vitro approach was employed to establish the 
enzymatic logic of the biosynthesis of AJI9561, a bis(benzoxazole) antibiotic  isolated 
from Streptomyces sp. AJ9561. The AJI9561 pathway was reconstituted using the 
precursors 3-hydroxyanthranilic acid and 6-methylsalicylic acid and five purified 
enzymes previously identified from the pathway as key enzymes for benzoxazole 
formation, including two adenylation enzymes for precursor activation, an acyl carrier 
protein (ACP), a 3-oxoacyl-ACP synthase and an amidohydrolase-like cyclase. 
Intermediates and shunt products isolated from enzymatic reactions containing 
different enzyme and precursor combinations were assessed for their competence 
for various steps of AJI9561 biosynthesis. Further bioinformatic analysis and in silico 
modelling of the amidohydrolase-like cyclase shed light on the oxazole cyclisation 
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1.1 A brief history of antibiotic discovery 
1.1.1 Antibiotics of microbial origin 
The first documentation of microbial antagonism was arguably Pasteur and Joubert’s 
(1877) report on the inhibitory effect of Enterobacteriaceae on the growth of 
pathogenic Bacillus anthracis, and they coined the term “antibiose” for this 
antagonistic phenomenon. However, it was only in 1929 that Fleming famously 
observed, on an agar plate of Staphylococcus, the clear halo surrounding a mould 
later identified as Penicillium notatum. The antibacterial substance secreted by P. 
notatum was named penicillin (Fleming, 1929). It was later isolated and tested in 
mice infected with Streptococci (Chain et al., 1940), and introduced for therapeutic 
use in the same year (Abraham et al., 1941). As the antibiotic was in high demand 
during World War II, intensive efforts were made to establish its industrial production 
and it became widely available by 1943 (Richards, 1964). Soon afterwards, the 
unique ß-lactam pharmacophore of penicillin was revealed by the work of Hodgkin 
(1949). 
Meanwhile, in 1939, tyrothricin had been isolated from Bacillus brevis (Dubos, 
1939). Tyrothricin consists of two bactericidal agents, gramicidin and tyrocidine 
(Dubos and Hotchkiss, 1941). They were found to be highly effective against a range 
of Gram-positive pathogens, and are the first antibiotics discovered from the 
deliberate screening of soil bacteria. Waksman, a Rutgers soil microbiologist, also 
joined the search for antibiotics. From various strains of Streptomyces, his group 
discovered more than a dozen antibiotics, including the peptide antibiotic 
actinomycin, the broad-spectrum streptothricin, and most notably, the first anti-
tuberculosis drug streptomycin (Waksman and Woodruff, 1940; Waksman and 
Woodruff, 1942; Schatz et al., 1944). Interest in natural product research grew rapidly 




microorganisms. This period marks the start of the golden age of antibiotics. 
Chloramphenicol, cephalosporin, chlortetracycline, erythromycin, vancomycin, 
kanamycin and many more antibiotics of microbial origin were discovered and 
brought to clinical use, saving millions of lives over many decades (Ehrlich et al., 
1947; Brotzu, 1948; Duggar, 1948; McGuire et al., 1952; Brigham and Pittenger, 
1956; Umezawa et al., 1957). Figure 1.1 shows the structure of a selection of 




Figure 1.1. Structure and microbial origin of the antibiotics erythromycin A, 
penicillin G, vancomycin, chloramphenicol, gramicidin S and streptomycin.  
 
1.1.2 Antibiotic classification and mechanisms of action  
Antibiotics may either induce cell death (bactericidal) or inhibit cell growth 
(bacteriostatic). They may be classified according to their mechanisms of action, 
owing to their structural features and binding affinity to specific cellular targets. 
Known mechanisms of action include the inhibition of the processes of cell wall 
synthesis, DNA replication, RNA transcription, protein synthesis and essential 
metabolite synthesis; and the disruption of cell membrane function and of nucleic 



































































































1.1.3 Mechanisms of antibiotic self-resistance 
Microorganisms producing antibiotics develop self-resistance mechanisms to protect 
themselves from the lethal effect of their own products. To produce viable progeny, it 
is assumed that mechanisms of self-resistance have co-evolved with the 
biosynthesis of antibiotics. In fact, genes conferring self-resistance often cluster with 
the biosynthetic genes, and they are co-regulated by the same signals in response to 
environmental stress (Laskaris et al., 2010). In some pathways, multiple resistance-
conferring genes are observed and a combination of different mechanisms 
contributes to provide greater protection (Mao et al., 1999; Kim et al., 2008; Luo et 
al., 2011).  
Self-resistance may be achieved by the inactivation of antibiotics in the 
cytoplasm by chemical modification such as phosphorylation, adenylation or 
acetylation (Sugiyama et al., 1981; Sugiyama et al., 1985; Sugiyama et al., 1986); by 
the timely export of antibiotics using pathway specific-transporter proteins (Levy and 
McMurry, 1974; Tahlan et al., 2007); by the modification of endogenous cellular 
targets to render them insensitive to inhibition (Graham and Weisblum, 1979; 
Zalacain and Cundliffe, 1989; Kumagai et al., 1999); by the supply of an additional 
copy of a target enzyme whose active site is altered to abrogate antibiotic binding 
(Olano et al., 2004; Tao et al., 2016); or by the repair of damaged cellular targets 
(Lomovskaya et al., 1996).  
 
1.1.4 Emergence of antibiotic resistance in pathogens 
Soon after the introduction of antibiotics for clinical use, antibiotic resistance was 
noted to develop in the targeted pathogenic species. Antibiotic resistance is still an 
immense and growing threat to humanity, and poses a difficult challenge in modern 
medicine. Horizontal gene transfer promotes the spread of (self-)resistance 
mechanisms across different genera of bacteria, which is further accelerated by the 
overuse and misuse of antibiotics (Forsman et al., 1990; WHO, 2015). In 1940, a 
penicillin-resistant clinical strain of Staphylococcus was reported for the first time 
(Gardner, 1940). Abraham and Chain (1940) showed that bacteria utilise an enzyme 
named penicillinase to hydrolyse the β-lactam pharmacophore of the antibiotic. It 
soon became clear that antibiotic resistance was problematic not only with the use of 
penicillin, but also with that of other antibiotics. Tetracycline-resistant Shigella, 
methicillin-resistant Staphylococcus, penicillin-resistant Pneumococcus and 
erythromycin-resistant Streptococcus were identified, with many more examples 




resistance (Olarte and de la Torre, 1959; Jevons et al., 1963; Kislak et al., 1965; 
Dixon, 1968).  
While clinical cases of resistance have continued to climb (Knight and Collins, 
1955), the rate of natural product discovery from bacteria has slowed down since the 
1960s. The reasons for this include the frequent rediscovery of known molecules 
from bioactivity-guided screening, and the relative difficulty of conducting medicinal 
chemistry on complex natural product templates. Moreover, as antibiotics are 
typically taken for short, one-off courses and since resistance is known to develop 
quickly, research and development in antibiotics offer little incentive for 
pharmaceutical companies. With the rise of the ESKAPE pathogens (Enterococcus 
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, 
Pseudomonas aeruginosa and Enterobacter spp.) and other multidrug-resistant 
“superbugs” such as Escherichia coli O157:H7, Clostridium difficile, Neisseria 
gonorrhoea and Mycobacterium tuberculosis, it is estimated that by 2050, 10 million 
people each year could lose their lives to infections no longer treatable with existing 
medication (AMR Review, 2016). There is an urgent need for new antimicrobials and 





1.2 Streptomyces as a prolific source of bioactive natural 
products 
1.2.1 The genus Streptomyces  
Actinomycetes belong to the order Actinomycetales and represent a diverse group of 
Gram-positive, filamentous bacteria characterised by the high G+C content in their 
genomes and a complex life cycle involving morphological differentiation. 
Actinomycetes consist of the genera Mycobacterium, Actinomyces, Nocardia, 
Streptomyces and Micromonospora (Waksman and Henrici, 1943). In particular, 
Streptomyces spp. produce a wide range of bioactive natural products, including two-
thirds of all known antibiotics (Bérdy, 2005), some of which have already been 
mentioned in Section 1.1.  
Among bacteria, Streptomyces spp. have some of the largest genomes, 
typically around 8 to 12 Mbp. They have a linear chromosome with DNA termini 
consisting of long terminal inverted repeats that are prone to large deletions and 
rearrangements (Birch et al., 1990; Lin et al., 1993; Yu and Chen, 1993). The central 
part of the chromosome, which contains all essential genes for normal growth and 
replication, spans 4 to 5 Mbp and is flanked by regions that are enriched in genes 
governing natural product biosynthesis (Bentley et al., 2002; Ikeda et al., 2003). 
Streptomyces spp. have a complex life cycle and undergo a programme of 
morphological differentiation (Figure 1.2) (Angert, 2005; Flärdh and Buttner, 2009). 
During germination, a spore swells and polarised growth takes place towards the tip 
of the emerging germ tube, which develops into a hypha. Hyphae extend by tip 
growth and branch into a vegetative mycelium that continues to grow into the solid 
substrate. In response to the increase in mycelial density, nutrient depletion and 
other stress signals, the growth of aerial hyphae is initiated by breaking the surface 
tension. Aerial hyphae differentiate into long chains of prespore compartments which 
develop thick walls, produce a grey spore pigment and acquire other characteristics 
of spores. The mature, dormant spores, which are desiccation-resistant but heat-
labile, are dispersed in the environment and germinate when the environmental 







Figure 1.2. The life cycle of Streptomyces. Adapted from Angert (2005). 
 
The onset of natural product biosynthesis in Streptomyces typically occurs 
during the stationary phase of growth and correlates, in growth on solid media, with 
the formation of aerial hyphae. Cluster-situated regulatory genes, like self-resistance 
genes, cluster with biosynthetic genes and are subject in turn to control by pleiotropic 
genes involved in quorum sensing, as exemplified by the A-factor signalling cascade 
in S. griseus (Horinouchi and Beppu, 1994; Horinouchi et al., 2007), and in other 
responses to environmental and physiological stress (Hood et al., 1992; Floriano and 
Bibb, 1996; Chater and Bibb, 1997; Challis and Ravel, 2000).  
 
1.2.2 The ecology and evolution of natural product biosynthesis 
Although a remarkable number of natural products of microbial origin have been 
shown to be useful in the clinic or as biocontrol agents, they are usually detected in 
their natural environment (for example, soil samples) at levels that seem too low to 
have any biological significance. However, Wellington and colleagues (Laskaris et 
al., 2010) have argued that production is easily underestimated, and adduce 
evidence for the role of antibiotic production in biocontrol of plant pathogens. Traxler 
and Kolter (2015) also argued that the limited diffusion of antibiotics away from the 
producing organism means that high local concentrations are achieved. They have 
reviewed a range of examples of soil bacteria using specialised metabolites for 
“competition sensing” under nutrient-limiting conditions. Some natural products play a 
role in morphological differentiation, quorum sensing and/or metal transport 




Winkelman and Drechsel, 1997), whereas a few others were postulated to be 
involved in the symbiotic or mutualistic interactions with higher organisms, like 
insects and plants (Currie et al., 1999; Coombs and Franco, 2003; Haeder et al., 
2009; Kaltenpoth et al., 2012). Still, there are many examples of natural products with 
no demonstrated bioactivity, or exhibiting bioactivities that could not be associated 
with any obvious selective advantage for the producer, and the ecological 
significance of natural product biosynthesis remains largely unknown.  
Firn and Jones (2000) have proposed that the possession of genes encoding 
biosynthetic pathways is crucial, even though many individual products of the 
pathways may not necessarily confer an immediate selective advantage, as the 
ability to produce such compounds is itself the advantageous and selectable trait. 
Interestingly, it is frequently observed that different species may produce common 
natural products, while strains belonging to the same species may not necessarily 
share an identical metabolic profile. Comparison between the genomes of different 
bacterial strains offered much insight into how biosynthetic pathways may have 
distributed and evolved to expand chemical diversity through time and their 
significance for the survival of the individuals and/or population as a whole. At the 
species level, closely-related strains appear to possess highly conserved genomic 
islands enriched with genetic mobile elements for vertical inheritance, as a means of 
cluster exchange in addition to horizontal gene transfer, potentially to maximise their 
capacity to produce chemicals as a population (Ziemert et al., 2014; Medema et al., 





1.3 Harnessing the biosynthetic potential of microorganisms 
1.3.1 Conventional methods for natural product discovery 
As discussed earlier in this chapter, the first bioactive natural products were 
discovered and studied mostly via bioactivity-guided screening of microbial isolates. 
Positive isolates were then subjected to fermentation, extraction, purification and 
structure elucidation. Reverse genetics, study of blocked mutants obtained by 
random mutagenesis and heterologous expression further contributed to the 
identification and characterisation of the different genes and enzymes responsible for 
natural product biosynthesis (Feitelson et al., 1985; Malpartida and Hopwood, 1986; 
Baltz and Seno, 1981; Roberts et al., 1993; Cortés et al., 1995).  
 
1.3.2 Mining for biosynthetic gene clusters in the age of genome sequencing 
In bacteria, genes that belong to a common biosynthetic pathway often cluster in 
proximity to each other on the chromosome, forming a “biosynthetic gene cluster” 
(also referred to as “cluster” in text). Recent advances in DNA sequencing leading to 
the increased availability of whole-genome sequences and biosynthetic gene cluster 
databases, such as AntiSMASH (Blin et al., 2017), ClusterFinder (Cimermancic et al., 
2014), Integrated Microbial Genomes (IMG) (Markowitz et al., 2012) and multigene 
BLAST (Medema et al., 2013), have greatly speeded up the identification of 
biosynthetic gene clusters. Tools are now widely available for the automated in silico 
annotation of putative protein function and the prediction of substrate specificity of 
enzymatic domains. This facilitates structural prediction of products of the clusters 
and provides insights into the biosynthetic logic of natural products. Examples of 
such tools include protein-protein BLAST (Altschul et al., 1990; Gish and States, 
1993), the Natural Product Domain Seeker (NaPDoS) (Ziemert et al., 2012) and 
SANDPUMA (Chevrette et al., 2017). 
 Streptomyces coelicolor A3(2) was the first member of the genus 
Streptomyces to have its genome fully sequenced (Bentley et al., 2002). It was 
already well known that varying the growth conditions of a typical streptomycete 
strain could change the profile of specialised metabolites produced, and this was the 
basis for the "One Strain, Many Compounds" (OSMAC) approach to prospecting for 
novel metabolites (Bode et al., 2002). The results of the sequencing revealed the 
untapped biosynthetic potential of even well-studied strains, as 23 different clusters 
were identified at a time when it was then only known to produce four bioactive 




dependent antibiotic (CDA). This finding initiated intensive research into harnessing 
the biosynthetic potential of microorganisms via whole-genome sequencing and 
genome mining.  
Genome mining has opened up immense opportunities not only for the 
discovery and activation of new and/or cryptic clusters, but also for the identification 
and study of enzymes with novel functionality and/or responsible for the 
biotransformation of valuable chemotypes (Zhou et al., 2015; Saha et al., 2017). The 
combination of genome mining and the use of high-throughput LC-MS analysis, 
MS/MS fragmentation analysis (Kleigrewe et al., 2015), molecular network analysis 
(Nguyen et al., 2013; Cimermancic et al., 2014) and/or metabolomic maps (Goodwin 
et al., 2015) has proven powerful in efficiently establishing connections between 
clusters and their products, and in prioritising clusters for study. Additionally, 
metagenomic sequencing of complex environmental samples and single cell sorting 
and sequencing allow access to genetic data for the mining of uncultured bacteria. 
The direct capture and mobilisation of clusters via heterologous expression bypass 
the need to culture the “unculturable” (Owen et al., 2013; Iqbal et al., 2016; Hover et 
al., 2018).  
Complete genome sequences are also particularly useful for the search of 
essential genes located away from a cluster and the identification and manipulation 
of duplicate or redundant copies of biosynthetic genes elsewhere on the 
chromosome (Lazos et al., 2010; Penwell et al., 2012; Cano-Prieto et al., 2015; Li et 
al., 2018).  
 
1.3.3 Heterologous expression of biosynthetic pathways  
As techniques in molecular genetics and synthetic biology continue to improve, the 
direct cloning, refactoring, mobilisation and heterologous expression of many whole 
biosynthetic gene clusters became possible (Pfeifer et al., 2001; Yamanaka et al., 
2014; Yin et al., 2015). Engineered heterologous hosts, with endogenous clusters 
removed and/or pleiotropic regulatory elements manipulated, have proved useful for 
analysis of biosynthetic gene clusters from poorly-characterised or genetically-
intractable strains (Gomez-Escribano and Bibb, 2011; Komatsu et al., 2010; Komatsu 





1.3.4 In vitro reconstitution of biosynthetic pathways  
The isolation and characterisation of individual enzymatic components of biosynthetic 
pathways have facilitated complete or partial reconstitution in vitro, complemented by 
mutational, structural and kinetic studies (Miller et al., 2002; Lowry et al., 2013). 
Bacterial proteins are commonly overexpressed and purified from E. coli. Other 
heterologous hosts may be used depending on the origin of genes, codon usage and 
the requirement for post-translational modifications (Gomez-Escribano and Bibb, 
2014; Ikeda et al., 2014). The reaction conditions of in vitro reconstitution are 
precisely controlled, and individual components may be substituted or removed. This 
allows the study of the (bio)chemistry of individual reactions and of the timing of 





1.4 The enzymes of natural product biosynthesis 
The study of the genes and enzymes responsible for natural product biosynthesis 
has been greatly facilitated by recent advances in molecular biology and sequencing 
technologies. In this section, the biosyntheses of various major classes of natural 
products from Streptomyces and related actinomycete genera, including terpenes, 
ribosomally-synthesised and post-translationally modified peptides, polyketides and 
non-ribosomal peptides, are discussed. The main focus will be on polyketides and 
non-ribosomal peptides as background for the work described in Chapters 3 to 7.  
 
1.4.1 Terpenes and terpene synthases 
In bacteria, terpenes arise from the acyclic precursor isopentenyl diphosphate (IPP) 
and its isomer dimethylallyl diphosphate (DMAPP), generated from either the 
mevalonate pathway or the mevalonate-independent methylerythritol phosphate 
pathway (Rohmer et al., 1996). Terpene synthases catalyse the (consecutive) 
condensation of IPP- or DMAPP-derived intermediates to produce an isoprenyl 
backbone which is often subject to extensive oxidative modifications, cyclisation 
and/or rearrangement reactions, giving rise to an impressive array of cyclic structures 
that vary greatly in their functional groups and carbon skeleton. Terpenes are 
classified by the number of isoprene units in the carbon skeleton: monoterpenes (2 
isoprene units; C10), sesquiterpenes (3 isoprene units; C15), diterpenes (4 isoprene 
units; C20), triterpenes (6 isoprene units; C30), tetraterpenes (8 isoprene units; C40) 
and polyterpenes.    
Production of the terpenes geosmin, 2-methylisobornel and albaflavenone is 
commonly observed in Streptomyces spp. In S. coelicolor A3(2), sco6073 encodes a 
sesquiterpene cyclase, geosmin synthase, for the conversion of farnesyl diphosphate 
(FDP) to germacradienol, and from germacradienol to geosmin (Cane and Watt, 
2003; Cane et al., 2006). The biosynthesis of both 2-methylisoborneol and 
albaflavenone involves tailoring enzymes: sco7701 encodes a SAM-dependent C-
methyltransferase to methylate geranyl diphosphate (GDP) at C-2, generating 2-
methylgeranyl diphosphate, the substrate of 2-methylisoborneol synthase (Sco7700), 
to yield 2-methylisoborneol (Wang and Cane, 2008). A two-gene operon (sco5222 
and sco5223) is responsible for the biosynthesis of albaflavenols and albaflavenone. 
FDP is converted by the epi-isozizaene synthase (Sco5222) to epi-isozizaene, which 
is subjected to further oxidative reaction(s) catalysed by Sco5223, a cytochrome 







Figure 1.3. Biosynthetic pathways to terpenes in S. coelicolor A3(2). (A) 
Geosmin. (B) 2-Methylisoborneol. (C) Albaflavenols and albaflavenone. 
 
S. coelicolor A3(2) also biosynthesises polyterpenoids, such as hopanoids 
and carotenoids. Squalene-hopene cyclase (Sco6764) catalyses the conversion of 
the acyclic squalene to the pentacyclic hopene (Poralla et al., 2000; Ghimire et al., 
2009). It is postulated that four other enzymes, a SAM-dependent enzyme 
(Sco6766), a nucleotide phosphorylase (Sco6765), a phosphatase and a pyridoxal-
dependent aminotransferase (Sco6769), are responsible for the installation of the 
aminohydroxylacyl side chain to yield the end product aminohydroxybacteriohopane 
(ATBH) (Figure 1.4). The isorenieratene cluster houses two operons, crtEIBV and 
crtYTU. CrtE, a geranylgeranyl diphosphate (GGDP) synthase produces GGDP 
using GDP and IPP as substrates and molecules of GGDP are condensed by CrtB, a 
phytoene synthase, to generate phytoene. CrtI, a phytoene desaturase, catalyses the 
conversion of phyotene to lycopene which is the substrate for cyclisation catalysed 
by CrtY, a lycopene cyclase, to yield β-carotene (Krügel et al., 1999). The last step of 
the isorenieratine pathway involves CrtU-catalysed intramolecular methyl transfer 
and desaturation of the aromatic end groups, to convert β-carotene to isorenieratine 
(Takano et al., 2005) (Figure 1.5). However, the role of the putative 














































































































































1.4.2 Ribosomally-synthesised and post-translationally modified peptides  
Ribosomally synthesised and post-translationally modified peptides (RiPPs) are 
derived from ribosomally-translated precursor peptides. A precursor peptide contains 
an N-terminal leader peptide and a core peptide. The leader peptide is important for 
recognition by post-translational modification enzymes and transporter proteins, 
whereas the core peptide is subject to extensive post-translational modifications and 
proteolytic cleavage from the leader peptide, to yield the mature final product. RiPPs 
are divided into subfamilies according to their specific post-translational modifications 
and resulting structural features. Prominent subfamilies include lanthipeptides, lasso 
peptides, and thiazole/oxazole-modified microcins (TOMMs) (Figure 1.6). Post-
translational modification contributes to the great structural diversity and rigid 




Figure 1.6. Structures of RiPPs belonging to different subfamilies. TOMM, 
thiazole/oxazole-modified microcin. 
 
Among post-translational modifications in RiPPs, formation of covalent 
crosslinks, macrocyclisation and heterocyclisation are the most frequently observed. 
For instance, lanthipeptides are polycyclic RiPPs with intramolecular thioester cross-
links arising from the nucleophilic addition of Cys thiols to dehydrated Ser or Thr 
residues (Schnell et al., 1988; Xie et al., 2004; Li et al., 2006). Lasso peptides, such 
.










































































as microcin J25 and lassomycin, are macrolactam structures through which the C-
terminal tail of the peptide is threaded. The macrolactams are formed from the 
intramolecular condensation of the N-terminal amino group with an ATP-activated 
side chain carboxylate of Glu or Asp in the middle of the peptide (Duquesne et al., 
2007; Gavrish et al., 2014) to form an isopeptide bond. Furthermore, multiple 
subfamilies of RiPPs contain small azol(in)e heterocycles derived from Cys, Ser and 
Thr, including linear azol(in)e-containing peptides, thiopeptides and cyanobactins. 
Biochemical studies on the microcin B17 biosynthetic pathway reveal that the 
heterocycles are incorporated post-translationally using an ATP-dependent 
cyclodehydratase complex, McbDCB, comprised of a YcaO-like cyclodehydratase, a 
dehydrogenase and a partner protein (Dunbar et al., 2012). Upon nucleophillic attack 
by the side chains of Ser, Cys or Thr in the precursor peptide McbA, the YcaO-like 
cyclodehydratase uses ATP to activate the peptide backbone amide, followed by N-
protonation and phosphate elimination to yield an oxazoline, a thiazoline or a methyl-
oxazoline moiety, respectively. MbcC, a flavin-dependent dehydrogenase, further 




Figure 1.7. Biosynthetic pathway to the thiazole/oxazole-containing microcin 
B17 involving the ATP-dependent cyclodehydratase complex, McbDCB. 
Enzyme(s) involved in each step is/are highlighted in blue.  
 
1.4.3 Polyketides and polyketide synthases 
Polyketide natural products continue to offer an abundant source of biologically-
relevant chemical diversity, with attractive potential for sustainable drug and 
agrochemical development. Clinically important polyketides include the antibiotics 
erythromycin A and rifamycin, the antiparasitic avermectin, the antifungal 
amphotericin B and the insecticide spinosyns A and D (Figure 1.8). Polyketides are 
biosynthesised by fatty acid synthase (FAS)-related enzymes called polyketide 
synthases (PKSs), from simple carboxylic acid-derived precursors (Donadio et al., 
1991; Jenke-Kodama et al., 2005; Zheng et al., 2012). Three types of PKS are 













































Figure 1.8. Structures and microbial origin of selected polyketide antibiotics. 
 
Type III PKS 
Type III PKSs, also known as chalcone synthase-like enzymes, are traditionally 
associated with plants but are also found in fungi and bacteria. Type III PKSs are 
single multifunctional enzymes that possess one active site to perform all required 
reactions, including the priming of CoA derivatives as extender units, chain 
elongation by intramolecular decarboxylative condensation and cyclisation, and they 
function in an iterative fashion (Figure 1.9) (Cortés et al., 2002; Achkar et al., 2005). 
Not only do type III PKSs produce chalcones, but also a variety of other molecules 
such as pyrones, acridones, and phloroglucinols.  
 
 
Figure 1.9. Type III PKS pathway to the unusual amino acid 
dihydroxyphenylglycine in Amycolatopsis mediterranei. DHPA, 




































































































Type II PKS 
Most aromatic polyketides are the product of type II PKSs, and are biosynthesised 
almost exclusively by bacteria and fungi. Type II PKSs consist of a single set of 
discrete, monofunctional enzymes that function iteratively for each round of chain 
elongation. A minimal set of enzymes includes two ketosynthase-like proteins (KSs), 
KSα and KSβ, which together form an active heterodimeric complex, and an acyl 
carrier protein (ACP) (Shen and Hutchinson, 1996). During biosynthesis, the 
polyketide chain is tethered to and presented by an activated ACP via a flexible 4'-
phosphopantetheine (4'-PP) arm, for assembly and elongation. KSα catalyses the 
intramolecular condensation on each extender unit, while KSβ has been proposed to 
function as a decarboxylase during initiation (Bisang et al., 1999) and to contribute to 
determination of polyketide chain length (Tang et al., 2003). KSβ shows remarkable 
sequence homology to KSα, with the catalytic Cys being replaced with Gln (Bisang et 
al., 1999). The full-length linear polyketide is modified by a ketoreductase (KR) and 
an aromatase/cyclase (CYC), yielding the aromatic core of the product. The 
regiospecificity of the aromatisation reaction is controlled through the precise 
orientation and correct folding of the linear polyketide in the active site pocket of the 
aromatase (Figure 1.10) (Zawada and Khosla, 1997; Ames et al., 2008; Lee et al., 
2012). Enzymes in a type II PKS may form a complex in the bacterial cell but are 




Figure 1.10. Type II PKS pathway to the aromatic polyketide antibiotic 
oxytetracycline.  
 
Iterative type I PKS  
Iterative type I PKSs are large, multifunctional enzymes organised into a module of 
FAS-related domains. They are commonly found in fungi but also play a role in 
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bacteria. Here, a minimal functional module consists of the KS, acyltransferase (AT) 
and ACP domains. The AT transfers (usually malonyl) extender units from an acyl-
CoA precursor to an activated ACP, and KS catalyses a decarboxylative 
condensation reaction between the ACP-bound extender unit and the growing 
polyketide chain, elongating the polyketide backbone by two carbon units. A 
"reductive loop" containing the ketoreductase (KR), dehydratase (DH) and/or 
enoylreductase (ER) domains is often found between the AT and ACP domains. KR 
stereoselectively reduces the β-keto group, DH dehydrates the resulting β-hydroxy 
group to an αβ-double bond and ER reduces the double bond to a single bond. The 
multifunctional, unimodular enzyme is used iteratively with varying degree of 
reduction for each extender unit, as reductive domains may be optionally used, or 
additional reductive enzymes may, during specific extension cycles, be recruited in-
trans, as in the lovastatin PKS (Kennedy et al., 1999; Auclair et al., 2001) (Figure 
1.11). Release of the full-length polyketide chain is typically catalysed by a 
thioesterase/Claisen cyclase (TE/CLC) domain, situated at the C-terminal end of the 
module, via hydrolysis or cyclisation. Notably, no TE is present in LovB of the 
lovastatin pathway, instead a condensation (C) domain is responsible for chain 
release. Moreover, non-reducing iterative type I PKSs in fungi consist of the highly 
regioselective product template (PT) domain, to control the aromatisation of reactive 
poly-β-ketone backbones to unique ring patterns (Li et al., 2010; Barajas et al., 
2017).  
 
Modular type I PKS 
Modular type I PKSs are large multifunctional enzymes organised as multiple 
modules of FAS-related domains, mostly found in bacteria. Each module catalyses 
one round of chain elongation of the polyketide backbone in an “assembly line” 
paradigm (Cortés et al., 1990; Donadio et al., 1991). Like iterative type I PKSs, the 
KS, AT and ACP domains comprise a minimal functional PKS module and optional 
reductive domains are often present. Domain composition of the reductive loop often 
differs in modules of the same pathway, conferring a variable degree of reduction for 
extender units incorporated by different modules. The substrate specificity and 
stereochemistry of PKS domains are outlined in Section 1.4.4. After the final round of 
elongation, a thioesterase domain (TE) releases the full-length polyketide chain 
through hydrolysis or macrocyclisation. A growing number of alternative release 







Figure 1.11. Iterative type I PKS pathway to dihydromonacolin L, the precursor 
to the cholesterol-lowering agent lovastatin, in Aspergillus terreus. Reductive 
and tailoring domain(s) involved in each elongation step is/are indicated in blue 
(LovB) and red (LovC).  
 
biosynthesis (Harvey et al., 2006), thioester reduction in alkaloid biosynthesis (Awodi 
et al., 2017), Baeyer-Villiger oxidative release of the furanone moiety of aurafurons 
(Frank et al., 2007), formation of a tetronate ring (Vieweg et al., 2014), and the 
spontaneous chain release in gliotoxin biosynthesis (Balibar and Walsh, 2006), have 
also been proposed or reported.  
The arrangement of modular type I PKS modules and domains dictates the 
order of catalytic reactions in the assembly line, a feature referred to as the 
colinearity rule (Cortés et al., 1995; Kao et al., 1995; Yu et al., 1999). This has been 
exploited to rationalise the chemical structure of polyketide products, as exemplified 
by many PKSs such as the 6-deoxyerythronolide B (6-dEB) synthase (DEBS) system 
that produces the aglycone of the macrolide antibiotic erythromycin A (Cortés et al., 
1990; Donadio et al., 1991) (Figure 1.12). Such modularity and predictability of PKS 
has prompted intensive research into the generation and optimisation of natural 
products with desirable properties, via genetic engineering of biosynthetic pathways 















































































Figure 1.12. Modular type I PKS pathway to the 6-dEB aglycone of 
erythromycin A. 6-dEB, 6-deoxyerythronolide B.  
 
Tailoring reactions  
Additional enzymatic processing of either the PKS-bound or released polyketide 
intermediate may take place, to further expand the chemical diversity and complexity 
of polyketides. Such reactions are usually catalysed by tailoring enzymes encoded 
within the same gene cluster (Betlach et al., 1998; Weitnauer et al., 2001; Chen et 
al., 2013). A broad range of tailoring reactions, including glycosylation, acylation, 
amidation, reduction, prenylation, carbamoylation and halogenation, is employed in 
PKS pathways. Some examples of the more prevalent oxygenation and methylation 
reactions are briefly described here.  
Oxygenation. PKS pathways utilise a range of enzymes to catalyse 
oxygenation reactions. EryK, a cytochrome P450 monooxygenase in the 
erythromycin pathway, catalyses the C-12 hydroxylation of erythromycin D to 
generate erythromycin C, an immediate precursor of the final product, erythromycin A 
(Stassi et al., 1993; Lambalot et al., 1995). In oxytetracycline biosynthesis, a 
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dependent manner (Zhang et al., 2008). For the formation of cyclic polyethers, 
polyolefinic polyketides are oxidised to epoxide intermediates by flavin-dependent 
epoxidases, in preparation for the subsequent intramolecular ring-opening/cyclisation 
reactions to form tetrahydrofuran and tetrohydropyran rings (Gallimore et al., 2006).  
Methylation. C- O- and N-methyltransferases (MTs) may be found in PKS 
pathways as discrete enzymes or enzymatic domains embedded in modules. In the 
erythromycin pathway, a discrete, SAM-dependent O-MT, EryG, is responsible for 
methylation at the C3 hydroxyl of the mycarose moiety of erythromycin C to yield 
erythromycin A (Paulus et al., 1990). Some PKS modules housing a SAM-dependent 
C-MT domain are capable of giving rise to the unusual geminal di-methyl group on 
the α-carbon of the PKS-bound intermediate. HMWP1 of the yersiniabactin pathway 
prefers malonyl-CoA over methylmalonyl-CoA and the two events of C-methylation 
may take place either before or after condensation is catalysed by KS (Miller et al., 
2002), whereas EpoM8 of the epothilone pathway specifies methylmalonyl-CoA and 
KS catalyses the condensation reaction after the formation of the geminal di-
methylmalonyl-ACP (Poust et al., 2015). 
 
1.4.4 Substrate specificity and stereochemistry of PKS 
PKSs are able to generate multiple chiral centres with various hydroxy and alkyl 
substituents along the carbon backbone of polyketides (Figure 1.13). At least some 
of the key features have been uncovered that contribute to the catalytic mechanism, 
substrate specificity and the highly-controlled stereochemistry of individual domains 
of modular type I PKSs. Many of these insights have been exploited for combinatorial 
biosynthesis and for the increasingly confident prediction of products of 
uncharacterised PKS biosynthetic gene clusters (genome mining).  
 
ACP domain 
The ACP domain contains a modified four-helix bundle and the catalytic Ser of the 
highly conserved GxDSL motif is situated at the N-terminal end of the second helix. 
ACP in its activated form (holo-ACP) has a flexible 4'-PP arm attached at the Ser 
residue, and is able to tether the substrate via a thioester linkage and present it to 
PKS active sites (Vance et al., 2016).  
 
AT domain  
Each round of polyketide chain elongation is initiated by the AT domain loading an 






Figure 1.13. Stereocentres controlled by PKS domains. Adapted from Keatinge-




Figure 1.14. Structural motifs I-III of AT domain that contribute to catalytic 
and/or extender unit specificity. Adapted from Reeves et al. (2001).  
 
αβ-hydrolase subdomain and the ferredoxin-like subdomain. ATs consist of three 
structural motifs, I, II and III, that contribute to their catalytic activity and/or substrate 
specificity (Reeves et al., 2001) (Figure 1.14). In motif II (GHSxG), if “x”, the residue 
immediately downstream of the catalytic Ser, is a branched hydrophobic amino acid, 






the AT is malonyl-specific; and a Gln or Met residue are found in other ATs. Non-
native starter or extender units may be incorporated to alter the α-carbon on the 
polyketide chains through swapping or site-directed mutagenesis of motifs II and/or 
III to alter the substrate binding motif of AT (Lau et al., 1999; Reeves et al., 2001; Del 
Vecchio et al., 2003; Lopanik et al., 2008).  
 
KS domain 
The KS domain belongs to the thiolase superfamily and has an αβαβα topology. KS 
elongates the polyketide chain via Claisen condensation between the growing 
polyketide chain and an extender unit. The catalytic triad Cys-His-His located within 
the conserved TACSSS, EAHGTG and KSNIGHT sequence motifs, is present in all 
functionally active KSs. Cys acts as a nucleophile to attack the thioester of the acyl-
ACP, while the second His contribute to the decarboxylation of the extender unit and 
the other His functions as a base to activate a water molecule for the nucleophilic 
addition to the activated carboxylate (Robbins et al., 2016).  
KSs that utilise potentially chiral extender units such as methylmalonate, are 
stereospecific. Methylmalonyl extender units are known to arise solely from (2S)-
methylmalonyl-CoA (Marsden et al., 1994). Following the condensation catalysed by 
KS, the α-methyl group is expected to appear in the elongated polyketide chain in the 
opposite stereochemical orientation, i.e. with inversion of configuration (Weissman et 
al., 1997; Staunton and Weissman, 2001). In certain extension modules, there 
appears to be retention of configuration, and this requires an additional epimerisation 
step catalysed by a side activity of the KR domain of the same module (Xie et al., 
2016). 
As discussed in Section 1.4.5 below, the KS domains of so-called trans-AT 
modular PKSs differ in sequence in a way that reflects the specific type of substrate 
handed on from the previous module. In canonical modular PKS (cis-AT PKSs) KS 
domains tend to resemble each other much more closely, but it has recently been 
shown that a short sequence motif in the KS domain correlates with substrate 
structure (Zhang et al., 2017). Interestingly, the identified motif is in the same position 
as a point mutation that was recently shown to affect the selectivity of an engineered 




KR, DH and ER domains 
The KR domain belongs to the short-chain dehydrogenase/reductase (SDR) family. 
Both the catalytic and structural subdomains possess a highly conserved Rossmann 
fold. The catalytic subdomain contains the Gly-rich TGxxGxG motif and the NNAG 
motif for NADPH binding, as well as the YAAAN motif containing the catalytic Tyr. 
Hydride ion is delivered from NADPH to the β-keto group and the carbonyl oxygen 
accepts a proton from the catalytic Tyr. The transition state is further stabilised 
through the formation of a hydrogen bond with a conserved Lys residue in the active 
site.  
The stereochemical orientation of the resulting β-hydroxyl group is set 
through both the selection of substrate and the stereoselective hydride addition. 
There are three types of KR: type A and type B KRs give rise to L-β-hydroxy and D-β-
hydroxy, respectively, whereas type C KRs are unable to catalyse reduction due to 
the absence of either the catalytic Tyr or the NADPH binding motif (Caffrey, 2003). 
The LDD motif and several other fingerprint residues were identified through 
sequence alignment to distinguish different types of KRs for structural prediction 
(Reid et al., 2003; Baerga-Ortiz et al., 2006). Keatinge-Clay (2007) later extended 
this analysis on the basis of the crystal structure determined for an individual KR 
domain, to provide a predictive “code”, based on additional fingerprint residues. In 
this code, a number denotes the stereospecificity of individual type A and type B KRs 
towards  α-substituted extender units: A1/B1 and A2/B2 type KRs are specific for α-
substituents in the D- and L- orientations, respectively (Figure 1.15).  
The DH domain possesses a characteristic double hotdog fold and its 
catalytic dyad Asp-His is located in the hydrophobic tunnel between the two hotdog 
folds (Keatinge-Clay, 2008). The Asp in the HPALLD motif protonates the β-hydroxy 
of the substrate and the His in the HxxxGxxxxP motif abstracts the L-α-proton. The 
highly conserved Tyr in the YGP motif may facilitate substrate binding. Typically, DHs 
in canonical PKSs are paired with a type B KR and act on the resulting D-β-hydroxy 
to yield an α,β-trans double bond. There are also rare cases of the dehydration of L-
β-hydroxy produced by a type A KR, generating a cis double bond through the 
removal of the L-α-hydrogen (Chang et al., 2004; Alhamadsheh et al., 2007). 
Dehydrating bimodules split between two polypepetides are often observed in trans-








Figure 1.15. Partial sequence alignment of KR domains. The LDD motif and other 
fingerprint residues are indicated. Adapted from Keatinge-Clay (2007). 
 
The ER domain is a member of the medium-chain dehydrogenase/reductase 
(MDR) family. It comprises an NADPH binding subdomain and a substrate binding 
catalytic subdomain. Similar to DH domains, its active site is located between the two 
subdomains. ERs typically act on trans olefin moieties that are products of canonical 
DHs paired with a type B KR. The hydride from NADPH is transferred to the β-carbon 
of the substrate and the resulting transient enolate intermediate is reprotonated at the 
α-carbon. The Lys and Asp residues in the active site are thought to be important for 
the binding and stabilisation of intermediates. A specific side-chain in the active site 
(either Tyr or Val) is postulated to play a role in setting the stereocentre of α-
substituents (Kwan et al., 2010; Zheng et al., 2012).  
 
TE domain 
The TE domain has an α,β-hydrolase fold that forms an active site presenting its 
catalytic triad His-Asp-Ser for substrate binding and catalysis (Tsai et al., 2001). It is 
usually located at the C-terminus of the final module and catalyses either (i) the 




release the linear polyketide as a carboxylic acid. The Ser residue acts as a 
nucleophile and attacks the thioester of the acyl-ACP of the final module, while the 
His and Asp residues accept the proton from Ser, resulting in an acyl-O-TE 
intermediate. The intermediate is subsequently attacked by either a hydroxy group on 
the polyketide chain activated by the catalytic His or by water for a hydrolytic release. 
At least some TEs exhibit broad substrate specificity and are able to act on various 
substrate mimics (Aggarwal et al., 1995). 
 
1.4.5 Trans-AT PKS: a non-canonical class of modular type I PKS 
Trans-AT PKSs constitute a non-canonical class of modular type I PKS. They are 
characterised by the lack of an integrated AT domain within modules. Instead, a 
discrete AT encoded within the same gene cluster acts iteratively in-trans in each 
round of chain elongation (Cheng et al., 2003). Trans-AT PKS was first described in 
Bacillus subtilis in 1993 (Scotti et al., 1993), and since then many more have been 
found across different genera of bacteria.  
Unlike canonical modular type I PKS pathways, trans-AT PKSs often deviate 
from the colinearity rule. The arrangement of modules and domains does not 
necessarily represent the order of enzymatic reactions that take place, which makes 
structural prediction of the product challenging and poses a barrier to rational 
engineering. For instance, the presence of inactive domains (Molnár et al., 2000), 
split modules (Cheng et al., 2003), discrete reductive enzymes acting in-trans 
(Arakawa et al., 2005), dehydrating bimodules for the generation of diene moieties 
(Wagner et al., 2017), modules to introduce branched extension units (Heine et al., 
2014), iterative use of modules and skipping of modules (Ng et al., 2018; Carvolho et 
al., 2005) are among the unusual features that have been observed in trans-AT 
PKSs Pathways containing a gene encoding more than one trans-AT are also known 
to occur. The additional AT may have a gatekeeping function through the hydrolytic 
cleavage of stalled intermediates from ACPs (Jensen et al., 2012).  
 
Stringent substrate specificity of trans-AT KSs 
Evolutionary studies suggest that trans-AT PKSs diversified through horizontal gene 
transfer both within trans-AT PKSs as well as with canonical type I PKSs, whereas 
canonical type I PKSs evolved by gene duplication (Nguyen et al., 2008; Lohman et 
al., 2015). Some trans-AT KSs were found to have remnants of the AT domain of 
various lengths, which potentially represent the “evolutionary intermediates” between 




KSs from trans-AT PKSs display stringent substrate specificity and form 
distinct phylogenetic clades correlating to their substrates (Nguyen et al., 2008). 
Structural studies of various trans-AT KSs of different clades demonstrated that the 
combination of the subtle differences in some active site residues and the 
conformations adopted by three highly variable loops forming the active site tunnel 
contribute to their stringent requirement for substrate recognition and processing 
(Gay et al., 2014; Lohman et al., 2015) (Figure 1.16). In combination with the use of 
the colinearity rule, trans-AT KS phylogeny-based structural prediction represents a 
powerful tool to predict uncharacterised natural products governed by trans-AT 
PKSs, as exemplified by the previously uncharacterised thailandamide pathway 
(Nguyen et al., 2008) (Figure 1.17). It also provides useful insights for predicting 




Figure 1.16. Fingerprint residues of different clades of trans-AT KSs. The most 
highly represented residues that vary between the 16 KS clades are shown for each 
clade. Adapted from Gay et al. (2014).  
  
1.4.6 Overall architecture of PKS 
Structural elucidation and mechanistic study of PKS multienzymes have proven 
challenging, due to their enormous size and the presence of multiple active sites. 
Early structural models of PKS modules were deduced from information available for 
the analogous FAS. Structures of high resolution have been resolved for individual 
domains and didomains by X-ray crystallography or NMR, which provided much 
insight into substrate specificity and stereochemical control in polyketide biosynthesis 
(Tsai et al., 2001; Alekseyev et al., 2007; Zheng et al., 2010; Tang et al., 2006; 







Figure 1.17. Trans-AT KS-phylogeny based structure prediction of 
thailandamide B. Adapted from Nguyen et al. (2008).  
 
The first structures of intact PKS modules were made available in 2014 with 
the use of small-angle X-ray scattering (SAXS) and cryo-EM, respectively (Edwards 
et al., 2014; Davison et al., 2014, Dutta et al., 2014; Whicher et al., 2014). Similar to 
the previously established architecture of the porcine FAS module (Maier et al., 
2008), the modified version of module 3 of DEBS (KS-AT-KR-ACP-TE, additional TE 
from the same pathway artificially fused to the C-terminus of the module) dimerises 
at the KSs and shows a flat, disc-shaped overall structure. The ATs are located away 
from the axis of symmetry and the ACPs reside towards the C-terminal end of the 
reaction chamber (Edwards et al., 2014). In an independent study, module 5 of the 
pikromycin PKS (KS-AT-KR-ACP) was shown to adopt an overall arch shape 
instead, with the reaction chamber in the centre of the homodimer and the ATs lying 
in parallel to the neighbouring KS and KR domains on the side of the reaction 
chamber (Dutta et al., 2014). The transfer of substrate between domains was also 
investigated in the same study: the ACP occupies different positions within the 
reaction chamber to access the active site of other domains for catalysis (Dutta et al., 
2014; Whicher et al., 2014). Lowry and colleagues (2016), further proposed a 
turnstile mechanism for substrate turnover in a PKS module. The module adopts an 






central reaction chamber. As the polyketide intermediate exits, the module 
undergoes conformational change to a closed form, and the cycle repeats.  
 
1.4.7 Non-ribosomal peptides and non-ribosomal peptide synthetases 
Non-ribosomal peptides produced by non-ribosomal peptide synthetases (NRPSs) 
represent another large class of highly diverse natural products. Prominent non-
ribosomal peptides in clinical use include the penicillins and other β-lactams, 
glycopeptide antibiotics like vancomycin, and the immunosuppressant cyclosporine 
used in transplantation surgeries. NRPSs employ an assembly-line paradigm for non-
ribosomal peptide biosynthesis analogous to that of modular PKS. Each extension 
module selects and activates an amino acid and catalyses its condensation with the 
elongating peptide chain, before passing on the extended chain to the next module. 
In addition to proteinogenic amino acids, D-amino acids, methylated, formylated, 
halogenated and phosphorylated amino acids, and N-terminally attached fatty acid 
chains are often found in non-ribosomal peptides. As for PKS, the modular nature of 
NRPS offers opportunities for rational engineering (Mootz et al., 2002; Butz et al., 
2008).  
A minimal NRPS module consists of three core domains: a peptidyl carrier 
protein (PCP) that tethers and presents the elongating peptide chain via a flexible 4'-
PP arm, an adenylation (A) domain that activates specific amino acids as an 
aminoacyl-adenylate for loading onto the PCP to form a thioester derivative, and a 
condensation (C) domain that catalyses the peptide bond formation between two 
PCP-bound thioesters. Finally, a TE or C domain situated at the C-terminal end of 
the final module is usually responsible for chain release via hydrolysis or 
macrocyclisation. In NRPS pathways lacking a TE or C domain, alternative release 
mechanims are employed. For example, thioester reductases in the form of a 
discrete enzyme or an enzymatic domain within an NRPS module have been 
reported to release an aldehyde product instead (Gaitatzis et al., 2001; Kessler et al., 
2004). Unusual oxidative chain termination resulting in a terminal amide moiety, may 
also occur, catalysed by a final module whose A domain specifies glycine 
incorporation and which contains a flavin-dependent monooxygenase (MOx) domain, 
as described for example in the myxothiazol and melithiazol pathways (Weinig et al., 






As in PKS pathways, discrete tailoring enzymes or tailoring enzymatic domains 
integrated within modules are often present in NRPS pathways, to introduce a variety 
of functional groups or to modify amino acid side chains. In addition to some tailoring 
reactions common to PKS pathways, such as oxygenation and methylation, 
epimerisation and heterocyclisation reactions are often observed in NRPS pathways.  
Epimerisation. Integrated epimerisation (E) domains are found immediately 
downstream of the PCP domain in some NRPS modules. D-amino acids in non-
ribosomal peptides are often generated by the action of E domains on the PCP-
bound L-aminoacyl-intermediates, via the extraction of the α-carbon proton. The C 
domain of the following module is usually stereospecific for the epimerised substrate 
(Kessler et al., 2004; Koumoutsi et al., 2004). However, there are examples of 
modules lacking an E domain where a D-amino acid is nevertheless inserted (Patel et 
al., 2003). 
Heterocyclisation. In contrast to the heterocyclisation of RiPPs, which 
requires an ATP-dependent cyclodehydratase complex, heterocycle-forming NRPS 
modules utilise the heterocyclisation (Cy) domain to introduce azoline moieties. The 
Cy domain replaces the canonical C domain, and catalyses both peptide bond 
formation and the cyclodehydration, likely independent of each other (Bloudoff et al., 
2017). A minimal heterocycle-forming module or bimodule, split between two 
successive polypeptides of the assembly line, appears to consists of an A domain 
specifying activation of either Ser, Cys or Thr; a Cy domain; and a PCP (Pulsawat et 
al., 2007). Additionally, an oxidase (Ox) domain is usually present within the module 
for the formation of azoles from azolines, whereas standalone reductases have been 
observed in pathways generating azolidines. Tandem copies of Cy and/or Ox 
occasionally exist, even if only one round of cyclodehydration and dehydrogenation is 
required to be carried out (Wakimoto et al., 2014). 
 
1.4.8 Substrate specificity and overall architecture of NRPS domains 
Each NRPS module typically utilises one particular amino acid as the extender unit 
and such substrate specificity is (at least initially) conferred by the A domain. Conti 
and colleagues (1997) first reported the structure of the A domain catalytic subunit of 
GrsA from the gramicidin S pathway, co-crystallised with phenylalanine and AMP. 
This work revealed that the amino acid binds in a hydrophobic pocket and the 
carboxyl and α-amino groups interact with the highly conserved Lys and Asp, 




al. (2000) further identified 8 to 10 residues in the active site responsible for substrate 
binding. As the substrate binding pocket is highly conserved, the residues identified 
from an uncharacterised A domain could be compared to/with domains of known 
specificity, and used to infer its substrate specificity. From a combinatorial 
biosynthetic point of view, residues in the substrate binding pocket of an A domain 
may in principle be manipulated to alter, restrict or expand its specificity (Han et al., 
2012).  
The chirally selective C domains demonstrate a gatekeeping function through 
reinforcing specificity towards both the donor and acceptor substrates (Stindl and 
Keller, 1994; Luo et al., 2002; Meyer et al., 2016). In vitro studies by Belshaw et al. 
(1999) and Ehmann et al. (2000) have shown the substrate preference for C domains 
with the use of aminoacyl-CoAs or aminoacyl-N-acetylcysteamine thioesters (without 
the influence of substrate selection by A domains). C-domain structure and function 
has been recently reviewed (Bloudoff and Schmeing, 2017). It has also been 
possible to engineer NRPS assembly lines by alteration of PCP domains (Owen et 
al., 2016). 
Tanovic and colleagues (2008) reported the structure of SrfA-C from the 
surfactin pathway, an intact termination module comprising all four essential NRPS 
domains (C-A-apo-PCP-TE) in its apo-form. They showed that a rigid catalytic 
platform forms between the C and A domains, on which the flexibly-tethered PCP 
(via the A-PCP linker) may adopt different conformations to enable the loading and 
transfer of substrates. In 2016, the crystal structures of two holo-termination modules 
(C-A-holo-PCP-TE), captured at different stages of catalysis, were solved by Drake 
and colleagues (2016). It was demonstrated that conformational change in the A 
domain directs PCP for the loading of an activated substrate and the subsequent 
delivery of the loaded PCP to the C domain to receive the elongating peptide 
intermediate. It was also revealed that the A and C domains simultaneously catalyse 
peptide bond formation and amino acid adenylation at their respective active sites. 
The relative positions of C domain to A domain and TE to other domains in the 
terminal module varies among different pathways, the authors proposed this could be 
due to the catalytic platform being highly dynamic and that the structural snapshots 
may have been captured when different conformations were adopted.  
 
1.4.9 Hybrid PKS-NRPS 
Hybrid natural products, containing both ketide and amino acid units, are 




containing both PKS and NRPS modules, as exemplified by the epothilone pathway. 
The epothilone gene cluster encodes nine PKS modules and one NRPS module 
(Tang et al., 2000) (Figure 1.18). Two hybrid interfaces are observed among the first 
three modules, EpoA (PKS), EpoB (NRPS) and EpoC (PKS). This requires the C 
domain in EpoB to catalyse a condensation reaction between an acyl building block 
from EpoA and a peptidyl-PCP, whereas the KS of EpoC has to accept a peptidyl 
intermediate rather than a polyketide chain from the previous module. Defined N- and 
C-terminal motifs rich in basic residues are identified at the hybrid interfaces, which 
are likely facilitating such unusual intermodular interactions and the successful 
elongation of hybrid polyketide-peptide chains (Gokhale et al., 1999; Liu et al., 2004).  
Beyond hybrid polyketide-peptides, the structural diversity of polyketides is 
further expanded through the hybridisation of PKS with FAS (Metz et al., 2001; 
Kaulmann and Hertweck, 2002; Shulse and Allen, 2011), and PKS with both FAS 
and NRPS (Masschelein et al., 2013; Masschelein et al., 2015).  
 
1.4.10 Heterocycles in polyketide and peptide natural products 
Heterocycles are prominent features of bioactive natural products and serve as 
important scaffold components often required for bioactivity (Joule and Mills, 2010). 
The incorporation of heterocycles enhances structural complexity and confers 
conformational rigidity and stability for target binding (Storm and Strominger, 1973). 
The electronic distribution and molecular properties of heterocycles further contribute 
to their chemical versatility. Heterocyclic moieties may interact with electrophiles or 
nucleophiles; may behave as an acid or a base; and often act as ligands to 
coordinate metallic complexes (Liu and Sadler, 2011; Pozharskii et al., 2011). 
 In addition to azoline formation catalysed by Cy domains in NRPSs and 
cyclodehydratase complexes in RiPPs systems as discussed in Sections 1.4.7 and 
1.4.2, Nature has evolved to afford a wide variety of heterocyclic moieties via diverse 
biosynthetic routes, and novel chemistry and enzymology continues to be uncovered 
(Walsh, 2015; Hemmerling and Hahn, 2016). The rest of this thesis will focus on 
oxazole-containing natural products possibly arising from novel enzymology. 
Oxazoles and the related azol(in)es are five-membered heterocyclic moieties found 
in many natural products that are endowed with remarkable biological activities. 
However, the biosynthetic routes to the relatively uncommon 5-substituted azol(in)e 
moieties in hybrid polyketide-non-ribosomal peptides and bicyclic oxazoles remain to 
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1.5 Aims of this work 
The overarching aim of this work was to use a genomics-led approach to elucidate 
the key features of the biosynthetic pathways of two (groups of) heterocyclic natural 
products: phthoxazolins A-D, a group of oxazole trienes with antifungal and herbicidal 
properties, and the bis(benzoxazole) antibiotic AJI9561 (Figure 1.19). Analysis of the 
whole-genome sequences of two known phthoxazolin producers, in conjunction with 
gene deletion experiments, was expected to lead to the identification and 
characterisation of the phthoxazolin biosynthetic gene cluster, and to shed light on 
the mechanism of 5-substituted oxazole formation. Meanwhile, a core set of 
candidate enzymes involved in benzoxazole formation had been revealed by 
comparative sequence analysis of the biosynthetic gene clusters governing AJI9561 
and related benzoxazole antibiotics. The goal here was to establish the enzymatic 














Phthoxazolin A: R=H; 4Z,6Z,8E
Phthoxazolin B/C: R=OH; 4Z,6Z,8E









Genome analysis of the phthoxazolin-
producing strains Streptomyces sp. OM-5714 




As discussed in Section 1.3, advances in DNA sequencing have led to the increasing 
availability of complete microbial genome sequences. However, these are still greatly 
outnumbered in public databases by highly fragmented and poorly annotated 
sequences. For an accurate estimate of the biosynthetic potential of an antibiotic-
producing actinomycete, and to recover the sequence of individual biosynthetic gene 
clusters intact, a high-quality genome sequence is essential.  This is now the method 
of choice for identifying a target natural product gene cluster.   
 Phthoxazolin A (Figure 2.1) was discovered in 1989-1991 independently by 
laboratories in Japan (Ômura et al., 1990), Germany (Henkel and Zeeck, 1991) and 
France (Legendre and Armau, 1989). Ômura and colleagues used bioactivity 
screening against cellulose-containing plant pathogens such as Phytophthora spp. to 
isolate phthoxazolin A, and showed it to be an oxazole triene produced by 
Streptomyces sp. OM-5714, a strain obtained from a soil sample collected in 
Hiroshima, Japan (Ômura et al., 1990). They subsequently developed methods to 
increase its titre (Tanaka et al., 1993).  
 Phthoxazolin A was shown to inhibit cellulose biosynthesis in both a resting 
cell system and in a cell-free system from Acetobacter aceti subsp. xylinum, by 
targeting the incorporation of glucose and uridine diphosphate-glucose into cellulose 
(Ômura et al., 1990). It also exhibits considerable herbicidal activity against radish 
seedings and anti-proliferative activity against a human prostate cancer cell line 
(Ômura et al., 1990; Kawada et al., 2009). Ômura and colleagues also identified the 
strain Streptomyces sp. KO-7888 as a producer of phthoxazolins B-D (Figure 2.1) 




 Meanwhile, chemical screening of strain Streptomyces Gö-2 by Zeeck and 
colleagues revealed three phthoxazolins which they named inthomycins A-C 
(inthomycin A is identical to phthoxazolin A) (Figure 2.1). They rigorously 
characterised the compounds as geometric E/Z isomers, demonstrated a pattern of 
13C incorporation from 1-13C-acetate that confirmed their polyketide origin, and 
established the configuration at C-3 as (R)- (Henkel and Zeeck, 1991), an 
assignment later confirmed by total chemical synthesis (Hale et al., 2014). The 
herbicidal compound CL22T was originally isolated from the fermentation broth of 
Streptomyces griseoaurantiacus by screening for dicotyledon-specific herbicides and 
inhibitors of germination  (Legendre and Armau, 1989) and it too proved to be 




Figure 2.1. Structure of phthoxazolins A-D and inthomycins A-C, compared to 
that of oxazolomycins A-C from Streptomyces albus JA3453. 
 
 The compact structure of phthoxazolins shows several interesting features, 
including the 5-oxazole moiety, the 2,2-gem-dimethyl substituent, and the presence 
of a primary amide. Strikingly, too, the phthoxazolins are structurally identical to a 
portion of the oxazolomycin antibiotics (Mori et al., 1985; Kanzaki et al., 1998), 
(Figure 2.1) as discussed in more detail in Chapter 3 of this thesis. Elucidation of the 
biosynthetic pathway to the phthoxazolins was expected to shed light both on the 
mechanism of oxazole formation and on the relationship between phthoxazolin and 
oxazolomycin biosynthesis.  
In this chapter, the whole-genome sequences of both Streptomyces sp. OM-
5714 and Streptomyces sp. KO-7888 are reported, clarifying their phylogenetic 
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relationship. Detailed analysis and annotation of the genomes led to the identification 
of the phthoxazolin cluster in both strains, as well as uncovered other previously 









2.2 Results and Discussion 
2.2.1 Whole-genome sequencing of Streptomyces sp. OM-5714 and 
Streptomyces sp. KO-7888, the phthoxazolin producers  
Streptomyces sp. OM-5714 and Streptomyces sp. KO-7888 were kindly provided by 
Professor Satoshi Ômura and Dr. Yuki Inahashi from the Kitosato Institute, Japan. 
Whole-genome sequences were obtained in-house by Shilo Dickens and colleagues 
in the NextGen DNA Sequencing Facility, Department of Biochemistry, using both 
shotgun MiSeq and long-range mate-pair MiSeq data. Data were assembled, using 
an in-house pipeline, by Dr. Markiyan Samborskyy, and open reading frames were 
identified and visualised in the genome browser Artemis (Rutherford et al., 2000). 
 Streptomyces sp. OM-5714 has a genome size of 8.7 Mbp with 7789 putative 
protein-coding sequences (Figure 2.2). The final assembly had a single scaffold, 
A912_AS4_SC1_R2, covering over 91% of the genome and housing the majority of 
biosynthetic gene clusters. Six small unplaced scaffolds, which could not be mapped 
onto the core assembly due to the lack of overlapping regions, were also obtained. 
They are named A912_AS4_SC05, A912_AS4_SC06, A912_AS4_SC07, 
A912_AS4_SC08, A912_AS4_SC09 and A912_AS4_SC10, respectively, with 
biosynthetic gene clusters predicted in the former two unplaced scaffolds. The 
genome of Streptomyces sp. KO-7888 spans 8.5 Mbp, slightly smaller than that of 
Streptomyces sp. OM-5714, and has 7545 putative protein-coding sequences (Figure 
2.3). In the final assembly, the single scaffold A913_AS4_SC1_R3 covers over 95% 
of the genome and also houses the majority of biosynthetic gene clusters. There are 
five small unplaced scaffolds, A913_AS4_SC08, A913_AS4_SC10, 
A913_AS4_SC11, A913_AS4_SC12 and A913_AS4_SC13, of which only 
A913_AS4_SC10 was predicted to contain biosynthetic gene clusters. The G+C 
content (~72%), coding density and average gene length of the two strains are 
similar. Neither strain appears to house a plasmid.  
 
2.2.2 Phylogenetic studies and whole-genome comparisons of Streptomyces 
sp. OM-5714 and Streptomyces sp. KO-7888  
To uncover the phylogenetic context of the two phthoxazolin producers, an initial 
BLAST (Altschul et al., 1990) comparison was made of their near full-length 16S 
rRNA gene sequences to that of other Streptomyces spp. in the NCBI database. The 






Figure 2.2. Map of the linear Streptomyces sp. OM-5714 chromosome. The 
scales are numbered in megabases. The outermost rings show genes on, 
respectively, the forward and reverse strands (red, secondary metabolism; black, 
energy metabolism; pale blue, regulators; yellow, central metabolism; cyan, 
degradation of large molecules; magenta, degradation of small molecules; dark 
green, surface associated; orange, conserved hypothetical; pale green, unknown; 
grey, miscellaneous); the third ring in shows the essential genes for cell division, 
DNA replication, transcription, translation and amino acid biosynthesis; the fourth ring 
in shows the genes of secondary metabolism, clearly identifying the position of the 




shows the mobile genetic elements (blue, transposases; red, prophages or integrated 
plasmids); the sixth ring in shows the G+C content; and the innermost ring shows the 
G+C content bias (khaki, >1; purple, <1). (A) Main assembly. (B-C) Unplaced 




Figure 2.3. Map of the linear Streptomyces sp. KO-7888 chromosome. The 
outermost rings show genes on, respectively, the forward and reverse strands (red, 
secondary metabolism; black, energy metabolism; pale blue, regulators; yellow, 
central metabolism; cyan, degradation of large molecules; magenta, degradation of 
small molecules; dark green, surface associated; orange, conserved hypothetical; 
pale green, unknown; grey, miscellaneous); the third ring in shows the essential 
genes for cell division, DNA replication, transcription, translation and amino acid 




identifying the position of the large gene clusters for phthoxazolin, an arsenolipid and 
an unknown lipopeptide; the fifth ring in shows the mobile genetic elements (blue, 
transposases; red, prophages or integrated plasmids); the sixth ring in shows the 
G+C content; and the innermost ring shows the G+C bias (khaki, >1; purple, <1). (A) 
Main assembly. (B) Unplaced scaffold containing biosynthetic gene clusters.  
 
relationship of Streptomyces sp. OM-5714 and Streptomyces KO-7888 to each other, 
and to the type strains of Streptomyces coelicoflavus, Streptomyces 
thermocarboxydus and Streptomyces graminearus, which all share 100% identity in 
their 16S rRNA. Although none of these type strains have been genome-sequenced, 
the genome sequence of Streptomyces coelicoflavus var. nankaiensis has been 
published (Geng et al., 2009), which differs in its 16S rRNA gene sequence from the 




Figure 2.4. Phylogenetic tree based on 16S rRNA gene sequences of 
Streptomyces sp. OM-5714, Streptomyces sp. KO-7888 and other Streptomyces 
spp. Evolutionary history was inferred using the maximum likelihood method 
(Tamura and Nei, 1993). All positions containing gaps were eliminated and there 
were 1405 nucleotides in the final dataset. The scale bar represents 7 nucleotide 
substitutions per site. The bootstrap values were inferred from 500 replicates and are 




MUSCLE (Edgar, 2004) and the evolutionary analysis was conducted in MEGA7 
(Kumar et al., 2016). T, type strain. 
 
 Given the high 16S rRNA gene sequence similarity among different 
Streptomyces species that is illustrated in Figure 2.4, a complementary multilocus 
sequence analysis (MLSA) was performed using the sequences of the five 
housekeeping genes, atpD, gyrB, recA, rpoB and trpB (Guo et al., 2008; Labeda et 
al., 2017) (Figure 2.5). MLSA evolutionary distances were determined using MEGA7 
(Kumar et al., 2016) by calculating the Kimura 2-parameter distance (Kimura, 1980). 
Strain pairs having ≤ 0.007 MLSA evolutionary distance (Kimura 2-parameter 
distance) are considered conspecific (Rong and Huang, 2012). This analysis 
suggests the two phthoxazolin producers are variants of the same species (0.003 
MLSA evolutionary distance), and distinct from any described Streptomyces type 




Figure 2.5. Phylogenetic tree based on MLSA of five housekeeping gene 
sequences of Streptomyces sp. OM-5714, Streptomyces sp. KO-7888 and other 
Streptomyces spp. Evolutionary history was inferred using the maximum likelihood 
method (Tamura and Nei, 1993). All positions containing gaps were eliminated and 
there were 2514 nucleotides in the final dataset. The scale bar represents 25 
nucleotide substitutions per site. The bootstrap values were inferred from 500 




aligned with MUSCLE (Edgar, 2004) and the evolutionary analysis was conducted in 
MEGA7 (Kumar et al., 2016). T, type strain. 
 
Additionally, MUMmer 3, a bioinformatics software for the rapid alignment of 
whole (or draft) genome sequences (Kurtz et al., 2004), was used to compare the 
chromosome sequence of Streptomyes sp. KO-7888 against those of Streptomyces 
sp. OM-5714 and Streptomyces coelicolor A3(2). The alignments were generated 
and visualised in the form of dot plots by Dr. Markiyan Samborskyy (Figure 2.6). 
Figure 2.6A illustrates the differences on the chromosome of Streptomyces sp. OM-
5714 compared to that of Streptomyes sp. KO-7888, which correspond to the 
location of unique biosynthetic gene clusters. No major DNA rearrangement between 
the two strains was observed. In contrast, various events of DNA inversion were 
indicated between Streptomyces sp. OM-5714 and Streptomyes coelicolor A3(2) 
(Figure 2.6B).  
 
2.2.3 Annotation of the genomes of Streptomyces sp. OM-5714 and 
Streptomyces sp. KO-7888 
AntiSMASH 4.0 was used for the initial detection and analysis of biosynthetic gene 
clusters (Blin et al., 2017), and revealed a total of at least 26 and 24 biosynthetic 
gene clusters in Streptomyces sp. OM-5714 and Streptomyces sp. KO-7888, 
respectively. In both phthoxazolin producers, biosynthetic gene clusters are largely 
located on either ends of the linear chromosome, as observed in many other 
Streptomyces spp. (Gomez-Escribano et al., 2016). Manual analysis was 
subsequently carried out to delimit (and frequently to revise) predicted cluster 
boundaries. However, the original antiSMASH numbering was retained as closely as 
possible. Some clusters were judged to be composite and were split into distinct  
clusters. The full lists of manually annotated clusters are shown in Tables 2.1 and 
2.2. The properties of genes encoded in the individual clusters are detailed in 







Figure 2.6 Whole-genome sequence alignments of Streptomyces sp. KO-7888. 
The analysis was conducted in MUMmer 3 with a minimum match value of 128 base 
pairs. Red, forward strand match; blue, reverse strand match. (A) Against 




Table 2.1. Annotation of biosynthetic clusters encoded in the genome of 
Streptomyces sp. OM-5714 predicted using antiSMASH 4.0. Clusters were 
initially analysed using antiSMASH 4.0 but the limits shown here for the clusters were 
then determined by manual analysis. AntiSMASH numbering of clusters was kept but 
some clusters were judged to be composite and were split up manually into 
neighbouring but distinct clusters. ATBH, aminohydroxybacteriohopane.  
†Biosynthetic clusters unique to Streptomyces sp. OM-5714 (not present in 
Streptomyces sp. KO-7888).  
Cluster AntiSMASH 4.0 prediction Nucleotide  Gene ID  Annotation 
  From To From To  
A912_AS4_SC1_R2 
1 Siderophore 126212  149144  0132 0122 Coelichelin 
2 Bacteriocin 420880 431095 0394 0400  
3 Terpene 773291 800040 0721 0733 Hopene/ATBH 
4 Trans-AT PKS-NRPS 1040620 1139534 0923 0955 Phthoxazolin 
5a† Butyrolactone 1345705 1346766 1130 -  
5b - - - - -  
6a - - - - -  
6b Siderophore 1421033  1430152  1205 1213 Non-NRPS siderophore 
7 Terpene 1622455 1631434 1390 1395 Geosmin 
8 Bacteriocin 1646219 1657659 1412 1422  
9a† Terpene 1959829 1968783 1660 1667 Isorenieratene 
9b PKS-NRPS 1978758 2011393 1677 1700 Undecylprodigiosin 
10 Siderophore 2091793 2103046 1768 1774 Rhizobactin-like 
siderophore 
11 Type II PKS 2621090 2630022 2227 2235 Spore pigment 
12 Terpene 2715710 2718945  2315 2317 Albaflavenone 
13 NRPS 3664031 3745384 3202 3236 Unknown lipopeptide 
14 Siderophore 5241210 5253199 4615 4624 Desferrioxamine (NRPS-
independent siderophore) 
15 Melanin 5339462 5352844 4699 4711  
16 Ectoine 6306312  6317261 5562 5572  
17 Bacteriocin 6889825 6902500 6088 6098  
18 Type III PKS 7013081 7015895 6205 6207 Flaviolin 




20 Indole 7659409 7662093 6796 6797  
21 Terpene 7855680 7859245 6966 6986 2-methylisoborneol 
A912_AS4_SC05 
22† Type I PKS-NRPS 144935  175389  0155 0172 Unknown hybrid 
polyketide-peptide 
23† Type I PKS-other KS 355058 372595 0312 0317 Unknown polyketide 
A912_AS4_SC06 
24 Type II PKS 1  74431 0001 0073 Lomaiviticin-like (partial) 
24 Type II PKS 115054 126835 0118 0128 Lomaiviticin-like (partial) 
25 Butyrolactone 74929 82201 0074 0080  
 
Table 2.2. Annotation of biosynthetic clusters encoded in the genome of 
Streptomyces sp. KO-7888 predicted using antiSMASH 4.0. Clusters were initially 
analysed using antiSMASH 4.0 but the limits shown here for the clusters were then 
determined by manual analysis. AntiSMASH numbering of clusters was kept but 
some clusters were judged to be composite and were split up manually into 
neighbouring but distinct clusters. ATBH, aminohydroxybacteriohopane.  
‡Biosynthetic clusters unique to Streptomyces sp. KO-7888 (not present in 
Streptomyces sp. OM-5714).  
Cluster AntiSMASH 4.0 prediction Nucleotide  Gene ID  Annotation 
  From To From To  
A913_AS4_SC1_R3 
1 NRPS 125731  148660 0124 0135 Coelichelin 
2 Bacteriocin 421824 432608  0396 0402  
3 Terpene 792194 806816 0723 0735 Hopene/ATBH 
4 Trans-AT PKS-NRPS 1072939 1171762 0938 0969 Phthoxazolin 
5a - - - - -  
5b‡ Type I PKS 1386674  1427061  1161 1193 Arsenopolyketide 
6a‡ NRPS 1777986 1824374 1556 1577  
6b Siderophore 1829833 1839074 1587 1595  
7 Terpene 2033328 2042285 1771 1776 Geosmin 
8 Bacteriocin 2057332 2068914 1794 1804  
9a - - - - -  
9b PKS-NRPS 2282805  2315645 1972 1985 Undecylprodigiosin 





11 Type II PKS 2935852  2943655 2529 2536 Spore pigment 
12 Terpene 3047162  3050532 2632 2634 Albaflavenone 
13 NRPS 3963064 4044457 3489 3523 Unknown lipopeptide 
14 Siderophore 5525881 5539012 4856 4866 Desferrioxamine (NRPS-
independent siderophore) 
15 Melanin 5624979  5638365  4940 4952  
16 Ectoine 6569243 6580182 5774 5784  
17 Bacteriocin 7132401 7145069 6294 6305  
18 Type III PKS 7255883 7258697 6412 6414 Flaviolin 
19 Terpene 7772125 7782459 6888 6895 Carotenoid 
20 Indole 7857553 7860237 6968 6969  
21 Terpene 8053745 8057309 7138 7140 2-methylisoborneol 
22 - - - - -  
23 - - - - -  
A913_AS4_SC10 
24 Type II PKS 12688 94547 0015 0089 Lomaiviticin-like 
25 Butyrolactone 95045 102432 0090 0096  
 
 It was revealed that not only are the two strains closely-related to S. coelicolor 
A3(2) phylogenetically, but they also harbour many clusters common to S. coelicolor 
A3(2), including ones giving rise to the terpenes hopene and 
aminotrihydroxybacteriohopane (ATBH) (clusters 3), geosmin (clusters 7), 
albaflavanone (clusters 12), isorenieratene (clusters 19 and 9a) and 2-
methylisoborneol (clusters 21), the non-ribosomal peptide-derived siderophore 
coelichelin (clusters 1), the polyketide-derived spore pigment (clusters 11), flaviolin 
(clusters 18) and undecylprodigiosin (clusters 9b), the siderophores desferrioxamines 
(clusters 14) and ectoine (clusters 16). The above clusters contain homologues of all 
essential genes required for the biosynthesis of the predicted products in S. 
coelicolor A3(2), many of which were described in Section 1.4, and will not be 
discussed any further here. Various clusters putatively encoding bacteriocin, 
siderophore, indole alkaloid, butyrolactone and melanin pathways were also 
identified.  
 Although the two highly-identical phthoxazolin-producing strains house 21 of 
the same clusters, some clusters were only found in one of them. The genome of 




unknown hybrid type I PKS-NRPS (cluster 22), an unknown type I PKS (cluster 23) 
and an additional butyrolactone cluster (cluster 5a), none of which are present in 
Streptomyces sp. KO-7888; whereas clusters 5b and 6a, predicted to encode an 
arseno-PKS and an NRPS pathway, respectively, were only found in Streptomyces 
sp. KO-7888.  
 Cluster 5b is homologous to a gene cluster only recently discovered in S. 
coelicolor A3(2) (sco6837-sco6812) and S. lividans 66 (sli_1077-sli_1103) (Cruz-
Morales et al., 2016). The clusters direct the biosynthesis of a novel 
arsenopolyketide. Homologues of the polyketide synthase (Orf1168), enzymes 
responsible for C-As bond formation (Orf1171, Orf1176-Orf1177), arsenic resistance 
and regulatory proteins (Orf1165, Orf1172) were identified in our cluster. The exact 
structure of the metabolite has not been reported, but two structures were deduced 
from liquid chromatography-mass spectrometry (LC-MS) data (Figure 2.7). By mining 
for the co-location of genes coding for C-As bond-forming enzymes, Cruz-Morales 
and colleagues (2016) revealed arseno-related clusters are unexpectedly prevalent 




Figure 2.7. Structures of potential arsenopolyketides. 
 
2.2.4 Bioinformatics analysis of uncharacterised biosynthetic gene clusters 
Five previously uncharacterised biosynthetic gene clusters were identified from the 
whole-genome sequences of Streptomyces sp. OM-5714 and Streptomyces sp. KO-
7888. Present in both of the strains are a hybrid trans-AT PKS-NRPS (clusters 4), a 
lipopepide NRPS (clusters 13) and a lomaiviticin-like type II PKS (clusters 24). The 
remaining two clusters include another hybrid PKS-NRPS (cluster 22) and a cluster 
encoding polyunsaturated fatty acid synthase-related enzymes (cluster 23), both of 
which were only found in Streptomyces sp. OM-5714. In this section, these five 
clusters were analysed bioinformatically and evaluated for their capacity to generate 
new chemical diversity. The prediction of the incorporation of certain functional 
groups and the overall core structure of the plausible products were deduced from 













comparative sequence analysis on partial gene clusters with known homologues in 
the literature.  
 
Clusters 13: a novel lipopeptide product of an assembly-line NRPS?  
Analysis of clusters 13 suggests that it might encode biosynthesis of a novel 
lipopeptide related to known cyclic peptide and depsipeptide antibiotics, such as 
daptomycin and surfactin (Koumoutsi et al., 2004; Miao et al., 2005; Koumoutsi et al., 
2004). Cluster 13 in Streptomyces sp. OM-5714 spans a region of 81.4 kbp and 
contains 34 contiguous opening reading frames predicted to encode three NRPSs, 
four transporters or proteins potentially conferring resistance, five regulators, four 
enzymes involved in fatty acid biosynthesis and various tailoring enzymes (Figure 
2.8). Thirteen NRPS extension modules are encoded within the three multimodular 
NRPS-encoding genes (orf3232-orf3230), with one of the modules lacking an A 
domain and predicted to be inactive. The substrate specificity of A domains were 
predicted using SANDPUMA, a phylogenetics-inspired algorithm which combines the 
existing active-site motif-based algorithms for improved substrate prediction 
(Chevrette et al., 2017). A C-terminal TE domain is detected in Orf3230 and is 




Figure 2.8. Gene organisation of cluster 13 in Streptomyces sp. OM-5714. 
 
 Genes encoding enzymes responsible for the activation and incorporation of 



































discrete PCP (Orf3218) are homologues of DptE and DptF from the daptomycin 
pathway. Daptomycin is a lipopeptide antibiotic comprised of a cyclised 
tridecapeptide coupled to a mid-chain fatty acyl side chain. DptE activates branched 
fatty acyl chains in an ATP-dependent manner and the fatty acid chains are 
transferred to DptF (Wittman et al., 2008). The C domain of the first NRPS module 
then catalyses the condensation between the fatty acid and the first amino acid to 
initiate daptomycin biosynthesis. Notably, two acyl-CoA dehydrogenase-encoding 
genes (orf3220 and orf3219) are located in tandem immediately downstream of the 
acyl-CoA ligase-encoding gene. This gene arrangement has been observed in 
several biosynthetic gene clusters giving rise to unsaturated lipopeptides, such as 
ramoplanins, taromycins and enduracidins (McCafferty et al., 2002; Yamanaka et al., 
2014; Yin et al., 2006) (Figures 2.9 and 2.10). In the enduracidin cluster, the acyl-




Figure 2.9. Set of candidate genes involved in the biosynthesis of unsaturated 
fatty acyl chains in ramoplanins, taromycins and enduracidins, and their 
homologues in cluster 13 of Streptomyces sp. OM-5714.  
 
Cluster 13 also houses adjacent genes coding for a glucose-1-phosphate 
thymidylyltransferase (Orf3208) and a thymidine-5'-diphospho(TDP)-glucose 4,6-
dehydratase (Orf3209), which would together convert glucose-1-phosphate into TDP-
4-dehydro-6-deoxy-D-glucose. Other deoxysugar biosynthetic genes may be 
encoded elsewhere in the genome, so the exact identity of the eventual sugar donor 
is unknown. The glycosyltransferase encoded by orf3207 may be responsible for the 
installation of such a sugar moiety onto the peptide backbone. In summary, cluster 
13 may therefore goven the biosynthesis of a novel dodecapeptide incorporated with 
a rare unsaturated fatty acyl chain and a sugar moiety. A linear representation of the 

















Figure 2.10. Structures of the unsaturated fatty acyl chain-containing 





Figure 2.11. Linear representation of the acyl-peptide backbone of the 
lipopeptide predicted to be encoded by cluster 13. Substrate specificity for A 






















































Ramoplanin A1: R1 = 
Ramoplanin A2: R1 = 












































Taromycin A: R2 = 























































Enduracidin A: R3 = 








Cluster 22: a hybrid polyketide-peptide featuring a novel starter unit derived 
from coronafacic acid biosynthesis? 
Cluster 22 is unique to Streptomyces sp. OM-5714 and appears to encode an 
unusual PKS-NRPS biosynthetic pathway. The gene organisation of the cluster is 
shown in Figure 2.12. Notably, the cluster houses a set of genes (orf0166, orf0163-
orf0160) encoding enzymes from the early part of the pathway to coronatine and the 
related coronafacoyl-amino acid conjugates. These are phytotoxins produced by the 
plant pathogens Pseudomonas syringae and Streptomyces scabiei, respectively 





Figure 2.12. Gene organisation of cluster 22 in Streptomyces sp. OM-5714. 
CPC, 2-carboxy-2-hydroxycyclopentanone.  
 
 Cfa5, an acyl-CoA ligase, activates succinic semialdehyde, derived from 2-
oxoglutarate catabolism, by adenylation and then Cfa3, a KS, catalyses a single 
round of decarboxylative condensation between the adenylate and a malonate 
extender unit. Cfa4, a putative cyclase, and Cfa2, a DH, subsequently catalyse the 
formation of the Cfa1-bound 2-carboxy-2-hydroxycyclopentanone (CPC) (Figure 
2.13B). The homologues of Cfa1-Cfa5 in cluster 22 may assemble the enzyme-
bound CPC as a starter unit for the hybrid PKS-NRPS assembly line. In any event, 
the association of cfa genes with a gene cluster for PKS-NRPS biosynthesis is 
unprecedented. 
 
Cluster 23: polyunsaturated fatty acid synthase-related? 
Cluster 23 is another previously-uncharacterised biosynthetic gene cluster unique to 
Streptomyces sp. OM-5714. The 17.5 kbp cluster harbours gene coding for 





















Figure 2.13. Comparative sequence analysis of cfa1-5 in cfa cluster from 
Pseudomonas syringae, cfa-like cluster from Streptomyces scabiei and their 




Figure 2.14. Biosynthesis of coronafacic acid-derived molecules. (A) Structures 
of coronatine and coronafacoyl-L-leucine. (B) Biosynthetic pathway to coronafacoyl-
amino acid conjugates in Streptomyces scabiei, with the use of a CPC starter unit. 
CPC, 2-carboxy-2-hydroxycyclopentanone.  
 
thioesterase (Orf0317), a discrete ACP (Orf0318) and a ROK-family transcriptional 
regulator (Orf0312). Homologues of orf0318-orf0313 with an identical gene 
arrangment were identified using protein-protein BLAST in a variety of actinomyete 
bacteria, including Saccharopolyspora, Kutzneria, Actinopolyspora and 
Kitasatospora. In Kitasatospora sp. Root107, the homologues of orf0316 and orf0315 




the cluster across the Actinomycetales encourages the view that the cluster is 




Figure 2.15. Gene organisation of cluster 23 in Streptomyces sp. OM-5714. 
Homologous clusters in Saccharopolyspora erythraea NRRL 2338, Kutzneria albida 
DSM 43870, Actinopolyspora mortivallis DSM 44261 and Kitasatospora sp. Root107. 
A canonical polyunsaturated fatty acid (pfa) cluster from Shewanella pealeana is 
shown. The fatty acid synthase(-related) domains are indicated.  
 
Clusters 24: an atypical angucycline-like aromatic polyketide PKS?  
Atypical argucyclines are a small but emerging group of aromatic polyketide natural 
products, typically characterised by a benzo[b]fluorene core. They have attracted 
considerable attention due to their potent anti-proliferative activity. Among the first to 
be described were the dimeric lomaiviticins from Salinospora spp. (He et al., 2001; 
Colis et al., 2014; Woo et al., 2012; Kersten et al., 2013; Janso et al., 2014), 
kinamycins (Ito et al., 1970; Gould et al., 1997; Gould et al., 1998; Bunet et al., 
2011), nenestatin A (Jiang et al., 2017), and the related benzo[a]fluorene fluostatins 
from Streptomyces spp. and Micromonospora spp. (Akiyama et al., 1998; Baur et al., 
2006) (Figure 2.16).  
Lomaiviticins are potent antibacterial and cytotoxic agents comprising two O-
glycosylated benzo[b]fluorene moieties symmetrically linked via a C2-C2' bond. 




lomaiviticins C-E are heterodimers of a diazofluorene and a hydroxyfulvene. Initial 
analysis of cluster 24 in both Streptomyces sp. OM-5714 and Streptomyces sp. KO-
7888 by antiSMASH 4.0 indicated that approximately half of the genes in this large 
cluster show considerable similarity to those in the lomaiviticin cluster. Although the 
gene order is very different, this prompted a closer analysis of the pathway to a 




Figure 2.16. Structures of lomaiviticins and related benzofluorene-containing 
natural products.  
 
The aromatic core of benzofluorene-containing natural products is commonly 
assembled by type II PKS systems and modified by a series of (redox) tailoring 
enzymes, as exemplified in many pathways giving rise to angucyclines and 
angucyclinones (Fernandez-Moreno et al., 1992; Decker and Haag, 2005; Yang et 
al., 1996). Cluster 24 contains the “minimal” type II PKS components, KS (Orf0016), 
KSβ (Orf0015), and ACP (Orf0079), as well as the homologues of tailoring enzymes 
used in the jadomycin pathway to yield the precursor to angucyclines (Orf0078, 
Orf0080, Orf0077, Orf0076, Orf0062) (Meurer et al., 1997; Kulowski et al., 1999). It 
has been demonstrated in the kinamycin pathway that an adjacent pair of oxidases, 




al., 2015a); the homologues in cluster 24, Orf0082 and Orf0081, likely catalyse the 
same series of B-ring redox transformations to afford hydroquinone-kinobscurinone 




Figure 2.17. Proposed biosynthetic pathway to the product of cluster 24. 
 
 The biochemical role of various biosynthetic components, including those 
responsible for diazo formation and dimerisation, are yet to characterised. Through 
comparative sequence analysis, Janso and colleagues (2014) identified a set of six 
enzymes proposed to be responsible for diazo formation from the lom and kin 
clusters, including an N-acetyltransferase, an adenylosuccinate lyase), a glutamine 
synthase, an amidase, a 4Fe-4S ferredoxin and a hypothetical protein, to convert 
hydroquinone-kinobscurinone to prekinamycin. Homologues of all six candidate 
enzymes are, again, present in our cluster (Orf0068-Orf0073). Intriguingly, the same 
set of enzymes is also found in the nes and fls clusters whose products do not 




biosynthesis possibly involve diazo intermediates that later undergo diazo reduction 
(Janso et al., 2014; Jiang et al., 2017). It is unclear whether or not the product of 




Figure 2.18. Organisation of candidate genes involved in diazo group 
installation in cluster 24 in Streptomyces sp. KO-7888. Homologous sets of 
genes from the kinamycin (kin) cluster in Streptomyces ambofaciens ATCC 23877, 
the lomaiviticin (lom) cluster in Salinispora pacifica DPJ-0019, the nenestatin (nes) 
cluster in Micromonospora echinospora SCSIO 04089 and the fluostatin (fls) cluster 
in Micromonospora rosaria SCSIO N160 are shown.  
 
Following diazo formation, prekinamycin undergoes a series of oxidative A-
ring modifications. Wang and colleagues (2015b) showed that the conversion of 
prekinamycin to kinamycin F involves an epoxy intermediate in kinamycin 
biosynthesis, and confirmed the epoxidase acitivty of an αβ-hydrolase, Alp1U. The 
hydrolases/monooxygenases (Orf0045, Orf0043-Orf0042) and the Alp1U-homologue 
(Orf0019) in cluster potentially play similar roles. Orf0039 may catalyse a subsequent 
reduction to generate substrates for dimerisation by an NADPH-binding protein 
homologous to Lom19 (0040). Lom19 was identified as the candidate dimerisation 
enzyme by both Kersten et al. (2013) and Janso et al. (2014), due to its significant 
sequence identity to ActVA-orf4 in actinorhodin biosynthesis (Taguchi et al., 2012). It 
was proposed that ActVA-orf4 and Lom19 may employ a similar strategy for 
catalysing the regiospecific C-C bond formation between the monomeric precursors 




 Homologues of some sugar biosynthetic genes involved in the TDP-L-
oleandrose pathway are located throughout cluster 24 (orf0033-orf0035, orf0054, 
orf0055, orf0074). The TDP-L-oleandrose pathway and the closely related TDP-L-
mycarose pathway in the biosynthesis of various polyketides linked with the 
respective sugar moieties have been extensively studied (Summer et al., 1998; 
Gaisser et al., 1998; Salah-Bey et al., 1998; Chen et al., 1999; Draegar et al., 1999). 
For instance, in the avermectin pathway, a set of seven enzymes, AveDCGIFHE, 
encoding a glucose-1-phosphate-thymidylyltransferase, a TDP-glucose 4,6-
dehydratase, a TDP-4-keto-6-deoxyglucose 2,3-dehydratase, a TDP-4-keto-6-deoxy-
L-hexose 3-ketoreductase, a TDP-4-keto-6-deoxyglucose 3-epimerase, a TDP-6-
deoxy-L-hexose 3-O-methyltransferase and a TDP-4-ketohexulose reductase, 
respectively, catalyses the conversion of glucose-1-phosphate to TDP-L-oleandrose 
(Figure 2.19). Homologues of the first six enzymes in the TDP-L-oleandrose pathway 
are encoded in cluster 24, but no AveE homologue was found anywhere on the 
chromosome. A TDP-4-ketohexulose-reductase other than AveE may catalyse the 
reduction to yield TDP-L-oleandrose. One or more of the glycosyltransferases 
encoded in the cluster (Orf0031, Orf0032, Orf0051) may be responsible for the sugar 




Figure 2.19. Biosynthetic pathway to TDP-L-oleandrose. 
 
Intruguingly, cluster 24 also houses sulfate adenylyltransferase subunits 
(Orf0021 and Orf 0022) and an adenylylsulfate kinase (Orf0020) for generating the 
sulfo donor, 3'-phosphoadenyl-5'-phosphosulfate (PAPS) (Figure 2.20), and a 
putative sulfotransferase. The latter enzyme, encoded by orf0036, is a homologue of 
lom10. Since known lomaiviticins are not sulfated, the significance of the presence of 















































Figure 2.20. Biosynthetic pathway to PAPS. APS, adenyl-5'-phosphosulfate; 
PAPS, 3'-phosphoadenyl-5'-phosphosulfate.  
 
2.2.5 Identification of the putative phthoxazolin biosynthetic gene cluster 
The structure of phthoxazolins suggest a polyketide-peptide origin, as for the 
analogous portion of oxazolomycin (Zhao et al., 2010). Two clusters in Streptomyces 
sp. OM-5714 were predicted as hybrid PKS-NRPSs (clusters 4 and cluster 22). The 
genes and enzymes of cluster 22, which was only found in Streptomyces sp. OM-
5714, were described earlier in Section 2.2.4. Cluster 4, a hybrid trans-AT PKS-
NRPS, consists of the reductive (KR and DH) domains required for successive αβ-
double bond formation to afford the triene moiety, as well as the methylation domains 
for C-methylation to generate the unusual germinal dimethyl group. Cluster 4 is 
present in the genome of both phthoxazolin producers and was determined as the 





2.3 Concluding remarks 
The whole-genome sequences of two phthoxazolin producers, Streptomyces sp. OM-
5714 and Streptomyces sp. KO-7888, have been obtained by shotgun nextgen DNA 
sequencing using the Illumina platform. Phylogenetic analysis has revealed the two 
phthoxazolin producers are variants of the same species and, although they are 
apparently distinct from previously-described type strains, they are nevertheless 
closely related to the model organism Streptomyces coelicolor A3(2). Detailed 
analysis and annotation of both genomes showed that most of the recognised 
biosynthetic gene clusters are shared with S. coelicolor A3(2) and with each other. 
However, certain shared clusters were apparently novel to this species, and a very 
few found only in either Streptomyces sp. OM-5714 or Streptomyces sp. KO-7888, 
housing novel combinations of biosynthetic genes. Meanwhile, our collaborators, Dr. 
Yuki Inahashi and Prof. Satoshi Ōmura (Kitasato Institute, Japan), used the whole-
genome sequences we determined to identify cluster-situated regulatory genes. 
Overexpression of the SARP family transcriptional regulator located in the NRPS 
gene cluster (cluster 13) in Streptomyces sp. KO-7888 led to the production and 
isolation of two novel unsaturated lipopeptides. There are notable structural 
differences between the predicted product, based on bioinformatic analysis (see 
Section 2.2.4), and the elucidated structures (Figure 2.21). It was also a surprise that 
the lipopeptides contain a primary amide, as with phthoxazolins. Finally, the 
phthoxazolin gene clusters of each strain were identified with high confidence. The 
detailed analysis and characterisation of these clusters are discussed in Chapters 3, 




Figure 2.21. Structure of unsaturated lipopeptides isolated from Streptomyces 































Characterisation of the unusual trans-AT 





The putative phthoxazolin clusters from Streptomyces sp. OM-5714 and 
Streptomyces sp. KO-7888 were identified as a new member of the growing list of 
hybrid trans-AT PKS NRPS clusters. Hybrid trans-AT PKS-NRPSs, often decorated 
with unusual biosynthetic and/or tailoring components, give rise to structurally-
diverse, bioactive polyketide-peptides including mupirocin, lankacidin, and bryostatin. 
Notably, the putative phthoxazolin clusters were revealed to be unexpectedly large, 
consisting of many non-canonical features and PKS- and NRPS-encoding genes that 
do not appear necessary for phthoxazolin biosynthesis. This chapter describes 
detailed bioinformatic analysis of the cluster, and experiments using in-frame deletion 
and point mutagenesis of various genes, to establish the biosynthetic role of their 





3.2 Results and Discussion 
3.2.1 Detection of phthoxazolins in Streptomyces sp. OM-5714 and 
Streptomyces sp. KO-7888 
Streptomyces sp. OM-5714 and Streptomyces sp. KO-7888 are known to produce 
phthoxazolin A, and phthoxazolins A-D, respectively. For both producer strains, 
peaks corresponding to the proton and sodium adduct ions of phthoxazolin A and 
phthoxazolins B-D were detected using liquid chromatography-mass spectrometry 
(LC-MS), with a retention time of 19.1 min and 16.3/16.9 min, respectively (Figures 
3.1 and 3.2). In accord with the literature, they all showed the expected MS/MS 
fragmentation pattern and a UV absorption maximum at approximately 276 nm to 
278 nm with shoulders on either side of the peak (characteristic of trienes). 
Phthoxazolins B, C and D could not be distinguished from each other using LC-MS, 
as the three stereoisomers share the same molecular weight and fragmentation 
pattern. Furthermore, the accurate masses of phthoxazolin A and phthoxazolins B-D 




Figure 3.1. Detection of phthoxazolin A from Streptomyces sp. KO-7888 by LC-
MS. (A) MS at 18.6-19.6 min. *, proton adduct ion; **, sodium adduct ion. (B) UV 
spectrum at 18.6-19.6 min. (C) Selected ion monitoring of m/z [M+Na]+ 313.15. (D) 
MS/MS fragmentation of parent ion m/z [M+Na]+ 313.15. 
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Figure 3.2. Detection of phthoxazolins B-D from Streptomyces sp. KO-7888 by 
LC-MS. (A) MS at 15.8-17.4 min. *, proton adduct ion; **, sodium adduct ion. (B) UV 
spectrum at 15.8-17.4 min. (C) Selected ion monitoring of m/z [M+Na]+ 329.15. (D) 
MS/MS fragmentation of parent ion m/z [M+Na]+ 329.15.  
 
3.2.2 Gene organisation of the putative phthoxazolin clusters and preliminary 
definition of the cluster boundaries 
The putative phthoxazolin clusters from the two Streptomyces spp. are nearly 
identical: they both span a region of 80.7 kbp, and house 21 open reading frames 
designated phoxB-phoxV (Figure 3.3). PhoxB-phoxV together encode four trans-AT 
PKSs, three NRPSs, three hybrid trans-AT PKS-NRPSs, a 4'-
phosphopantetheinyltransferase (PPTase), three regulatory proteins, a membrane 
protein, a cytochrome P450 enzyme, and several other tailoring enzymes and 
proteins of presently unknown function. Although the exact boundaries of the gene 
clusters are yet to be determined experimentally, the gene products encoded by the 
regions immediately upstream and downstream of the initially chosen boundaries, 
nitrate respiratory enzyme subunits and cellulases, respectively, are unlikely to be 
involved. The properties and putative function of the gene products of genes within 
and flanking the clusters from Streptomyces sp. OM-5714 and Streptomyces sp. KO-
7888 are shown in Tables 3.1 and 3.2, respectively.  
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Figure 3.3. Gene organisation of the putative phthoxazolin cluster. Genes 
flanking the upstream and downstream regions of the cluster are shown in white.  
 
Table 3.1. Properties of genes within and flanking the putative phthoxazolin 





Species  Putative function GenBank 
accession no.  
orf-4 240 99/100 Streptomyces 
coelicoflavus 




orf-3 164 99/99 Streptomyces  sp. 
CS159 




orf-2 528 99/100 Streptomyces 
coelicoflavus 




orf-1 1231 98/99 Streptomyces 
diastaticus 










phoxC 287 99/99 Streptomyces 
coelicoflavus 
XRE family transcriptional 
regulator 
WP_007445625.1 
phoxD 148 97/96 Streptomyces spp. Membrane protein WP_087788858.1 
phoxE 386 97/98 Streptomyces spp. Esterase  WP_007445627.1 
phoxF 847 96/97 Streptomyces 
coelicoflavus 
NRPS WP_108988779.1 
phoxG 1742 96/96 Streptomyces sp. 
CS159 
PKS-NRPS WP_087788856.1 








PhoxI 2910 92/93 Streptomyces PKS WP_108988777.1 
phox BCDE  F      G    H        I                  J          K LM              N














phoxJ 3008 97/98 Streptomyces sp. 
CS159 
NRPS WP_087788854.1 
phoxK 560 99/99 Streptomyces 
coelicoflavus 
PKS WP_108988775.1 





phoxM 363 98/98 Streptomyces sp. 
CS159 
Hypothetical protein WP_087788851.1 
phoxN 4867 97/97 Streptomyces sp. 
CS159 
PKS WP_087792773.1 
phoxO 1158 97/97 Streptomyces 
coelicoflavus 
NRPS WP_108988772.1 
phoxP 400 99/99 Streptomyces spp. Hypothetical protein OzmP  WP_087788849.1 
phoxQ 879 98/98 Streptomyces sp. 
CS159 
PKS WP_087788848.1 
phoxR 6109 97/97 Streptomyces sp. 
CS159 
PKS-NRPS OWA21555.1 
phoxS 1106 98/98 Streptomyces spp. Malonyl-CoA-ACP 
transferase 
WP_007388965.1 
phoxT 272 98/98 Streptomyces 
coelicoflavus 
XRE family transcriptional 
regulator  
WP_007388964.1 









orf+1 611 97/99 Streptomyces sp. 
CS159 
Rhamnogalacturonan lyase  WP_087788844.1 
orf+2 891 92/94 Streptomyces 
rubrogriseus 
Xyloglucanase  WP_109028527.1 





orf+4 579 98/98 Streptomyces spp. Cellulose 1,4-beta-
cellobiosidase 
WP_011031002.1 









diastaticus dependent oxidoreductase  
orf+7 277 99/99 Streptomyces 
coelicoflavus 
Aldo/keto reductase WP_007388979.1 
orf+8 608 99/99 Streptomyces sp. 
CS159 
Long-chain fatty acid-CoA 
ligase 
WP_087788836.1 
orf+9 504 97/98 Streptomyces sp. 
NRRL WC-3753 
Multidrug MFS transporter 
 
KPC88094.1 




transcriptional regulator  
 
EHN78694.1 
orf+11 293 100/100 Streptomyces spp. LysR family transcriptional 
regulator 
WP_007388971.1 
orf+12 336 98/98 Streptomyces sp. 
NRRL WC-3753 
Bile acid-sodium symporter KPC88096.1 
 
Table 3.2. Properties of genes within and flanking the putative phthoxazolin 





Species  Putative function GenBank 
accession no.  
orf-4 240 99/100 Streptomyces 
coelicoflavus 




orf-3 164 99/99 Streptomyces  sp. 
CS159 




orf-2 528 99/100 Streptomyces 
coelicoflavus 




orf-1 1231 98/99 Streptomyces 
diastaticus 










phoxC 287 99/99 Streptomyces 
coelicoflavus 




phoxD 148 96/95 Streptomyces spp. Membrane protein WP_087788858.1 
phoxE 386 97/98 Streptomyces spp. Esterase  WP_007445627.1 
phoxF 847 96/97 Streptomyces sp. 
CS159 
NRPS WP_087788857.1 
phoxG 1744 95/96 Streptomyces sp. 
CS159 
PKS-NRPS WP_087788856.1 









PhoxI 2921 92/93 Streptomyces 
coelicoflavus 
PKS WP_108988777.1 
phoxJ 3008 97/98 Streptomyces sp. 
CS159 
NRPS WP_087788854.1 
phoxK 462 99/99 Streptomyces sp. 
NRRL WC-3753 
Cytochrome P450 KPC72422.1 





phoxM 363 98/98 Streptomyces sp. 
CS159 
Hypothetical protein WP_087788851.1 
phoxN 4866 97/97 Streptomyces sp. 
CS159 
PKS WP_087792773.1 
phoxO 1158 97/97 Streptomyces sp. 
NRRL WC-3753 
NRPS KPC71002.1 
phoxP 400 99/99 Streptomyces spp. Hypothetical protein OzmP  WP_087788849.1 
phoxQ 879 98/98 Streptomyces sp. 
NRRL WC-3753 
PKS KPC71004.1 
phoxR 6084 96/97 Streptomyces sp. 
CS159 
PKS-NRPS OWA21555.1 
phoxS 1106 98/98 Streptomyces spp. Malonyl-CoA-ACP 
transferase 
WP_007388965.1 
phoxT 272 99/98 Streptomyces 
coelicoflavus 
XRE family transcriptional 
regulator  
WP_007388964.1 









orf+1 611 98/99 Streptomyces sp. 
CS159 
Rhamnogalacturonan lyase  WP_087788844.1 
orf+2 891 92/94 Streptomyces 
rubrogriseus 
Xyloglucanase  WP_109028527.1 
















orf+6 233 96/98 Streptomyces sp. 
M1013 
SDR family NAD(P)-
dependent oxidoreductase  
WP_076977235.1 
orf+7 277 98/99 Streptomyces sp. 
CS159 
Aldo/keto reductase WP_087788837.1 
orf+8 608 99/99 Streptomyces sp. 
CS159 
Long-chain fatty acid-CoA 
ligase 
WP_087788836.1 
orf+9 504 97/98 Streptomyces sp. 
NRRL WC-3753 
Multidrug MFS transporter 
 
KPC88094.1 




transcriptional regulator  
 
EHN78694.1 
orf+11 293 100/100 Streptomyces spp. LysR family transcriptional 
regulator 
WP_007388971.1 
orf+12 336 98/98 Streptomyces sp. 
NRRL WC-3753 
Bile acid-sodium symporter KPC88096.1 
 
As the two clusters are highly identical, bioinformatics analysis of only the 
cluster from Streptomyces sp. KO-7888 is shown in the following sections of this 
chapter.   
 
3.2.3 Organisation of PKS and NRPS modules and enzymatic domains 
The unexpectedly large putative phthoxazolin cluster encodes a total of 16 
PKS/NRPS modules. Fifty-nine PKS/NRPS domains were identified using 
antiSMASH 4.0 (Figure 3.4) and the in silico analysis of individual domains is detailed 
in Sections 3.2.5 and 3.2.6.  
 
3.2.4 Comparative sequence analysis of the phthoxazolin and oxazolomycin 
clusters 
As phthoxazolins are structurally identical to a portion of the oxazolomycin antibiotics, 
considerable similarity between the corresponding biosynthetic gene clusters was 
expected. Indeed, six conserved genes were identified, five of which encode PKS 
and NRPS enzymes (proposed to be involved in the early steps of oxazolomycin 
biosynthesis (Zhao et al., 2010)) and one gene encodes a protein of unknown 







Figure 3.4. Organisation of PKS and NRPS modules and enzymatic domains. 
Detection and annotation of PKS and NRPS domains were performed using 
antiSMASH 4.0 (Blin et al., 2017). Modules are indicated with brackets and 
numbered 1 to 16 according to gene order. ACP, acyl carrier protein; PCP, peptidyl 
carrier protein; AT, acyltransferase; TD, terminal reductase; KS, ketosynthase; C, 
condensation; FkbH, FkbH-like; DH, dehydratase; KR, ketoreductase; A, adenylation; 




Figure 3.5. Comparison of the gene organisation of the phthoxazolin (phox) 
cluster to that of oxazolomycin (ozm). Sequence identities of conserved proteins 


































amino acid sequence identity to PhoxN, PhoxO, PhoxQ and PhoxR, respectively, 
their PKS/NRPS domain organisation is also comparable. Noticeably, the gene 
organisation differs between the two clusters, and the putative phthoxazolin cluster 
consists of many genes that are not present in the oxazolomycin cluster. The role of 
these genes in the biosynthetic pathway is unclear.  
 
3.2.5 In silico analysis of PKS domains 
Trans-AT domains 
PhoxS encodes a discrete AT-AT-Oxidoreductase (Ox) tri-domain (Figure 3.6). Both 
trans-AT domains contain the highly conserved GQGSQ loop, and the presence of 
the GHSxG and APFH/YAYH motifs signifies that the domains are specific for 
malonyl-CoA rather than methylmalonyl-CoA extender units (Figure 3.7). In the 
oxazolomycin pathway, Zhao et al. (2010) demonstrated that the second AT domain 
of OzmM (AT-AT-Oxidoreductase) is solely responsible for the loading to all PKS 
modules, via in-frame deletion experiments. Based on sequence homology, the 




Figure 3.6. Protein-BLAST analysis of PhoxS. Putative conserved domains are 
shown. Note that the C-terminal oxidoreductase domain was detected using protein-
BLAST but not antiSMASH 4.0. Blue, AT domain; green, oxidoreductase domain.  
biosynthesis. Trans-AT domains with an oxidoreductase domain fused at the C-
terminal end are occasionally observed, but their function is unknown (Piel et al., 
2002; El-Sayed et al., 2003; Zhao et al., 2010).   
 
PhoxS-AT2      -FPGQGSQQRGMGKELFTRYPRET-------AIADRVLGYSIEELCVHDPER----RLGR 
OzmM-AT2       -FPGQGSQAKGMGKDLFEEFPEET-------ALADSVLGHSIRELCVEDPRR----ELKL 
PhoxS-AT1      MFSGQGSQYYRMGQELHESDEVFRTALLRYDAVVAGLLGESVLARIL-DPDRRKNEPFVD 
OzmM-AT1       -----------MGSALYETEPVFRRVMDRLDAAASGELGESVLAALY-APGRGRAEPFDD 
 
PhoxS-AT2      TEYTQPALYVVSALTHLDRLAEDAEPADYLIGHSLGEYAALFAAGVFDFETGLRLVQRRG 
OzmM-AT2       TRFTQPALYVVSALAWLRERRENPVPPDFLVGHSLGEYVALFAAGSFDFETGLRLVARRG 
PhoxS-AT1      TRLTHPAIVMI-ELALAETLRAKGIEPDYLLGSSLGEYAAAVVSGSIDAETCLRLLVRQA 
OzmM-AT1       IAFTHPAIVMV-ELAAAETLIASGIRPDLLLGASLGEFTASVLAGVLDADACLRILVRQA 
 
PhoxS-AT2      ALMAAAGGGGMAAVVGCDEATVLRVLADSGIDELDLANYNAPDQFVLSGPAERVDAARDA 




PhoxS-AT1      DGLHAGPRGGMLAVITRPDGRDR---LPALP-GCEVAARNYPGHIVVAGADADLDRAEAT 
OzmM-AT1       AAVRDAPRGGMLAVLDDVALHAR---LPLLRERTEIAARNYPGHFVLAGAHEDLVAAEEE 
 
PhoxS-AT2      FESAGVRAVRLNVSAPFHSRHMRDTATEFARFLDGFTLRDPAVPVLANVDAQPYAPGTVK 
OzmM-AT2       FEGLGAHYVQLNVSAPFHSRYLRDTAEEFGRYLEGFTLRDPAVPVIANVDARPYRPGEVA 
PhoxS-AT1      LRAADVLHQRVPVEYAYHSSLMDGVLAECRAAFDGVTFAPPRIPWVSCVDGRLVERPGA- 
OzmM-AT1       LRARKVVCHRVPVPYAFHSRLMDSGEPLFRSAMAGTELRPPRLPVISCATGGQVERVTV- 
 
Figure 3.7. Partial sequence alignment of AT domains. Conserved motifs 
discussed in the text are highlighted in yellow.  
 
ACP domains 
The highly conserved signature motif GxDS(L/I) of ACP is present in PhoxN-ACP8, 
ACP10, PhoxQ-ACP12, PhoxR-ACP13, ACP15 and ACP16, and is modified by one 
residue in PhoxG-ACP2, PhoxI-ACP3a, ACP3b, ACP4, ACP5 and PhoxN-ACP9 
(GxDSV, GxGSA, GxDSV and GxNSL, respectively). As the Ser residue essential for 
4'-PP attachment was identified in all ACP domains, they are all potentially functional 
(Figure 3.8). 
 
                                        *                                                                                                          
PhoxG-ACP2          -ARIRRHVADLLG-FDTDQLNVTTPLTSLGIDSVTAVRAQALVEADFGRVLPVAAL---- 
PhoxI-ACP3a         -AVLRELVGSRLG-VPVDSVDAGLGYYELGLGSADLLALVSELEERLSVELSPTVMFEYR 
PhoxI-ACP3b         -AVLRELVGSRLG-VPVDSVDAGLGYYELGLGSADLLALVSELEERLSVELSPTVMFEYR 
PhoxI-ACP4          --HLRRVLASALK-LGPERLDPDTPLERFGMDSVLAVTMVQPLEDTFG-PLSRTLLFEVR 
PhoxI-ACP5          -QAMAQAWADVLQ-VDAATLTGRTDFFSLGGNSLLATRLINLLKERAGVELPVEAVFSAP 
PhoxN-ACP8          -RLLRELIAAETG-LDPAELAEDAPFDRLGIDSLMIAKLNRELDRHFD-ALSKTLFFEYA 
PhoxN-ACP9          -EHLREVLAGVLK-LPAGRLDSRVPLDDYGLDSVLVMESNSLLGKDFP-GLRGTVFFEFR 
PhoxN-ACP10         -RQVTDVFARVLE-MTRDQLDPDLTFENYGVDSLVVLELTRALEAVYG-PQPATLLFERI 
PhoxR-ACP12         --HLTESIGKVVGGR--HLAAPDTNLFDLGLDSLVLIEVVAKLAEELGFEVQAASFVEFP 
PhoxR-ACP13         -ERLRDLVERV-L-KLDERIDPGRPLADYGFDSLSGMKIVAAVDEEFGVAVPLGDFFEQP 
PhoxR-ACP15         -ELVLRLLAEELK-LPEAEIAVAEPFDRYGVDSLITMSLIRRLEEHVG-PLSKTLLFEYV 
PhoxR-ACP16         --WLLDRLAAELR-FDRAKLAGDVPVHDYGMDSIMVSQLVQTVAQRLDVSVDPSALLEHP 
 
Figure 3.8. Partial sequence alignment of ACP domains. The highly conserved 
motif GxDS(L/I) is highlighted in yellow. The Ser residue essential for 4'-PP 
attachment is marked with an asterisk.  
 
KS domains 
The Cys-His-His triad essential for the catalytic activity of KS was observed in 8 out 
of 11 KS domains. The His residue in the highly conserved HGTGT motif essential 
for catalysing decarboxylative condensation is absent in PhoxI-KS5 (Cyc-Ala-His) 
and PhoxR-KS16b (Cys-Asn-His), suggesting they may be inactive and that modules 
containing these KS domains are not involved in chain elongation.  
As a clade assignment system is available for substrate prediction of trans-AT 
KSs (Nguyen et al., 2008; Gay et al., 2014), all 11 KS domains in the gene cluster 




AT PKS pathways1 (Figure 3.9). PhoxI-KS4, PhoxN-KS9, PhoxN-KS10 and PhoxR-
KS16a are predicted to accept intermediates containing an αβ-double bond (clade 
IX). They are strong candidates for accepting intermediates containing the first two 
double bonds of the triene moiety. PhoxR-KS13 specifies for substrates with a 
double bond and an α-methyl group (clade VII), presumably accepting intermediates 
after the third double bond of the triene moiety is generated. In fact, PhoxN-KS9, 
PhoxN-KS10 and PhoxR-KS13 are highly identical to the KS domains belonging to 
modules 4, 5 and 6 of the oxazolomycin pathway, whereas PhoxQ-KS12 and PhoxN-
KS8, corresponding to the KS domains in modules 2 and 3 of the oxazolomycin 
pathway, are predicted to accept substrates from an NRPS module (clade XVI).  
 
KR domains 
All eight KR domains show the N-terminal Rossmann fold required for the binding of 
the cofactor NADPH. The Lys-Ser-Tyr-Asn tetrad located in the active site was 
observed in the majority of KRs except for PhoxN-KR10 (Ser-Tyr-Cys) and PhoxR-
KR13 (Ser-Tyr-Ser). It is unclear whether or not these two type-C2 domains are 
functional. PhoxN-KR8, KR9, KR10 show high sequence homology with OzmN-KR3, 
KR4 and KR5, respectively, which are found in the triene-producing modules 3-5 of 
the partly analogous oxazolomycin pathway. Further analysis of KR domains was 
carried out to predict the stereochemistry of the potential β-hydroxyl group produced 
(Keatinge-Clay, 2007; discussed in Section 1.4.4) (Figure 3.10). PhoxI-KR4, PhoxN-
KR8 and PhoxR-KR15 contain a modified LDD motif (IED or LRD) at fingerprint 
position 1 and no Pro residue at fingerprint position 5, and thus, were predicted to be 
type B1 KRs giving rise to D-β-hydroxyl groups. This is consistent with the general 
rule that DH domains typically operate on products of type B instead of type A KRs. 
The stereochemistry of the putative products of PhoxN-KR9 and PhoxR-KR16 is 
ambiguous from inspection of the residues, as neither the LDD motif (characteristic of 
type B KRs) nor a Trp residue at fingerprint position 2 (characteristic of type A KRs) 
was observed.  
 
DH domains 
The highly conserved N-terminal HxxxGxxxxP motif was observed in all DH domains 
except in the truncated PhoxR-DHt16. The downstream YGP motif and a modified 
 
                                                
1 Bacillaene, bryostatin, chivosazol, difficidin, disorazol, lankacidin, leinamycin, macrolactin, mupirocin, 






Figure 3.9. Clade assignment of KS domains for substrate specificity 
prediction. (A) Phylogenetic tree of trans-AT PKS KS domains. Evolutionary history 
was inferred using the maximum likelihood method (Jones et al., 1992). All positions 
containing gaps were eliminated and there were 97 amino acids in the final dataset. 
Sequences were aligned with MUSCLE (Edgar, 2004) and the evolutionary analysis 
was conducted in MEGA7 (Kumar et al., 2016). Clade assignments are taken from 
Nguyen et al. (2008). (B) Predicted substrate structures of the KS domains. Domains 
lacking the catalytic His residue essential for decarboxylative condensation are 
coloured in grey.  
 
HPxxLDxxxQ motif were found in PhoxN-DH8, DH9 and DH10 (NPxxLDxxxH, 







































































































































                                       *                       *              *   * 
                   1                                                2      3  4 5 6 
OzmN-KR3        SA--DAYLLHKSWEEFTGVVAPKALGAVHLDRLTADDPLDLFVCFSSVAAAFG--NAGQSDYAYANAF 
OzmN-KR4        AD--QCSLLDAEAARFTGLLSVKAHGVRLLDALTADEPLDLFVVFSSIASVVG--DFGACAYAAANRF 
OzmN-KR5        LV--DKPIRRLAEAELRTALDAKADTVWSMFRALRGERPDFVLLYSSAVTFEG--NHGQAGYAAGCHV 
OzmH-KR6        FN--ASTIAELTEPELRAALAAKVDGSLALVGALGDEPLDFLAFFSSVGSFVS--AAGNAAYVAASSF 
PhoxI-KR4       IE--DNFVVRKSPGELDRVLAPKVAGLVHLDELTREQPLDLFVCFSSIAGAFG--NPGQSDYAAANAF 
PhoxN-KR8       LR--DGFALTKSAEDFAAVLAPKTAGLRALDAATADDPLDFFVAFSSIAAHIG--NPGQTDYAYANAY 
PhoxN-KR9       AD--EGR-ADGDRERFARLLGAKTHGLVHLDRLTREDPLDLFVVFSSVSSLIG--DFGAAGYATANRF 
PhoxN-KR10      LV--NQVLRELPEDGLRTALESKTDATWSLLRAVREVPLDFALLYSSGVAFEG--NHGQAGYAAGCTF 
PhoxR-KR13      FD--NHTLADLDEETFTAATRVKTRGSAALAAAVDGQDLDFLVYFSSAGSFGS--FAGNGAYICASAT 
PhoxR-KR15      LR--DGLIRTKQRADADAVLAAKVHGTVLLDEATADEPLDYFVTFSSAAAAFG--NAGQSDYAFANAF 
PhoxR-KR16      TDFENPAFVRKPQTGVARVLAPKVFGLDALVECFRDEPLGLFVLYSSVAAAVPALAVGQSDYAMANAY 
 
Figure 3.10. Partial sequence alignment of KR domains. Fingerprints 1 to 6 for 
the prediction of β-hydroxy stereochemistry are indicated (Keatinge-Clay, 2007). The 
Lys-Ser-Tyr-Asn tetrad in the active site is marked with asterisks and highlighted in 
yellow. Fingerprints characteristic of type B1 and type C2 KRs are highlighted in cyan 
and magenta, respectively.  
 
PhoxN are presumably responsible for catalysing the formation of the three double 
bonds, giving rise to the triene moiety in phthoxazolins. The modified motifs may play 
a role in the formation of the third double bond in the non-canonical cis-conformation, 
as well as the second double bond in either conformation to afford a mixture of the 
geometrically isomeric phthoxazolins. Alternatively, a presently unknown domain 
exhibiting epimerase activity may be responsible. The DH3a-ACP3a-ACP3b-DH3b 
module in PhoxI shows unusual domain architecture and contains two additional 
DHs. The second and third motifs are poorly conserved in PhoxI-DH3a (LGG, 
HPxxFExxxL), suggesting inactivity; whereas PhoxI-DH3b may potentially be able to 
offer trans-DH activity as both motifs are present with all three catalytically important 
residues, Tyr, Asp and Gln intact (Figure 3.11). 
 
MT domains 
Two C-MT domains were found in the third module of the PKS PhoxN and the first 
module of the hybrid PKS-NRPS PhoxR, respectively. Both domains contain the His-
Glu catalytic dyad, the highly conserved Tyr and Asn residues (Skiba et al., 2016), as 
well as the S-adenosyl-L-methionine (SAM) cofactor binding motifs 
(V/I/L)(L/V)(D/E)(V/I)G(G/C)G(T/P)G and LL(R/K)PGG(R/I/L)(L/I)(L/F/I/V)(I/L) (Kagan 
and Clarke, 1994; Miller et al., 2003) (Figure 3.12), and are potentially capable of 
methylating at positions C-2 and C-4 (geminal di-methyl). There is also an N-MT 
domain in the NRPS PhoxJ. The role of this domain is unclear as N-methylation is 






PhoxR-DHt16      ------------------------------------------------------------ 
PhoxI-DH3a       --------------------------NPLLAGHVVYGRSLLPGVGYVDLVLQVLARHGHP 
PhoxN-DH10       ------------AQGPRRWEHRLTADEPVLRDHVVDGRPVLPGVGHLDLVAEAS----GG 
OzmN-DH5         ---------------------TLDPADPVVRDHVVGGRAVLPGVGHLDLVVRAL----GE 
PhoxI-DH3b       --------------------------EPYLRDHQVRGGLVLPGVAQLEMARVAVARALGR 
PhoxN-DH9        AAPHPLVDANESTVTEVRFRKTLRARDPLLRDHVIEGRPLLAGAATLEFVRAAAALAEPG 
OzmN-DH4         ---HPLLDANESTLDEIRFRRTFLADEPLVRDHVIEGRALLAGAVCLEMARAAAGLAGLD 
PhoxR-DH15       -----------------------TGEEFFLRDHVVGGDLVLPGVAHLEMGRLSGELAAGG 
PhoxN-DH8        PGPHPMLDENVSTLDTLAYRSTRTGTEFYLADHRVGTEPVLPAAGQLELARAAGELSL-G 
OzmN-DH3         ---HPLLGANVSTLAEHRYATELTGDEFFIADHRVEGRAIMPAVGYLEMARAAGALSLPA 
 
                   // 
           * 
PhoxR-DHt16      ----LDEFAAGGAPDGSWTGVVDPRRPAAGEP------------------------LPAD 
PhoxI-DH3a       ----YDLLHSGLMKLGGAVHHRPGDW-----------IAELELAPEHQ---SSTGAFLFH 
PhoxN-DH10       EAAFYRALAGQGLPYGPFFRRVRQVWTGRDEV-----LGRIGE-PTG-----DDPAHALH 
OzmN-DH5         HEELYEGLRRRGLPYGPHFRRVAQAWTGDRTA-----LARLHR-PEECS---DAARGPLD 
PhoxI-DH3b       GEHVYGLYGGLGLEYGPSQRSLTELRTGRDAEGGRQVLAELRL-PEAAE---PLHGGLMH 
PhoxN-DH9        GPTAYTEYAAAGFAYGPSFHVIDEIRTGAGEA-----LVRLTR-NGAAP------DTQLP 
OzmN-DH4         GAAVRAAYDRARFAYGPAFDVIEEVRFGEGGA-----LLTLAL-PEPDG------ATALP 
PhoxR-DH15       GTDCYDGFVRLGFAYGPAFRVIEEIAQGPGEA-----LATLRL-PEPQR--ADAGAYAFH 
PhoxN-DH8        HTDCYDILRAHGLDYGPRMRALTEVRLGDGEA-----LGTLEL-PDGAP----LDGVLLN 
OzmN-DH3         ADDLYDLLRARGLDYGPAMRSLRELRRGRDEA-----LGVLEL-SGAARAAGDADAFVLH 
 
                          *   *  
PhoxR-DHt16      PAAYGTAWTGGQQVDWPALHPGGRPARVALPGYPFDGDRVWLAAADAELTALGAGRAAHD 
PhoxI-DH3a       PALFEAGLLGGGVALGM----LHGDNDGPGLYLPLMFDRFRAAGP---LGGRCYVRVPAD 
PhoxN-DH10       PGVLDAALHTVA-ALLV----RR-RGEHAPPMLPFAADRVEVFGA---VPTTGWSHVRE- 
OzmN-DH5         PGTLDAALHPLA-LL-L----AD-EGASGRPLLPFAADRVEIHAP---LPDEGWSHVRD- 
PhoxI-DH3b       PSILDGALQATM-GLWL----G--DGGSAALALPFALARADAVAV---TPATAYAWIRHR 
PhoxN-DH9        PALLDGALRACH-WTG-----RTTAPRAGELAVPFSLGALDSFAP---LPEVCHAHARP- 
OzmN-DH4         PALLDGALRACH-WAD-----RPSPEESDGLAVPFNLGTLEIRAPRGTLPRRCYAHAVP- 
PhoxR-DH15       PSLLDAALQTAG-RLVP----GAGDPAGPAPYLPFSLGSVRLHAA---LPERGYAY---- 
PhoxN-DH8        PALLDGALHALV-VLLA----RAY-GERADGFLPLALGELTVHAP---VTGPCHVHVA-- 
OzmN-DH3         PSLLDAALHAVV-GLLA----AR--ADEGITFLPLALGRLDVLAP---LPRHCLAHVTLP 
 
Figure 3.11. Partial sequence alignment of DH domains. Conserved motifs 
discussed in the text are highlighted in yellow. Catalytic residues are marked with an 
asterisk. DH domain sequences from the oxazolomycin (ozm) pathway were included 
for comparison. 
 
HMWP1-C-MT1       AIIFPQSASDGVEVLYQEFSFGRYFNQIAAGVLRGIVQTRQ----PRQPLRILEVGGGTG 
EpoE-C-MT8        EILFPGGSFDMAERIYQDSPIARYSNGIVRGV----VESAARVVAPSGTFSILEIGAGTG 
PhoxN-C-MT10      ---------------YRGDPVTDRCNAEVARLVVEQVEARRAAD-PAAPVRILEIGAGTG 
PhoxR-C-MT13      ------------QNFYKGNPLTDSFNLLVHDTVRHFLDLRLPRLPRGRTVEVVELGAGTG 
 
HMWP1-C-MT1       GTTAWLLPELNGVP-ALEYHFTDISALFTRRAQQKFAD-YDFVKYSELDLEKEAQSQGFQ 
EpoE-C-MT8        ATTAAVLPVL--LPDRTEYHFTDVSPLFLARAEQRFRD-HPFLKYGILDIDQEPAGQGYA 
PhoxN-C-MT10      GTTATVLAALASCGDGVEYVFTDVSPAFVRKARNRFGARYPFARFETLDIEADAAGQGLT 
PhoxR-C-MT13      ATSERVLPALAAHPGRVGYTFTDISPRFLEHGRERFAERYDFARFQVLNLERGLTEQGFE 
 
                                   *                         * 
HMWP1-C-MT1       AQSYDLIVAANVIHATRHIGRTLDNLRPLLKPGGRLLMREITQPMRLFDFVFGPLVLP-- 
EpoE-C-MT8        HQKFDVIVAANVIHATRDIRATAKRLLSLLAPGGLLVLVEGTGHPIWFDITTGLIEGWQK 
PhoxN-C-MT10      PGVHDVVLATNVLHATRRLSDTLTGAKRLLRRGGALLLVEGTRARHQLALVFGLTTGWWL 
PhoxR-C-MT13      PACADLVVATNVVHATSDLRATLRKAKALLRPGGWLVLNELTSVRPLLTIGGGVLEGWWA 
 
Figure 3.12. Partial sequence alignment of C-MT domains. The conserved 
residues and SAM cofactor binding motifs discussed in the text are highlighted in 
yellow. The His-Glu catalytic dyad is marked with asterisks. Sequences of C-MT 
domains involved in geminal di-methyl formation from the yersiniabactin (HMWP) and 




3.2.6 In silico analysis of NRPS domains 
A domains 
All four A domains contain the two invariant Asp and Lys residues for the correct 
positioning of amino acids. The substrate specificity of individual domains was 
predicted based on the eight variable residues present in the substrate binding 
pocket (Figure 3.13 and Table 3.3). The key residues displayed by Ser-specific A 
domains are found in PhoxJ-A6, including the highly conserved His-Ser dyad for 
hydrogen bonding with the hydroxyl side chain of the substrate (Challis et al., 2000); 
whereas PhoxO-A11 and PhoxR-A14 were predicted to specify for Gly. The residues 
in the binding pocket of PhoxJ-A7 do not show significant similarity to those identified 
in characterised A domains, so its substrate specificity could not be predicted. 
 
            235 239                                    278 
      ..  .                                      . 
GrsA-A            SFDASVWEMFMALLTGASLYIILKDTINDFVKFEQYINQKEITVITLPPTYVVHL----- 
MycC-M1-Ser       TFDVSVWELFWWSIVGSKVVLLPNGGEKNPELILDTIEQKGVSTLHFVPAMLHAFLESME 
EntF-M1-Ser       SFDVSVWEFFWPFIAGAKLVMAEPEAHRDPLAMQQFFAEYGVTTTHFVPSMLAAFVASLT 
PhsB-M1-Ser       HFDVSVWEMFWTLATGATLVLARPDGHRDPQYLAGRLVEEGVTDVHFVPSMLAAFLDVGA 
Cda1-M1-Ser       GFDVSVWEFFWPLVQGATLVVARPGGHTDPAYLAGTVRREGVTTLHFVPSMLDVFLREPA 
McyA-M1-Ser       SFDVSVWEFFWPLLAGATLVVAKPEGHKDSTYLIQLIQKQQITTLHFVPSMLRVFLQEPE 
OzmL-M13-Ser      SFDVSVWEFFWPLLTGATLVVAGPDEHKDPARLAELIDGERVTTAHFVPSMLQVFLGQDG 
PhoxJ-A6          SFDVSVWEFFWPLLAGARLAIAAPGGHRDPAYLLSAVRAFGVTTLHFVPSMLRSVVQEPD 
PhoxJ-A7          GFDVSVPELFWPLQVGAAVVVARPDGQKDPEYLARLIREERVTDLHFVPSMLAEFLSEPA 
DhbF-M1-Gly       AFDISALELYLPLISGAQIVIAKKETIREPQALAQMIENFDINIMQATPTLWHALVTSEP 
Cda2-M2-Gly       GFDIAGLEIFLPLLHGAVLVLADEETARDPHALLHRVSASGITMVQATPSLWQGVAAVAG 
OzmO-M1-Gly       CFDIAGLELYLPLVTGGEVRVAPADTVADGFALRELVEAYRPTVMQATPVTWRMLIDAG- 
OzmH-M7-Gly       CFDIAALELFLPLVTGGRVEIVPAEVARDGVLLRRLLDSSPATVVQATPATWKMLLAAG- 
PhoxO-A11         CFDIAGLELYLPLVRGGTVEVLPAAEAADGVALRERVERSAPTVLQATPTTWQMLLAAG- 
PhoxR-A14         CFDISGLELYLPLVAGGTVEVLAAEDARDGLRLREALERARPTVVQATPATWSMLLAAG- 
 
                              299                          322     330 
                               . .                          .       .. 
GrsA-A            ------DPERILSIQTLITAGSATSPSLVNKWKE------KVTYINAYGPTETTICATTW 
MycC-M1-Ser       QTPSGKLKRKLASLRYVFASGEALTPKHVDGFQRIITPVSHAQIINLYGPTEATIDVSYF 
EntF-M1-Ser       PQ---TARQSCATLKQVFCSGEALPADLCREWQ----QLTGAPLHNLYGPTEAAVDVSWY 
PhsB-M1-Ser       -L------PEGHSLRRVFCSGEALSPGLRDRLFA---RLPHVELHNLYGPTEAAIEVTHW 
Cda1-M1-Ser       -A---AALGGATPVRRVFCSGEALPAELRARFR----AVSDVPLHNLYGPTEAAVDVTYW 
McyA-M1-Ser       -L------KECSSLKRVFCSGEALSLDLTQRFF----EHFDCELHNLYGPTEAAIDVTYW 
OzmL-M13-Ser      -L-----AGRCADLRRVVCSGEALPFALQERFFA---KLPGTELHNLYGPTEAAVDVTSW 
PhoxJ-A6          -W------ARCTTVRQVFCSGEALPADLCVRHY----EQHTAPLHNLYGPTEAAVDVSHW 
PhoxJ-A7     A-------ELCTGLRRVETAGEALPVELAERFA---RVLPDTELHNLYGPTEGGP-ITAC 
DhbF-M1-Gly       ---------EKLRGLRVLVGGEALPSGLLQELQ-----DLHCSVTNLYGPTETTIWSAAA 
Cda2-M2-Gly       ---------DELAGVRVLVGGEALPSELARALT-----DRARSVTNLYGPTEATIWATAA 
OzmO-M1-Gly       -W-------RGGPGLTVLCGGEALPADLAADLVR---RA--DRVMNMYGPTETTIWSSVD 
OzmH-M7-Gly       -W-------TGGRGLKVLCGGEALDQDTAELLLA---RA--DQVWNMFGPTETTIWSAVC 
PhoxO-A11         -W-------TGDPALRALCGGEPLPPELAVRLAP---RV--GALFNMYGPTETTIWSTVD 
PhoxR-A14         -W-------QGDPALKVLCGGEALPADLAEALLA---GN--GQVWNLYGPTETTIWSAAS 
 
Figure 3.13. Partial sequence alignment of A domains. Sequences of 
characterised A domains from the mycosubtilin (myc), enterobactin (ent), 
phosphinothricin (phs), calcium-dependent antibiotic (cda), microcystin (mcy), (2,3-
dihydroxybenzoate (dhb) and oxazolomycin (ozm) pathways were included for 
comparison. Residues in substrate binding pocket are highlighted in yellow. Residue 





Table 3.3. Prediction of substrate specificity of A domains. Residue numbering 
refers to the A domain of GrsA from the gramicidin pathway.  
Amino acid residues in substrate binding pocket A domain 
235 236 239 278 299 301 322 330 331 517 
Predicted 
specificity  
PhoxJ-A6 D V W H F S L V D K Ser 
PhoxJ-A7 D V P H E A L P N/A K N/A 
PhoxO-A11 D I L Q L G M I W K Gly 
PhoxR-A14 D I L Q L G L I W K Gly 
  
PCP domains 
The Ser residue essential for 4'-PP attachment is present in all five PCP domains 
(Schlumbohm et al., 1991) (Figure 3.14). The highly conserved signature motif 
LGGxS of PCP was identified in PhoxJ-PCP6 and PCP7, and is modified by one to 
three residues in PhoxF-PCP1, PhoxN-PCP11 and PhoxR-PCP14 (AGAxC, AGGxS, 
AGMxS). 
 
         * 
PhoxF-PCP1         ---IVSKAAALLDVK--EIDTETDLFDAGATSVDAVRLVAVLDRELNVRLSLDDVFADAR 
PhoxJ-PCP6         ERHLAEVCAELLGFDADRVSAEDNFFALGGHSLMITVLVARLKD-SGLHITVQDVFTATT 
PhoxJ-PCP7         -RTLCRIVADVLGLT--RVGLQDNFFDLGGHSLLATRLTLRIRKETGAELPLQLIFSGAT 
PhoxN-PCP11        ERRIAQVWCEVLGLE--RVGAEDNFFDAGGDSLRLTSVVATLRERLGLQVTRLDMFGRPT 
PhoxR-PCP14        ------MVAALVDARPEDIGAHTPLGEAGMNSVGFTALSAELRKAYGITEYPTLFYRRGT 
 
Figure 3.14. Partial sequence alignment of PCP domains. The signature motif 
discussed in the text is highlighted in yellow. The Ser residue for 4'-PP attachment is 
marked with an asterisk.  
 
C domains 
PhoxJ-C6 and PhoxR-C14 both display the characteristic active site HHxxxDG motif, 
whereas a modified version is identified in PhoxG-C2 (HHxxxDL) and PhoxJ-C7a 
(HHxxxDA). PhoxJ-C7b is unlikely to be functional as the motif is poorly conserved 
(PWxxxDG), with both essential His residues missing (Figure 3.15). PhoxG-C2 is an 
additional C domain observed at the C-terminus of the hybrid PKS-NRPS module. 
Although the function of this domain is presently unclear, some NRPS systems are 
known or proposed to release the full-length peptide using a C domain via 
intermolecular nucleophilic attack of the thioester bond (Griffiths et al., 1984; Weber 







PhoxJ-C6  RVRLLRRSEQ-EHHLLVTTHHSVSDGWSVGVFFRDLVALYEAFGEGRPDPLEPLPVQYAD 
PhoxJ-C7a RLVVAEEPHSRRRYLLLTAHHLIEDATSLRLILAEL----AAHMAGRAD-LLAAPAPYRD 
PhoxJ-C7b  RAHLLTVSDD-RHIGVLTRPWGVFDGWSVNVVLADLLELYRAFSRGRTAELPELPLSYAG 
PhoxR-C14  RATLYSLGDG-RNALLLTFHHLVFDGVSIALLLRELESGYRALLEGRALSTERPARGYAD 
 
Figure 3.15. Partial sequence alignment of C domains. The active site motif 
discussed in the text is highlighted in yellow.  
 
Formylation (F) domain 
In addition to the A domain and PCP domain detected using antiSMASH 4.0, protein- 
BLAST analysis revealed the presence of an N-terminal formylation (F) domain in the 
NRPS PhoxO (Figure 3.16). PhoxO-F11 contains the Asn-His-Asp catalytic triad, and 
the HxSLLPxxxG loop for N10-formyltetrahydrofolate (N10-fH4F) cofactor binding, 
which is known to be required for the activity of formyltransferases involved in 
ribosomal peptide biosynthesis (Schmitt et al., 1996; Gatzeva-Topalova et al., 2005; 
Williams et al., 2005), is modified by two residues (HxGPLPxxxG) (Figure 3.17).  
Similar to the F domain-containing NRPS module (LgrA) involved in the 
initiation of linear gramicidin biosynthesis, PhoxO may possibly constitute the loading 
module of the phthoxazolin pathway, too. Notably, PhoxO and its homologues, 
OzmO and CongA, from the pathways governing oxazolomycin and another 5-
oxazole-containing polyketide-peptide, conglobatin, show the same domain 
organization and predicted amino acid specificity. The significance of this finding is 




Figure 3.16. Protein-BLAST analysis of PhoxO. Putative conserved domains are 





                          * *                                   * 
ApdA-F   YVLPQEILELPRQFAINYHDAPLPRYAGVNATSWALMNQEKTHGVTWHIMAAMVDAGDIL 
CongA-F  RMLPAALLDLPRELPVNFHDGPLPRHAGLNATTWAVLEREVSHGVTWHVMTEGADEGDVL 
OzmO-F         RMLPDDVLALPERMPVNFHDALLPRHAGLHATSWAVLEGAAEHGVTWHVMEREADTGDVL 
PhoxO-F11      RMLPEEVLALPTRLPVNFHDGPLPRHAGLFATSWAILDGDKQHGVTWHVMHLEADAGDVL 
LgrA-F         YILDKEIVSRFRGRIINLHPSLLPWNKGRDPVFWSVWD-ETPKGVTIHLIDEHVDTGDIL 
 
Figure 3.17. Partial sequence alignment of NRPS F domains. The conserved 
motif for N10-fH4F cofactor binding is highlighted in yellow. Catalytic residues are 
marked with asterisks.   
 
Terminal reductase (TD) domain 
PhoxF comprise a PCP domain and a rare terminal reductase (TD) domain. TD 
domains belong to the short-chain dehydrogenase/reductase (SDR) superfamily and 
in several NRPS systems, a TD domain integrated at the C-terminus of the last 
module catalyses the reductive release of the full-length peptide, yielding an 
aldehyde product/intermediate (Silakowski et al., 2000; Kessler et al., 2004; Read 
and Walsh, 2007). PhoxF-TD shows approximately 30% sequence identity to known 
TD domains from the myxochelin, linear gramicidin and lyngbyatoxin pathways. In 
PhoxF-TD, both the Asn-Ser-Tyr-Lys catalytic tetrad and the Gly-rich NAD(P)-binding 
motif (S/T)GxxGxxG required for activity are present (Figure 3.18). This domain could 
potentially be involved in chain release in the phthoxazolin pathway. There is no 
conventional C-terminal thioesterase (TE) domain in the phthoxazolin cluster that 
might mediate chain release. Investigation of the mode of chain release and primary 
amide formation is discussed further in Chapter 5.   
 
PhoxF-TD      ALDDHAEDLSLIMADLAAADRLPWCGDPE----PVPPRRVLLTGATGFLGGHMLLDLLRH 
MxcG-TD       MLADAELPEEIVPRLPTPGAEAPLAPSP---GPAAPLRQVLLTGATGFVGAHLLDQLLRQ 
LgrD-TD       ------LKDEVVL-DPAIQAEHPYVGDP------SQFQAALLTGATGFLGAFLLRDLLQM 
LtxA-TD       ------LAAEVVL-NPQIA---PYQSRPVELDRNTHPASVLLTGATGFLGAYLLYELLKQ 
 
             // 
 
                                  *                      * 
PhoxF-TD      LLANDVDSVVSVAAAVDFLRGYPSLRRTNVLGVLSLAELAMTGRPKPLHHISSIAVFNEI 
MxcG-TD       GLAAECDMILHNAAVVSVVREYGSLQATNVRGTRELLRLAASVRPKPLHYVSTLAVAPQA 
LgrD-TD       ELAEKVDVLYHNGALVNFVYPYAALKKANVKGTEEILRLAVAKKTKPVHFVSTIFTFASE 
LtxA-TD       KLTELIDAIYHNGAQVSAIEPYTYLKPTNVLGTSELLDFAARCRVKPLHFVSTAAVAVSS 
 
     *   * 
PhoxF-TD      GIAS---MGEDDPVAHVDRLTAGYDKSKWAAEAALRRARDRGLKATFLRPGGIVGHTRTG 
MxcG-TD       NLSPEVP---EAFVPAHPGLRDGYQQSKWAAERLVEQASERGLPVTVYRLGRVSGALDSG 
LgrD-TD       ETEESMAFREEDMPENSRVLTSGYTQSKWVAEHLVNLARERGIPAAIYRCGRMTGDSETG 
LtxA-TD       KGNPDIIYENFR-LGADSVLPSGYVSSKWVAEELVWVASDRGLPVTVHRPGRISGDTTTG 
 
Figure 3.18. Partial sequence alignment of NRPS TD domains. Mxc, myxochelin 
pathway from Stigmatella aurantiaca Sg a15; Lgr, linear gramicidin pathway from 




motif discussed in the text is highlighted in yellow. Catalytic residues are marked with 
asterisks.   
 
3.2.7 Investigation of the role of various candidate biosynthetic, tailoring and 
regulatory genes  
Development and optimisation of genetic manipulation protocol for 
Streptomyces sp. OM-5714 and Streptomyces sp. KO-7888 
As a prerequisite for genetic manipulation, the antibiotic sensitivity profiles of the 
phthoxazolin producers were established in this work. Both strains were resistant to 
ampicillin, carbenicillin and thiostrepton at 100 µg/mL, the highest final concentration 
tested; and they were both sensitive to apramycin, kanamycin and streptomycin at 25 
µg/mL2. Apramycin was used as a selection marker in all DNA constructs described 
in this chapter and in Chapters 4 and 5.  
As the genetic manipulation of the strains had not been previously reported, 
initial attempts of conjugation were performed according to protocols established for 
well-characterised Streptomyces spp., such as S. coelicolor and S. lividans. 
However, they were unsuccessful as the strains grew and sporulated too rapidly, 
which led to a large number of false positive exconjugants being generated. The 
conjugation efficiency was improved by flooding the agar plate for selection at an 
earlier time point with a larger volume of antibiotic solution. As Streptomyces sp. KO-
7888 appeared to be the more amenable target for conjugation, all mutants 
described in this work were produced from this strain. 
 
In-frame deletion of candidate biosynthetic and tailoring genes 
As the putative phthoxazolin cluster is unusually large for the production of such a 
relatively simple molecule, in-frame gene deletions were carried out to establish the 
role of individual genes in the pathway, and to define the boundaries of the gene 
cluster. DNA constructs for in-frame deletion of various biosynthetic and tailoring 
genes were prepared by cloning arms of homology flanking the targeted region into 
pYH7, a shuttle vector suitable for maintenance in both Escherichia coli and 
Streptomyces spp. The in-frame deletion constructs were introduced into the 
recipient Streptomyces sp. KO-7888 by conjugal DNA transfer from the methylation-
deficient E. coli ET12567, which bears a helper plasmid. The resulting exconjugants 
were subjected to alternate rounds of plating on agar with and without the selection 
                                                




antibiotic, to promote chromosomal integration and the subsequent loss of construct 
backbone by homologous recombination, and obtain the desired deletion. In-frame 
deletion mutants were confirmed by PCR (and DNA sequencing of the targeted 
regions), and were subjected to fermentation to check for the production of 
phthoxazolins.  
 From these mutagenesis attempts, in-frame mutants ΔphoxG (PKS-NRPS), 
ΔphoxI (PKS), ΔphoxJ (NRPS), ΔphoxR (PKS-NRPS), ΔphoxU (discrete 
dehydratase), ΔphoxV and Δorf+5 (SAM-dependent methyltransferases) were 
successfully generated. The production of phthoxazolins was not affected in ΔphoxG, 
ΔphoxI, ΔphoxJ, ΔphoxU, ΔphoxV and Δorf+5, indicating that they are not involved in 
the pathway. On the other hand, the deletion of phoxR abolished production (Figure 
3.19). This, for the first time, experimentally linked phthoxazolins to the cluster initially 
identified by genome mining.   
 
Point mutagenesis of carrier protein domains in phoxR 
PhoxR, which was shown to be essential for phthoxazolin biosynthesis, comprises 
three PKS modules and an NRPS module (Figure 3.20). The first PKS module 
(“module 13”) in PhoxR was predicted by bioinformatic analysis to incorporate the 
fifth malonate extender unit required for phthoxazolin biosynthesis, whereas the role 
of the remaining modules (“modules 14, 15 and 16”) are unclear. To investigate the 
biosynthetic role of individual modules in PhoxR, the attachment site of the 4'-PP 
“swinging arm” was precisely removed on each of the four ACP/PCP domains in turn, 
by carrying out point mutagenesis of the Ser residue to Ala.   
 As expected, inactivation of ACP13 abolished phthoxazolin production. 
Surprisingly, ΔPCP14-S2778A, ΔACP15-S4259A and ΔACP16-S5512A also 
produced little or no phthoxazolin (Figure 3.21). Traces of phthoxazolins could be 
seen in some but not all replicates of fermentation cultures. These results suggest 
that all four modules in PhoxR are involved in the biosynthetic pathway, potentially 
extending the polyketide-peptide chain by an additional Gly (incorporated by “module 
14”) and two additional malonate units (incorporated by “modules 15 and 16”) before 










Figure 3.19. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type 





Figure 3.20. Module and domain organisation of the hybrid PKS-NRPS PhoxR. 
Modules are indicated with brackets and numbered according to order of genes in 
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carrier protein; AT, acyltransferase; KS, ketosynthase; C, condensation; DH, 
dehydratase; KR, ketoreductase; A, adenylation; cMT, C-methyltransferase; DHt, 




Figure 3.21. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type, 
phoxR in-frame deletion and phoxR carrier protein point mutants. Selected ion 
monitoring of m/z [M+Na]+ 313.15 is shown.  
 
In silico analysis and overexpression of putative regulatory genes  
PhoxC and PhoxT are putative DNA binding proteins belonging to the xenobiotic 
response element (XRE) family of transcriptional regulators. Based on sequence 
homology with other XRE family-like regulators, both proteins were predicted to 
contain an N-terminal helix-turn-helix domain which presents residues for specific 
and non-specific DNA interactions as well as a conserved salt bridge to stabilise the 
helix-turn-helix structure (Beamer and Pabo, 1992; Padmanabhan et al., 1997; 
Luscombe et al., 2000) (Figure 3.22). Two additional genes, orf+11 and orf+12, were 










































proteins belonging to the Lrp/AsnC (leucine-responsive) and LysR families, 
respectively.  
 
PhoxC      GRRLQELRETA----GLKREEAAKVLRVAP-ATVRRMEMAEVALKIPYVQILLTAYGVASEEV 
PhoxT      GPLLRAWRERR----RVSQLELALRADSSA-RHISFVETGRSRPSEEMVLRLAEHLDVPVRER 
CAA24991   ARRLKAIYEKKKNELGLSQESVADKMGMGQ-SGVGALFNGINALNAYNAALLAKILKVSVEEF 
AAD41788   GSEIKKIRVMR----GLTQKQLSDNICHQ--SEVSRIESGAVYPSMDILQGIAAKLQVPIIHF 
CAB63661   LKRLRAERIAK----GMNQDEMAKAMGWHTRSSYAKRENGITTISATELVKMASILGYGTNQL 
CAB88448   GQELRRLRELK----GMTAEEVAERLLVSG-SKISRLENGRRSISQRGVRDLCGVYEVEDQRI 
CAC01451   GRQLRSLRRAA----GLTQLQLGLRVGYHH-SVVSRLEAGLREPPVGLVRRLDAVL-ETGGEL 
AAG32546   GQVFRFFREA-----RHISLSEATGGEFSK-SMLSRFENGQSELSAQKLFSALSAIHTETEEF 
 
Figure 3.22. Partial sequence alignment of XRE-family like regulators. Residues 
involved in specific (yellow) and non-specific (green) DNA binding, and salt bridge 
formation (cyan) are highlighted.  
 
 PhoxC, phoxT, orf+11 and orf+12 were individually cloned into the shuttle 
vector pIB139, immediately downstream of a strong constitutive promoter PermE. 
Following conjugation, the overexpression constructs were introduced into the 
chromosome at the attB attachment site in an integrase-dependent manner and 
stably maintained in the presence of a selection antibiotic. Loss of phthoxazolin 
production was observed in the strain with phoxC overexpressed (Figure 3.23), 
implying that PhoxC is possibly acting as a negative regulator of the pathway. In the 
other three strains, no obvious alteration in the production level could be observed. 
 
In-frame deletion of a putative global regulatory gene 
It has recently been reported that cryptic phthoxazolin production in S. avermitilis KA-
320 was activated via the disruption of an avaR3 homologue (Suroto et al., 2017). 
AvaR3 is a pleiotropic, γ-butyrolactone autoregulator receptor that has been shown 
indirectly to control the biosynthesis of other polyketide natural products such as 
avermectin and filipin, either positively or negatively (Miyamoto et al., 2011). AvaR3 
homologues (35% sequence identity) were identified in Streptomyces sp. KO-7888 
and Streptomyces sp. OM-5714, both distant from the phthoxazolin clusters. To test 
the idea that the AvaR3 homologues may play a similar regulatory role in our 
producer strains, an in-frame deletion was carried out. The signals corresponding to 
phthoxazolins in the wild-type and ΔavaR3 strains were comparable (no increase in 








Figure 3.23. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type 
and deletion of a putative AvaR3-like regulator. Selected ion monitoring of m/z 




Figure 3.24. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type 
and avaR3 homologue mutant. Selected ion monitoring of m/z [M+Na]+ 313.15 is 




























































3.2.8 Proposed biosynthetic pathway to phthoxazolins 
Based on in silico analysis and results obtained from mutagenesis experiments 
detailed earlier in this chapter, a preliminary proposal could be made for the 




Figure 3.25. Proposed biosynthetic pathway to phthoxazolins. Loading and 
extension modules 1 to 8 are indicated. PKS (orange) and NRPS (red) domains 
proposed to be involved in biosynthesis are shown. The domain predicted to be 
inactive is coloured in grey. Module numbering from Section 3.2.3 (according to gene 
order) are indicated below the modules. CP, carrier protein; MCoA, malonyl-CoA; 
CYP, cytochrome P450.   
 
The proposed pathway comprises two Gly-specific NRPS modules and seven 
malonyl-CoA-specific trans-AT PKS modules, which between them catalyse up to 
eight rounds of acyl/peptidyl chain extension. A presently unidentified enzyme 
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catalyses the release of the phthoxazolin A portion of the fully-extended chain. 
Phthoxazolin A may then be hydroxylated at C-10 by PhoxK, the only putative 
cytochrome P450 enzyme encoded within the cluster, to yield phthoxazolins B-D. 
Alternatively, PhoxK may catalyse the hydroxylation on PKS-NRPS-bound 





3.3 Concluding remarks and future work  
The unusually large trans-AT PKS-NRPS clusters governing phthoxazolin 
biosynthesis in Streptomyces sp. OM-5714 and Streptomyces sp. KO-7888 were 
subjected to detailed bioinformatic analysis and in vivo characterisation. All modules 
in the hybrid PKS-NRPS PhoxR were shown to be essential for phthoxazolin 
biosynthesis, whereas a number of other biosynthetic, tailoring and regulatory genes 
were found to be unnecessary for phthoxazolin biosynthesis. Through the 
overexpression of phoxC, the putative XRE-family like protein was identified as a 
likely candidate of the negative regulator of the cluster. The role of some genes in the 
cluster including phoxB, phoxL and phoxM, yet to be manipulated, still remain 
obscure and further work, ideally gene deletion/inactivation in combination with 
heterologous expression, would be required to delimit the cluster boundaries with 
confidence. Nevertheless, based on the preliminary work presented in this chapter, a 
biosynthetic pathway to phthoxazolins was proposed. The formation of the 5-oxazole 
and primary amide moieties, both key features of phthoxazolins, are investigated in 






Investigation of a key enzyme in phthoxazolin 





4.1.1 Oxazole-containing natural products  
Oxazoles are five-membered heterocycles containing a nitrogen atom and an oxygen 
atom. They are found in many natural products that are endowed with remarkable 
biological activities. Prominent examples include the 50S ribosomal subunit inhibitor 
virginiamycin M (Di Giambattista et al., 1989; Pulsawat et al., 2007), the antimitotic 
agents rhizoxin (Scherlach et al., 2006; Partida-Martinez and Hertweck, 2007) and 
disorazoles (Carvalho et al., 2005; Tierno et al., 2009), the DNA gyrase inhibitor 
microcin B17 (Li et al., 1996; Parks et al., 2007) and plantazolicin which targets the 
plasma membrane of Bacillus anthracis (Lee et al., 2008; Molohon et al., 2016) 
(Figure 4.1).  
 
4.1.2 Biosynthetic routes to oxazole and the related azol(in)e moieties  
The biosynthetic routes to 2,4-substituted azol(in)es in RiPPs and (polyketide-) non-
ribosomal peptides are well characterised. Early isotopic labelling studies revealed 
that the azol(in)e moieties originate from the amino acids Ser, Cys and Thr (Bayer et 
al., 1995; Lau and Rinehart, 1995). Although common biosynthetic precursors are 
utilised, the two classes of peptide natural products employ distinct enzymatic 
machineries and catalytic mechanisms to generate the heterocycles. In RiPPs, the 
heterocycles are created post-translationally using an ATP-dependent 
cyclodehydratase complex consisting of a YcaO-like cyclodehydratase, a 






Figure 4.1. Structure and microbial origin of oxazole-containing natural 
products.  
 
(discussed in Section 1.4.2). In contrast, NRPS modules utilise an embedded 
heterocyclisation (Cy) domain to introduce azoline moieties. An oxidase (Ox) domain 
is often present within the same module for the conversion of azolines to azoles 
(Bloudoff et al., 2017) (discussed in Section 1.4.7).  
On the other hand, the biosynthetic route to the relatively uncommon 5-
substituted oxazole moieties in polyketide-non-ribosomal peptides (including 
phthoxazolins, oxazolomycins and conglobatin), likely arising from a different 
mechanism, remains to be elucidated. This chapter presents the bioinformatic 
analysis, in silico structural modelling and in-frame deletion of phoxP, a proposed 
candidate for the cyclase catalysing 5-oxazole formation in phthoxazolin 










































































































4.2 Results and discussion 
4.2.1 Identification of candidate enzymes for 5-oxazole formation  
Comparative sequence analysis of the phthoxazolin, oxazolomyin and conglobatin 
clusters revealed that the three contiguous genes phoxO, phoxP and phoxQ have 
counterparts in both the other clusters (Figure 4.2). As discussed in Chapter 3, 
PhoxO, comprising an F domain, an A domain specific for Gly and a PCP domain, 
potentially serves as the loading module in phthoxazolin biosynthesis; and PhoxQ 
was predicted as the first extension module. Sequences of PhoxOQ and homologues 
are approximately 50% identical, whereas PhoxP and homologues share more than 
70% sequence identity, the highest amongst all three genes. This focused interest in 
the role and significance of PhoxP, a hypothetical protein of presently unknown 




Figure 4.2. Comparison of gene organisation of the phthoxazolin (phox), 
oxazolomycin (ozm) and conglobatin (cong) clusters. (A) Genes conserved 
across all three clusters are coloured and their amino acid sequence identities are 
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4.2.2 In silico analysis of PhoxP 
Two conserved protein domains were detected in PhoxP using protein-BLAST: a 
large N-terminal domain belonging to a subfamily of the adenine nucleotide α 
hydrolase (αANH)-like superfamily (Aravind et al., 2002); and a small C-terminal 
domain resembling the N-terminal domain of some ATP-dependent DNA ligases 
(Sekiguchi and Shuman, 1997) (Figure 4.3). Members of the αANH-like superfamily 
include N-type ATP pyrophosphatases and ATP sulphurylases, and form an α-ß-α-
fold which binds to the adenosine group. An N-terminal SGGKD motif is strongly 
conserved in multiple families of the superfamily, and this motif is also present in 
PhoxP and its homologues OzmP and CongE (Figure 4.4). Furthermore, 
phylogenetic anaylsis showed that PhoxP, OzmP and CongE form a distinct clade 




Figure 4.3. Protein-BLAST analysis of PhoxP. Yellow, αANH-like domain. Purple, 
DNA ligase N-terminal domain.   
 
CongE      -----------------------MRVCQICALKEEHPGVSLDDDGVCSLCRLGVVGDLLE 
PhoxP      MTGRPDATTPTAQPDPSVSPGGSVSSCQVCSLKAGHPGVVLDDQGVCNLCNLDFAEDLLV 
OzmP       -------------------MEPTIVRCKICSLKEGHPGIVLDDQRVCSLCNLDFAGDLLV 
 
CongE      NFSYTDQVHEEFTRSGPNPNGDYDCLFMYSGGKDSTYMLDKFVNEYGKRVLAYTFDVPFE 
PhoxP      NYRYTSEVFTEFQQAPPG-TGEYDCLFMYSGGKDSTYMLDKFANEYGKRVLAFTFDVPFE 
OzmP       NYKYTNEVFAEFQAAPPDPRGEFDCLFMYSGGKDSTYMLDKFVNEYGKRTLAYTFDVPFE 
 
CongE      SSHAADNIALAREKIPATFVLDSDDDNIKTVMREVFNRPVT-KPGKYLDEKLPCVSCRTF 
PhoxP      SEHAAQNIALAREKIPATFVLDADDDNIKLMMREVFNRPAPKKPGKYLDEKLPCVSCRTF 
OzmP       STHAAQNIKLAQEKLPATFVVDADDDNIKKMMRDVFNRPRPKKPGQYLDEKLPCVSCRTF 
 
CongE      FVIRAILYAFRNRIPYIALCADPQQILTMESDVREVVRGFYQTFGARLTDEVFRKEAEQI 
PhoxP      FVLRAILMAYRQKIPYIALCADPQQILTMESNVREIVRDFYKTFGERLVDTLFGGQLEEL 
OzmP       FVIRAILHAYREHIPYIALCADPQQILTMESNVREVVRGFYKSFGPELASELFDGEIEEI 
 
CongE      LFADDADLPKIVFPFIAMRYSYDPDRIVADLKAKGLYNSSPLETHCTLFPLLNYYSFKNW 
PhoxP      LFDDDENLPKIVFPFIAMRHEYDPDRIVEELRAKGLYQSSPMETHCTLFPLLNYYSYSNF 
OzmP       LFAEDDELPKIVFPFIAMRHDYDPDRMVAELKEKGLYASSPMETHCTLFPLLNYYSFKNW 
 
CongE      DCMFYKLNAASHRRAVRRNKNYDRSTFSITFPRAADLPSIEERMKRVVLDIAGTRGDPAA 
PhoxP      DCMFYKLNASSHVRSVKRNASYDRNTFSIKFPRSLDLADVEDRLGKVVKEIAAGEGDRDE 
OzmP       DCMFYKLNASSYTRAVSRNKDYDRSTFSIKFPRSLDLPEVEEKLKRVVLEIAAGEGDREQ 
 
CongE      HRRELIDIFRELGATEDAARFVTEGFLGMRTVAADLGITL-------------------- 
PhoxP      HERSLIDLFQRMDASEDAARFVARSFLDMRSVAADLGIRLS------------------- 
OzmP       HRAALVELFKQMDTTDDGAAFIAETFLDMRAVAADLGIKVG------------------- 
 
Figure 4.4. Complete sequence alignment of PhoxP and its homologues. The 







Figure 4.5. Phylogenetic tree of proteins belonging to the αANH-like 
superfamily. Evolutionary history was inferred using the maximum likelihood method 
(Jones et al., 1992). All positions containing gaps were eliminated and there were 
210 amino acids in the final dataset. Sequences were aligned with MUSCLE (Edgar, 
2004) and the evolutionary analysis was conducted in MEGA7 (Kumar et al., 2016). 
Functionally-characterised proteins are shown in bold. NAD+, β-nicotinamide adenine 
dinucleotide; GMP, guanosine monophosphate; PAPS, phosphoadenosine 
phosphosulphate.   
 
 As PhoxOPQ, OzmOPQ and CongAEB are highly conserved, it is tempting to 
suggest that hybrid PKS-NRPS pathways governing 5-oxazole-containing natural 
products share a common mechanism for 5-oxazole formation. The F domain-
containing loading module PhoxO possibly generate a formylated glycyl thioester 
which is subject to subsequent chain extension catalysed by the next module(s), 
PhoxQ (and PhoxN). PhoxP was proposed to catalyse 5-oxazole formation as a 
cyclodehydratase, via the nucleophilic attack of either the carbonyl keto group or the 































be a hint that PhoxP function alongside PhoxO and PhoxQ, early on in the 




Figure 4.6. Proposed mechanism of 5-oxazole formation in phthoxazolin 
biosynthesis. (A) Involving PhoxP and early modules of the pathway. (B) Potential 
mechanisms of ATP-dependent oxazole ring closure catalysed by PhoxP. CD, 
cyclodehydratase.  
 
4.2.3 In silico structural modelling of PhoxP and its homologues  
The structure of PhoxP was modelled in silico using the protein fold recognition 
server, Phyre2 (Kelley et al., 2015). Multiple templates were selected to maximise 
confidence and alignment coverage , as no structural homologue of PhoxP was 
available (Table 4.1 and Figure 4.7). 
 An open α/ß structure with one parallel ß-sheet was identified as the conserved 
ATP binding domain (Asp83-Lys273) (Figure 4.8), which is a fold common across 
members of the N-type ATP pyrophosphatases. The PP-loop (YSGGKDS) crucial for 
interaction with the ß- and γ-phosphates of ATP was found in this domain, towards 











































































the N-terminal end of α-helix-3. The sequences flanking the ATP binding domain 
appear to be unique to PhoxP and were modelled at a relatively low confidence, as 
none of the existing templates offer sufficient alignment coverage. They appear to 
form another domain that wraps around the side of ATP binding domain where the 
PP-loop is located. The structures of OzmP and CongE were also modelled using the 
same parameters, and they adopt a similar domain arrangement (Figures 4.9 and 
4.10). This domain-domain interface in PhoxP, OzmP and CongE may contribute to 
forming the active site as in many N-type ATP pyrophosphatases, and may facilitate 
the interaction between the putative ATP-dependent cyclodehydratases and their 
respective PKS-NRPS partner(s).  
 
Table 4.1. Alignment coverage, identify and confidence of templates used for 
the in silico structural modelling of PhoxP.  
PDB ID Function % Alignment coverage  % Identity % Confidence 
5UDW Sulfur transferase  40 14 99.4 
3VRH 2-Thiouridine synthetase  44 18 99.3 
5GHA 2-Thiouridine synthetase 
(TtuA) 
44 15 99.2 
3BL5 tRNA modifcation enzyme  35 18 99.1 
1XNG NAD+ synthetase  36 12 99.1 
2C5S tRNA modifcation enzyme  30 24 99.1 
1KH2 Argininosuccinate 
synthetase (AsS) 




Figure 4.7. Structural model of PhoxP. The N- and C- terminal ends, and the PP-
loop-containing α-helix-3 (α3) of the protein are indicated. Light blue, ATP-binding 









Figure 4.8. ATP-binding domain of PhoxP. Overlaid with the ATP-binding domain 
of two other N-type ATP pyrophosphatases, AsS (PDB: 1KH2) and TtuA (PDB: 





Figure 4.9. Structural model of OzmP. The N- and C- terminal ends, and the PP-
loop-containing α-helix-3 (α3) of the protein are indicated. Light green, ATP-binding 










Figure 4.10. Structural model of CongE. The N- and C- terminal ends, and the PP-
loop-containing α-helix-3 (α3) of the protein are indicated. Yellow, ATP-binding 
domain; orange, domain of unknown function; red, PP-loop.  
 
4.2.4 In-frame deletion of phoxP and gene complementation  
The in-frame deletion of phoxP yielded a mutant strain deficient in phthoxazolin 
production (Figure 4.11). In-trans gene complementations were performed with 
phoxP amplified from Streptomyces sp. KO-7888 and Streptomyces sp. OM-5714, 
expressed under the constitutive ermE promoter. Phthoxazolin production was 
restored in both complemented strains. This confirmed that PhoxP is essential for 
phthoxazolin biosynthesis. However, as no non-cyclised shunt products could be 
detected, the direct involvement of PhoxP in catalysing the oxazole ring closure could 
not be established at this stage. 
OzmP and congE, were also tested for their ability to complement ΔphoxP. 
ΔPhoxP::ozmP was able to produce phthoxazolins at a lower level compared to that 
of the phoxP-complemented strains, whereas the introduction of congE failed to 
restore production (Figure 4.11). This is somewhat surprising as the homologues 
show a comparable level of sequence homology to phoxP and are predicted to act on 
the same substrate, an enzyme-bound N-formylglycyl intermediate. A possible 
explanation would be that CongE lacks the crucial residues, which are conserved in 












Figure 4.11. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type, 
phoxP mutant and complemented phoxP mutants.  
   
4.2.5 Attempted reconstitution of 5-oxazole formation in vitro  
Cloning, expression and purification of PhoxNOPQS  
Genes encoding enzymes proposed to be involved in the early steps of phthoxazolin 
biosynthesis were amplified and cloned into the protein expression vectors, pET-
28a(+) and pET-29b(+). E. coli BL21(DE3) was used as the heterologous host. The 
pET systems are driven by the IPTG-inducible bacteriophage T7 promoter and 
contain terminal His tags for protein purification by Ni2+ affinity chromatography. 
Proteins were eluted from the affinity column with buffer containing an increasing 
concentration of imidazole and clean protein fractions were subject to buffer 
exchange and concentration with centrifugal filter units of an appropriate molecular 
weight cut-off.  The NRPS/PKS modules, PhoxO, PhoxQ and PhoxN (Val1-Gly1483), 









































the myxothiazol pathway, to obtain the multienzymes in their holo-form (Silakowski et 
al., 1999).  
The 300 mM imidazole elution fraction containing the 125.5 kDa PhoxO was 
concentrated using a 100 kDa cut-off filter (Figure 4.14), whereas the 100 mM to 300 
mM imidazole elution fractions were used for the other four enzymes (Figure 4.12). 
One-hundred kilodalton cut-off filters were used for PhoxN (Val1-Gly1483) (157.4 
kDa) and PhoxS (121.2 kDa), and 30 kDa cut-off filters were used for PhoxQ (93.1 
kDa) and PhoxP (46.2 kDa). The yields of PhoxN (Val1-Gly1483), PhoxO, PhoxP, 
PhoxQ, and PhoxS were 9.89, 0.28, 1.20, 8.16 and 19.9 mg L-1 culture, respectively.  
 
Cloning, expression and purification of FolD and the chemoenzymatic 
synthesis of the formyl donor N10-formyltetrahydrofolate  
FolD, encoding an NAD+-depdent formyltrasferase, was used to synthesise the 
formyl donor N10-formyltetrahydrofolate (N10-fH4F) required by the F domain from 
tetrahydrofolate (H4F) and formaldehyde, chemoenzymatically (Schönafinger et al., 
2006) (Figure 4.13). FolD was amplified from the genomic DNA of E. coli DH10B and 
cloned into pET-28(a). The 100 mM to 300 mM imidazole elution fractions containing 
the 33.2 kDa FolD were combined and concentrated using a 10 kDa cut-off filter 
(Figure 4.14). The yield of FolD was 39.5 mg L-1 culture.  
 The reaction mixture, consisting of H4F, formaldehyde, NAD+, β-
mercaptoethanol and purified FolD in potassium phosphate buffer (pH 6.0) was 
incubated at 21 °C for 2 hours. Product formation was monitored by UV spectroscopy 
at 340 nm. 
 
One-pot enzymatic assay  
Due to the instability of some of the larger multienzymes, the in vitro assay was 
carried out in a one-pot manner, instead of adding individual enzymes stepwise, to 
minimise processing and incubation time. The one-pot reactions consist of purified 
PhoxO, PhoxQ, PhoxN (Val1-Gly1483), PhoxS and PhoxP, ATP, MgCl2, Malonyl-
CoA, Gly (Ser or no amino acid for the controls), NADPH and the FolD reaction in 25 
mM Tris-HCl buffer (pH 7.5). PPTase and CoA were also added to convert modules 
still in their apo-form to holo-form. In a parallel set of experiments, pre-purification cell 
lysate of PhoxO, PhoxQ, PhoxN (Val1-Gly1483), PhoxS and PhoxP was used in 







Figure 4.12. SDS-PAGE of purification fractions of PhoxN (Val1-Gly1483), 




















































































































































































Figure 4.14. SDS-PAGE of purification fractions of FolD. Imidazole concentration 
of elution buffers is indicated.  
 
precipitated for subsequent thioester cleavage with potassium hydroxide. The treated 
samples were subjected to LC-MS analysis, but unfortunately no m/z peak 






















































































4.3 Concluding remarks and future work 
PhoxP was found to be essential for phthoxazolin production via an in-frame deletion 
experiment. PhoxP was proposed as an ATP-dependent cyclodehydratase to 
catalyse 5-oxazole formation on an enzyme-bound formylglycyl intermediate, 
unprecedented for oxazole formation, and possibly plays a key role in the initiation of 
phthoxazolin biosynthesis. PhoxP and its homologues from the oxazolomycin and 
conglobatin pathways show high sequence homology, indicative of a common and 
potentially novel biosynthetic route to incorporating the 5-oxazole(s) in hybrid PKS-
NRPS systems. Moreover, they represent a new clade of enzymes within the 
functionally-diverse adenine nucleotide α hydrolase superfamily. In silico structural 
modelling further revealed a conserved ATP binding domain and a seemingly novel 
domain fold that could be involved in facilitating the interaction between the putative 
cyclodehydratases and their protein partner(s). In vitro reconstitution of the early 
steps of phthoxazolin biosynthesis was attempted in a one-pot manner to validate the 
proposed catalytic role of PhoxP and the timing of 5-oxazole formation, but was 
unsuccessful. For future work, validation and optimisation of the individual steps of 
the in vitro reaction should be carried out. Point mutagenesis and crystallographic 
studies of PhoxP could also provide important insights into the mechanism of and 






Investigation of chain release and primary 




Another important question to address in phthoxazolin biosynthesis is the mode of 
chain release and primary amide formation. As discussed in Chapter 3, no 
thioesterase (TE) was identified in the phthoxazolin clusters; and the inactivation of 
the carrier proteins in PhoxR, the hybrid PKS-NRPS proposed to be involved in the 
last chain extension step(s), demonstrated that all four modules in the PhoxR are 
essential for phthoxazolin biosynthesis, implicating that a polyketide-peptide chain 
larger than phthoxaozlin may possibly be biosynthesised prior to release, via a 
presently unknown mechanism (see Section 3.2.7).  Also, no obvious candidate for 
catalysis of the installation of the primary amide moiety could be identified within the 
clusters. These findings prompted a search for the enzyme(s) responsible.  
 
5.1.1 Primary amides in natural product biosynthesis  
Primary amide moieties are often observed in peptide natural products, and to a 
lesser extent, in polyketides (Figure 5.1). A number of distinct biosynthetic routes to 
primary amides, catalysed by different enzymes have been reported.  
Asparagine synthetase B (AsnB)-like enzymes catalyse (primary) amide 
formation in various PKS, NRPS and RiPP pathways (Zhang et al., 2007; Wang et 
al., 2011, Tao et al., 2016). AsnB-like enzymes belong to a class of ATP-dependent 
glutamine amidotransferases and utilises Gln and ammonia as nitrogen donors 
(Figure 5.2A). For instance, OxyD in the oxytetracyline pathway (type II PKS) 
catalyses the amidation of a malonyl starter unit (Pickens and Tang, 2010), wheareas 
TsrC converts a carboxylate intermediate into the mature RiPP thiostrepton (Liao and 







Figure 5.1. Structure and microbial origin of primary amide-containing natural 
products.  
 
The biosynthesis of another RiPP nosiheptide employs a distinct strategy for 
amidation. The terminal dehydroalaninyl moiety derived from Ser of the extended 
precursor peptide was proposed to undergo tautomerisation to form a methyl imine 
intermediate, and NosA catalyses an enamide dealkylation to yield the mature 
nosiheptide with a primary amide moiety (Yu et al., 2011; Liu et al., 2015) (Figure 
5.2B). The biosynthetic pathways to several other thiopeptides including GE2270A, 
nocathiacin and berninamycin A were also shown or postulated to share a common 
mechanism for primary amide formation, catalysed by NosA homolgoues in the 
respective clusters (Tocchetti et al., 2013; Ding et al., 2010, Malcolmson et al., 2013). 
On the other hand, the hybrid PKS-NRPS pathways governing melithiazol 
and myxothiazol extend the polyketide-peptide chains with an additional Gly, and an 
integrated, luciferase-like monooxygenase (MOx) domain in the final NRPS module 





































































































intermediate, leading to the release of melithiazol A and myxothiazol A, respectively 
(Weinig et al., 2003; Müller et al., 2006) (Figure 5.2C). Furthermore, Jordan and 
Moore (2016) also speculated the role of Amm4, an F420-dependent oxidase, in 





Figure 5.2. Alternative biosynthetic routes to primary amides. (A) ATP-
dependent transamidation. (B) Enamide dealkylation. (C) Flavin-dependent oxidative 
peptide cleavage.  
 
This chapter presents the bioinformatic analysis and in-frame deletion of 
various candidate genes, both within and outside of the phthoxazolin cluster, thought 






























































5.2 Results and discussion 
5.2.1 Investigation of phoxE and phoxF 
In silico analysis of PhoxE, a putative α/ß hydrolase 
PhoxE belongs to the α/ß hydrolase fold superfamily (Figure 5.3). The α/ß hydrolase 
fold is common to a number of hydrolytic enzymes including bacterial lipases, serine 
peptidases, carbohydrate esterases and PKS/NRPS thioesterases (Lenfant et al., 
2012). As the only putative enzyme containing an α/ß hydrolase fold, PhoxE was 




Figure 5.3. Protein-BLAST analysis of PhoxE. Yellow, αß-fold hydrolase domain. 
 
In silico analysis of PhoxF, a putative NRPS containing a TD domain 
As discussed in Section 3.2.6, PhoxF encodes an unusual NRPS module comprising 
a PCP domain and a TD domain. All conserved motifs characteristic of an active 
reductase were identified from PhoxF-TD. The motifs are either fully conserved or 
have up to three residues substituted with similar amino acids. The domain was 
suspected to be responsible for the release of an aldehyde product, as observed in 
several other NRPS systems (Gaitatzis et al., 2001; Velasco et al., 2005; Bailey et 
al., 2007; Li et al., 2008). However, how the primary amide moiety in phthoxazolins 
may arise from an aldehyde is unclear. 
Another candidate for chain release previously identified within the cluster is 
the C-terminal C-domain in PhoxG. However, as described in Section 3.2.7, in-frame 
deletion of phoxG did not affect phthoxazolin production and so PhoxG-C2 was 
excluded from further investigation.  
 
In-frame deletion of phoxE and phoxF  
In-frame deletion mutants ΔphoxE and ΔphoxF were successfully generated. Neither 
of the mutants showed altered phthoxazolin production (Figure 5.4), and so PhoxE 
and PhoxF are not involved in the biosynthetic pathway and the enzyme responsible 








Figure 5.4. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type, 
phoxE mutant and phoxF mutant. Selected ion monitoring of m/z [M+Na]+ 313.15 
is shown.  
 
5.2.2 Investigation of an asparagine synthetase-like gene 
In silico analysis of Orf0034 
As asparagine synthetase B (AsnB)-like enzymes have been shown or proposed to 
catalyse primary amide formation in the biosynthesis of various natural products, the 
amino acid sequence of OxyD, the AsnB-like enzyme from the oxytetracycline 
pathway, was used to detect homologues in the genomes of the phthoxazolin 
producers, using an in-house protein-BLAST tool created by Dr. Markiyan 
Samborskyy. Orf0034, a gene putatively encoding an AsnB-like enzyme 32% 
identical to OxyD, was identified more than 1 Mbp away from the phthoxazolin 
clusters. The N-terminal Cys-Arg-Asn-Asp required for glutamine-dependent activity 
and the SGGLD ATP-binding motif are present in Orf0034 (Boehlein et al., 1996; 
Larsen et al., 1999) (Figures 5.5 and 5.6). However, the Leu, Val and Gln residues 
essential for ß-aspartyl-AMP intermediate formation are replaced with Phe, Ile and 

































Figure 5.5. Protein-BLAST analysis of Orf0034. Pink, asparagine synthetase 
B/glutamine amidotransferase superfamily domain. Green, N-terminal domain for 
glutamine binding and hydrolysis. Yellow, C-terminal domain for ATP, Mg2+ and Asp 
binding.  
 
AsnS         MCSIFGVFDIKTD-AVELRKKALELSRLMRHRGPDWSGIY----ASDNAILAHERLSIVD 
Orf0034      MCGIAGTYHWPDG-----KAVTDRLTEVLAHRGPDGAGRYSHPAGAGEVHLGHRRLAIVD 
FdmV         MCGIAGWVVRQDGRPREDPAVAEAMAGAMACRGPDEQGVR----GGRHVTLVHTRMAVID 
OxyD         MCGIAGWIDFERN-LAQERATAWAMTDTMACRGPDDAGLW----TGGHAALGHRRLAVID 
TueE         MCGIAGWVSYRRD-LTQQPQVLDGMNGTMACRGPDAGDTW----VGRHAALGHRRLAVID 
 
AsnS         VNA-GAQPLYNQ---QKTHVLAVNGEIYNHQALRAEYGD-RYQFQTGSDCEVILALYQEK 
Orf0034      LSGTGAQPMVSG-----GLALTYNGELYNAPELRRELESAGASFRGTSDTEVVLEAWRRW 
FdmV         LLG-GRQPMAADESEDPAATLTYCGEIYNAAELRSDLAGRGHRFRTRSDTEVVLRAYLEW 
OxyD         PAH-GRQPMHSTLPDGTSHVITFSGEIYNFRELRVELESQGHRFRTHCDTEVVLHGYTRW 
TueE         LPG-GAQPMRVGTGDGD-VVMVYSGETYNYTELRDELRRRGHRFTTESDTEVVLRGYVEW 
 
              // 
 
AsnS         ---AVKDNVTDKNELRQALEDSVKSHLMSDVPYGVLLSGGLDSSIISAITKKYAARRVED 
Orf0034      AEGQERARSGELPDLAAVVEESTRSHLLSDVPVATFLSGGLDSSYLTALAARH------- 
FdmV         ---HEEDLAGTVATVRGLLESSVARELVSDVPLSVLLSGGLDSSTVAALAARALADG--- 
OxyD         ---HTDDLETTIATVRGLLTDRVRRQLVSDVPLCTLLSGGLDSSAVTALAARA---G--- 
TueE         ---HTDDRQTTVARVRELLEDSISRQLVADVPRCTLLSGGLDSSVITAVAAQRLGER--- 
 
AsnS         QERSEAWWPQLHSFAVG------------LPGSPDLKAAQEVANHLGTVHHEIHFTVQEG 
Orf0034      -------RPGISAYTIGFRAEDARFEAM----PDDLRYARQVAARFGVDLHEIEIAPDVL 
FdmV         -D-----GGPVRTTTVTYSGYGDNFQPDLVRSAPDSPYARAVAEHIGAEHLEIELTTADL 
OxyD         -------DGPVRTFSVDFSGAGTRFQPDAVRGNTDAPYVQEMVRHVAADHTEVVLDSADL 
TueE         -------GETVRSFNVDFPGQAENFKAIALAPTLDTPYAHAVAEHVRSDHRDILLHGSAL 
 
 
AsnS         LDAIRDVIYHIETYDVTT----IRASTPMYLMSRKIKAMGIKMVLSGEGSDEVFGGYLYF 
Orf0034      D-LLPRM-T----YHLDEPI-GDPAAINTFLICSAAREAGVKVMLSGMGADELFAGYRKH 
FdmV         IDPVARR-TVLRAQDVPAPF-GDM-DTSTYQAFA-GVRRHSRVALTGESADEIFGGYSWV 
OxyD         AAPEVRA-AVLGATDLPPAFWGDM-WPSLYLFFR-QVRQHCTVALSGEAADELFGGYRWF 
TueE         ADPEVRR-AAVGARDFPNGI-GDR-DNSLHLLFK-AVREQSTVALSGESADELFGGYPWF 
 
Figure 5.6. Partial sequence alignment of AsnB and AsnB-like enzymes. OxyD, 
FdmV and TueE, AsnB-like enzymes from the oxytetracycline pathway in 
Streptomyces rimosus, fredericamycin pathway in S. griseus and Tü3010 pathway 
from S. olivaceus Tü 3010, respectively. AsnB, asparagine synthetase B in 
Escherichia coli K12, was included for comparison. The ATP binding motif and 
residues required for ß-aspartyl-AMP intermediate formation are highlighted in 







In-frame deletion of orf0034 
In-frame deletion of orf0034 was carried out and phthoxazolin production was not 
affected in Δorf0034 (Figure 5.7). This result suggests that the phthoxazolin pathway 
employs a mechanism distinct from that of the oxytetracycline, fredericamycin and 




Figure 5.7. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type 
and orf0034 mutant. Selected ion monitoring of m/z [M+Na]+ 313.15 is shown.  
 
5.2.3 Investigation of a luciferase-like monooxygenase gene in cluster 13 
In the light of the discovery of the two primary amide-containing lipopeptides by our 
collaborators Dr. Yuki Inahashi and Prof. Satoshi Ōmura (Kitasato Institute, Japan) 
(as discussed in Section 2.3), a closer examination of cluster 13, the NRPS cluster 
likely governing the production of the lipopeptides (see Section 2.2.4), was carried 
out. A luciferase-like monooxygenase gene orf3515 in Streptomyces sp. KO-7888 
(homologue of orf3228 in Streptomyces sp. OM-5714) was subjected to further 
investigation.  
 
In silico analysis of Orf3515 
Orf3515 belongs to the flavin-utilising monooxygenase superfamily (Figure 5.8), 
members of which include alkanesulfonate monooxygenases, nitrilotriacetate 
monooxygenases, alkanal monooxygenases and tetrahydromethanopterin 
reductases. Some of the residues implicated to be involved in the binding of the flavin 
cofactor are present in Orf3515 (Baldwin et al., 1995) (Figure 5.9). With the 
integrated monooxygenase (MOx) domain shown to be catalysing the release of the 


























Orf3515 may be responsible both the release of the lipopeptides and phthoxazolins, 




Figure 5.8. Protein-BLAST analysis of Orf3515. Red, luciferase-like 
monooxygenase domain.  
 
LuxA          MKFGNFLLTYQPPELSQTEVMKRLVNLGKASEGCGFDTVWLLEHHFTEFG-LLGNPYVAA 
Orf3515       MDLSLFYFAHDSTAPGEAGRYELLIEGAKLADRSGLAAVWTPERHFDPFGGAYPNPSVLG 
MelG-MOx      --FSLFYFASDERE-RSGDKYRLLMEGARFADEHGFTAVWTPERHFHSFGGIYPNPSVVS 
 
LuxA          AHLLGATETLNVGTAAIVLPTAHPVRQAEDVNLLDQMSKGRFRFGICRGLYDKDFRVFGT 
Orf3515       AAVAMCTQRVGIRAGSVVAPLHHPARIAEEWSVVDNLSGGRAGVAFASGWNTVDFALRPE 
MelG-MOx      AAIAATTRNLRIRAGSVVLPLHSPIRVAEEWSIVDNLSGGRVDLSFASGWHPNDFVLAPE 
 
LuxA          DMDNSRALMDCWYDLMKEGFNEGYIAADNEHIKFPKIQLNPSAYTQGGAPVYVVAESAST 
Orf3515       NHADRRALVRDTAEEVRRLWRGEALSTTDGLGRPVDIRAYPPA-VQPELPVWLTSAGGVD 
MelG-MOx      RYAGARGQLMSQIEAFQKLWRGEAVVFPNGLGQDVEVRTLPRP-IQPDVAIWLTAAGNPE 
 
LuxA          T-EWAAERGLPMILSWII-NTHEKKAQLDLYNEVATEHGYDVTKIDHCLSYITSVDHDSN 
Orf3515       TFRAAARMKAGILTHLLGQSLEEVAGKIAEYRRVAA-EEHDGWSGHVVLMLHTLLGDDLD 
MelG-MOx      TFRAAGERGLNVLTHLLGQNLAELAKKIQIYRDAWKAAGHGPGAGHVTLMLHTFLGEDRG 
 
LuxA          RAKDICRNFLGHWYDSYVNATKI-FDDSDQTKGYDFNKGQWRDFVLKGHKDTNRRID-YS 
Orf3515       QVREQVREPFTHYLKSSANLTAKSFT----GKDTDLSQLNADDMDYLA----ARAFDRYF 
MelG-MOx      AVRQKIQGPLREYLKSSVGLLRSVIGP--LPHGAEFESLSEADIDVLL----SKAIERYF 
 
Figure 5.9. Partial sequence alignment of flavin-dependent luciferase and 
luciferase-like monooxygenases. Residues involved in flavin-binding are 
highlighted in yellow. LuxA, luciferase α-subunit from Vibrio harveyi; MelG-MOx, 
luciferase-like monooxygenase domain from the melithiazol pathway.  
 
In-frame deletion of orf3515 
With the kind help of Dr. Katharina Dornblut, the in-frame deletion of orf3515 was 
successfully carried out. Encouragingly, phthoxazolin production was abolished in 
Δorf3515 (Figure 5.10). Gene complementation of the mutant is currently underway 
to confirm its involvement in the phthoxazolin pathway. Based on this provisional 
result, the putative flavin-dependent monooxygenase, Orf3515, appears to be a 
highly attractive candidate for catalysing the α-hydroxylation of the Gly-extended 
polyketide-peptide chain(s) on PhoxR to directly yield phthoxazolin A via non-







Figure 5.10. Phthoxazolin A production in Streptomyces sp. KO-7888 wild-type 
and orf3515 mutant. Selected ion monitoring of m/z [M+Na]+ 313.15 is shown. 
Peaks corresponding to phthoxazolin A is marked with an asterisk; the shift in 
retention time was due to the change of separation column in the LC-MS.  
 
5.2.4 Proposed mechanism of primary amide formation in phthoxazolin 
biosynthesis  
Similar to the melithiazol and myxothiazol pathways (Weinig et al., 2003; Müller et al., 
2006), we propose that the Gly-extended polyketide-peptide(s) on the hybrid PKS-
NRPS PhoxR are precursors to phthoxazolins. Orf3515, a flavin-dependent, 
luciferase-like monooxygenase coded by cluster 13, potentially catalyses α-
hydroxylation of Gly, and subsequent oxidative cleavage directly yields the primary 
amide phthoxazolin A (Figure 5.11). The first AT domain in PhoxS, belonging to the 
acyl hydrolase clade of trans-ATs (Jensen et al., 2012) (as discussed in Section 
3.2.5), may be responsible for the removal of the remnant chain(s) off the carrier 




Figure 5.11. Proposed mechanism of chain release and primary amide 

















































5.3 Concluding remarks and future work 
Orf3515, a putative luciferase-like monooxygenase encoded in cluster 13, was 
identified as a strong candidate for the catalysis of chain release and primary amide 
formation. Orf3515 was proposed as a flavin-dependent monooxygenase to α-
hydroxylate the Gly-extended polyketide-peptide chain(s) on PhoxR, yielding 
phthoxazolin A via oxidative cleavage. Gene complementation of the orf3515 in-
frame deletion mutant is currently underway to confirm its involvement in the 
phthoxazolin pathway. If confirmed, this would be another intriguing example of a 
remotely located gene playing an essential role in another biosynthetic pathway 
(Lazos et al., 2010; Li et al., 2018). For future work, in vitro assays could be carried 
out using purified Orf3515 and the proposed enzyme-bound (or the mimic of) Gly-
extended intermediates, to reconstitute the catalytic activity of the putative flavin-
dependent monooxygenase in chain release and primary amide formation and to 








Final remarks on phthoxazolin biosynthesis 
 
 
This short chapter summarises the findings on the characterisation of the trans-AT 
PKS-NRPS pathway to phthoxazolins, as described in Chapters 3, 4 and 5.  
 
The phthoxazolin biosynthetic gene cluster 
The unusually large phox clusters spanning 80.7 kbp were identified from the whole-
genome sequence of the phthoxazolin producers, Streptomyces sp. OM-5714 and 
Streptomyces sp. KO-7888. Bioinformatic analysis revealed the presence of more 
PKS/NRPS modules and domains than required for the biosynthesis of phthoxazolin 
(see Sections 3.2.2 and 3.2.3).  
This prompted the examination of the functional roles of genes and domains 
not thought to be involved in phthoxazolin biosynthesis, including phoxG, phoxI, 
phoxJ, phoxR (partial), phoxU and phoxV, via in-frame deletion experiments (see 
Section 3.2.7). The deletion of these genes, with the exception of phoxR, did not 
affect phthoxazolin production and the reason behind their presence in the cluster 
remains unclear. The phox cluster was also compared to the recently published 
cryptic phthoxazolin (ptx) cluster from S. avermetilis KA-320 (Suroto et al., 2017) 
(Figure 6.1). A similar gene organisation was observed: ptxHFEDCBA were identified 
as the counterparts of phoxINOPQRS and ptxG potentially encodes an NRPS fused 
with a C-terminal cytochrome P450 enzymatic domain, which corresponds to 
phoxJK. Counterparts of phoxLM and genes flanking the upstream region of phoxI 
and downstream region of phoxS were not identified in S. avermetilis KA-320, and 
are unlikely to be involved in phthoxazolin biosynthesis.  
Inactivation of individual acyl and peptidyl carrier protein domains in PhoxR 







Figure 6.1. Comparison of the gene organisation of the phthoxazolin clusters in 
Streptomyces sp. KO-7888 (phox) to that in S. avermetilis KA-320 (ptx). Phox 
genes demonstrated to be not required for phthoxazolin biosynthesis are indicated in 
dashed lines.  
 
biosynthesis. This provided first evidence that the polyketide-peptide chain may be  
extended beyond the phthoxazolin portion prior to release. This remains to be 
experimentally confirmed, perhaps by using substrate mimics in vivo to intercept, 
offload and detect intermediates from these modules (Riva et al., 2014; Ho et al., 
2017). It has clear implications for the mechanism of chain release (see below). 
 
Proposed mechanism for 5-oxazole formation   
PhoxOPQ were proposed as the candidate enzymes for 5-oxazole formation, based 
on sequence homology with their counterparts in the oxazolomycin and conglobatin 
pathways, OzmOPQ and CongAEB. PhoxP, encoding a hypothetical protein, was 
deleted in-frame which led to the loss of phthoxazolin production. The restoration of 
production by the complementation of phoxP in-trans confirmed that PhoxP plays an 
essential role in phthoxazolin biosynthesis (see Section 4.2.4). Although the attempt 
to reconstitute the catalytic activity of PhoxP alongside other Phox proteins in vitro 
was unsuccessful (see Section 4.2.5), PhoxP is proposed to act as an ATP-
dependent cyclodehydrase on a formylglycyl intermediate bound to one of the first 
modules in the pathway. PhoxP, OzmP and CongE together appear to represent a 
distinct clade of enzymes catalysing this novel function within the α-adenine 
nucleotide hydrolase superfamily.  
 
Proposed mechanism for chain release and primary amide formation 
The mechanism of chain release and primary amide formation were also investigated 
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The α-ß hydrolase PhoxE, the terminal reductase (TD) domain in PhoxF and the C-
terminal condensation (C) domain in PhoxG were initially considered as candidates 
for chain release, however, each were shown in turn not to be required for 
phthoxazolin biosynthesis. Also, an asparagine synthetase-encoding gene, orf0034, 
was identified distant from the phox cluster and was considered as a candidate for 
catalysis of the formation of the primary amide moiety of phthoxazolins starting from 
the corresponding carboxylic acid, as seen with several polyketides and non-
ribosomal peptides. However, the in-frame deletion of orf0034 did not affect the 
production of phthoxazolins.  
  In light of the recent discovery of two novel lipopeptides, both containing a 
primary amide moiety, produced by the phthoxazolin producer Streptomyces sp. KO-
7888 (Inahashi et al., manuscript in preparation), the corresponding NRPS cluster 
(cluster 13) that governs their biosynthesis (see Section 2.2.4) was re-examined. 
Orf3515, a luciferase-like monooxygenase-encoding gene was identified within the 
cluster, and it was subsequently deleted in-frame. The loss of phthoxazolin 
production was observed (see Section 5.2.3) and further work on the in-trans gene 
complementation of the mutant is currently underway to confirm its role in the 
phthoxazolin biosynthetic pathway.  
As the inactivation of individual carrier proteins in PhoxR by point 
mutagenesis resulted in the loss of phthoxazolin production (see Section 3.2.7), it is 
tempting to suggest that polyketide-peptide chain(s) longer than phthoxazolin may be 
biosynthesised prior to cleavage by Orf3515. As no phthoxazolin derivative 
containing additional extender units was detected, the cleavage possibly takes place 
on the enzyme-bound intermediate(s). Chain release in PKS and NRPS pathways by 
truncation is rare but not unprecedented. The myxothiazol and melithiazol pathways 
utilise an integrated flavin-dependent monooxygenase domain in the last module to 
hydroxylate the Gly-extended polyketide-peptide at the α-position, leading to the 
oxidative release of myxothiazol and a melithiazol precursor, respectively, both of 
which bear a primary amide moiety (Weinig et al., 2003). Zwittermicin A is also 
proposed to be liberated in a similar fashion from an Ala-extended chain (Kevany et 
al., 2009), in this case by a standalone monooxygenase. A further documented 
example of α-hydroxylation of a Gly residue in an NRPS is provided by the 
biosynthesis of the cyclodepsipeptide skyllamicin A in Streptomyces sp. Acta 2897 
(Pohle et al., 2011). The product of the gene sky39 is a flavin-dependent 
monooxygenase with 51% sequence identity to the MOx domain of MtaG, and the 




regenerate FMN for the monooxygenase. In this case, the resulting aminal appears 
to be stable to hydrolysis, and it is suggested that cleavage is prevented by the cyclic 
nature of the peptide (Pohle et al., 2011). 
Therefore, an analogous mechanism is proposed here for the phthoxazolin 
pathway: the remotely-encoded monooxygenase Orf3515 catalyses in-trans the α-
hydroxylation of the Gly residue in the extended polyketide-peptide(s), and the 
subsequent spontaneous cleavage of the N-C bond yields phthoxazolin A directly. If 
this mechanism is confirmed, by showing restoration of phthoxazolin production by 
in-trans complementation of  the orf3515 mutant with a wild type copy, this would 
provide a further example of an remarkable emerging feature of certain biosynthetic 
pathways, in which a remotely-located gene is required for the function of a 
biosynthetic gene cluster. Examples of this include the requirement for a remote 
acetyltransferase gene for the production of the iron-chelating peptide erythrochelin 
in S. erythraea (Lazos et al., 2010) and the requirement for the remotely-encoded 
methyltransferase GenL for the terminal methyl transfer step in the formation of the 
gentamicin C complex in Micromonospora echinospora (Li et al., 2018). 
Figures 6.1 and 6.2 show the gene organisation and the proposed 
biosynthetic pathway to phthoxazolins, respectively, revised according to this work. 
The hydroxylation by PhoxK, a putative cytochrome P450 enzyme, is tentatively 
proposed to be the terminal step in biosynthesis, but it cannot be excluded that 





Figure 6.2. Gene organisation of the phthoxazolin cluster (revised). MOx, 
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Figure 6.3. Proposed biosynthetic pathway to phthoxazolins (revised). CD, 
cyclodehydratase; MOx, monooxygenase; Cyp, cytochrome P450.  
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Enzymatic logic of the biosynthesis of the 




7.1.1 Benzoxazole-containing natural products  
Benzoxazoles are bicyclic heterocycles consisting of a benzene-fused oxazole 
moiety. Benzoxazole-containing natural products exhibit antibacterial, antiviral, 
antifungal, herbicidal, insecticidal and anti-proliferative activities (Figure 7.1). The 
aromatic and lipophilic planar structure of the benzoxazole moiety and the 1-oxygen 
and 3-nitrogen atoms potentially acting as hydrogen bond acceptors contribute to the 
molecular interactions with biological targets (Lin et al., 2004; Demmer and Bunch, 
2015). Also, substituted benzoxazoles are the isosters of nucleotides and may 
interact with nucleic acids and/or other structures comprising nucleotides. 
Streptomyces spp. produce many of the benzoxazole antibiotics including 
calcimycin, cezomycin, UK-1 and AJI9561. Due to their potent bioactivities, 
benzoxazole antibiotics attracted much interest in the fields of medicinal and 
synthetic chemistry (Kumar et al., 2002; McKee and Kerwin, 2008). However, the 
biosynthetic routes to this structurally unique class of natural products were rather 
underexplored until recently. Only the calcimycin cluster was reported prior to start of 
the work on AJI9561 in this laboratory (Wu et al., 2011).  
 
7.1.2 AJI9561 biosynthetic gene cluster  
AJI9561 is a bis(benzoxazole) antibiotic isolated from the soil bacterium 
Streptomyces sp. AJ9561 (Sato et al., 2001). It possesses antibacterial activity 
against S. lividans JT46, S. albus J1074 and Micrococcus luteus, and cytotoxic 







Figure 7.1. Structure, microbial origin and bioactivities of benzoxazole-
containing natural products.   
 
been elucidated but it is believed to share the same mechanism of metal ion-
mediated DNA binding, as with the structurally similar UK-1 and nataxazole (Deluca 
and Kerwin, 1997).  
   The AJI9561 producer strain, Streptomyces sp. AJ9561, was sequenced and 
assembled in-house by the DNA Sequencing Facility (Department of Biochemistry). 
From the whole-genome sequence, the AJI9561 (aji) cluster was identified and 
annotated by Dr. Qiulin Wu (Figure 7.2 and Table 7.1). The aji cluster spans 20.0 kbp 
and comprises of 12 ORFs putatively encoding a major facilitator superfamily (MFS) 
transporter, a TetR family transcriptional regulator, a 6-methylsalicylic acid (6-MSA) 
synthase (6-MSAS), four enzymes responsible for 3-hydroxyanthranilic acid (3-HAA) 
biosynthesis, a 4'-phosphopantetheinyl transferase (PPTase), two ATP-dependent 















































































Figure 7.2. Gene organisation of the aji cluster in Streptomyces sp. AJ9561. 
 
Table 7.1. Properties of genes within the aji cluster in Streptomyces sp. 
AJ9561. MFS, major facilitator superfamily; 6-MSAS, 6-methylsalicylic acid synthase; 
DHB, dihydroxybenzoate; ADIC, 2-amino-2-desoxyisochorismate; DAHP, 3-deoxy-D-
arabino-heptulosonic acid 7-phosphate.  
Gene Size 
(aa) 





ajiT 516 MFS transporter Streptomyces sp. 
SAT1 
84/91 ANH93872.1 





ajiB 1751 6-MSAS Streptomyces sp. 
Tu 6176 
83/88 CEK42827.1 
ajiA1 436 ATP-dependent ligase Streptomyces spp. 90/94 WP_018564638.1 
ajiG 347 3-oxoacyl ACP synthase Streptomyces spp. 93/95 WP_018564639.1 
ajiA2 540 ATP-dependent ligase Streptomyces sp. 
PsTaAH-124 
85/92 WP_018564640.1 
ajiP 88 ACP Streptomyces sp. 
PTY087I2 
71/88 WP_079137835.1 










ajiD 222 Isochorismatase Streptomyces sp. 
SAT1 
80/85 WP_079159103.1 





ajiF 495 DAHP synthase Streptomyces sp. 
SAT1 
81/86 WP_107440699.1 






ATP-dependent ligase3-Oxoacyl-ACP synthase 3-HAA biosynthesis
6-MSA biosynthesis
AmidohydrolaseACP





In both ATP-dependent ligases, AjiA1 and AjiA2, an adenylate forming 
domain containing an AMP binding site was identified. The family of adenylate 
forming enzymes, including the A domain in NRPSs, acyl-CoA ligases and aryl-CoA 
ligases, catalyses the ATP-dependent activation of a carboxylate substrate and the 
transfer of the resulting adenylate to the pantetheinyl group of either CoA or an/a 
acyl/peptidyl carrier protein. AjiA1 and AjiA2 showed high sequence similarities to 
coenzyme F390 synthetases and 2,3-dihydroxybenzoate-AMP ligases, respectively.  
AjiG belongs to the initiating condensing enzyme subclass of the 
decarboxylating/condensing enzyme family. This family of enzymes are involved in 
the biosynthesis of fatty acids, phospholipids and polyketide natural products. AjiG 
shows a high sequence similarity to 3-oxoacyl-ACP and a dimer interface was 
detected using protein-BLAST. It possesses a Cys-His-His catalytic triad, which is 
characteristic of condensaiton enzymes that act on ACP thioesters (as opposed to 
CoA substrates) exclusively (Heath and Rock, 2002). 
AjiP contains a putative phosphopantetheine-binding domain and shows high 
sequence similarity to other carrier proteins in PKS and NRPS pathways.  
AjiH belongs to the metallo-amidohydrolase superfamily. Metallo-
amidohydrolases are evolutionarily divergent and functionally versatile. They catalyse 
the hydrolysis of C-N, C-C, C-O, C-Cl, C-S and O-P bonds as well as non-hydrolytic 
reactions including decarboxylation, hydration and isomerisation (Holm and Sander, 
1997; Seibert and Raushel, 2005). Moreover, dihydroorotases catalyse the 
cyclisation of N-carbamoyl-L-Asp to L-dihydroorotate in pyrimidine biosynthesis 
(Figure 7.3). Some members of the cyclic amidohydrolase family are also capable of 
catalysing cyclisation reactions as the reverse reaction.  
 The putative PPTase, AjiI is likely responsible for the conversion of apo-AjiB 
and apo-AjiP to holo-AjiB and holo-AjiP, respectively. 
 
Biosynthesis of 6-methylsalicylic acid (6-MSA) 
One of the precursors to AJI9561, 6-MSA, is predicted to be produced by AjiB, 
annotated as a 6-MSA synthase (6-MSAS). The type I iterative PKS AjiB comprises 
of five enzymatic domains including a ketosynthase (KS) domain, an acyltransferase 
(AT) domain, a thioester hydrolase (THID) domain, a ketoreductase (KR) domain and 
an ACP domain. With the use of an acetyl-CoA starter unit and three malonyl-CoA 
extender units, 6-MSAS catalyses the formation of a 5-hydroxytetraketide which 
undergoes intramolecular aldol condensation, dehydration, aromatisation and 






Figure 7.3. Biosynthesis of 6-MSA catalysed by 6-MSAS. 
 
Biosynthesis of 3-hydroxyanthranilic acid (3-HAA)  
AjiCDEF form a subcluster in the aji cluster and together encode enzymes potentially 
involved for the biosynthesis of the other precursor 3-HAA (Figure 7.4). AjiF is a 3-
deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthetase. DAHP synthetase  
catalyses the first step of the shikimate pathway for chorismate biosynthesis, the 
condensation of phosphoenolpyruvate (PEP) and D-erythrose-4-phosphate (E4P) to 
give rise to DAHP. Chorismate from the shikimate pathway is then converted to 2-
amino-4-deoxychorismic acid (ADIC) by ADIC synthase AjiE via the nucleophilic 
attack of the side chain nitrogen of glutamine on C2 with the elimination of the C4 
hydroxyl group. The isochorismatase AjiD cleaves the enoylpyruvate side chain of 
ADIC to yield trans-2,3-dihydro-3-hydroxyanthranilic acid (DHHA). AjiC, a short-chain 
oxidoreductase, catalyses an oxidation reaction, aromatising DHHA to 3-HAA 















































































7.1.3 In vitro reconstitution of AJI9561 biosynthesis 
Dr. Qiulin Wu and Joachim Hug purified Aji enzymes and reconstituted the AJI9561 
biosynthetic pathway in vitro, allowing the functional role of individual enzymes to be 
established experimentally.   
 
Activation of 3-HAA and 6-MSA 
The precursors 3-HAA and 6-MSA were incubated individually with the ATP-
dependent ligases, AjiA1 and AjiA2. In the presence of ATP and MgCl2, the 
incubation of 6-MSA with AjiA2 enabled the activation and subsequent loading of 6-
MSA to the ACP AjiP (Figure 7.5), whereas the addition of AjiA1 to 3-HAA lead to the 
complete conversion of 3-HAA to a 3-HAA dimer (1) (Figure. 7.6). The ATP-
dependent ligases are substrate specific and did not act on the other precursor.  
As the 3-HAA dimer (1) could either be amide-linked or ester-linked, a 15N-
labelled 3-HAA dimer was enzymatically synthesised from chorismate and 15N-
glutamine, using CalB1, CalB2, CalB3 (homologues of AjiE, AjiD and AjiC in the 
calcimycin pathway) and AjiA1 for structural elucidation. 15N and 1H NMR analysis of 









































Oxazole ring closure catalysed by the amidohydrolase-like AjiH  
The functional role of AjiH was first established via a one-pot reaction containing 3-
HAA, AjiA1, ATP, MgCl2 and the amidohydrolase-like AjiH (Figure 7.7). 3-HAA was 
converted efficiently to the 3-HAA oxazole dimer (2) containing the benzoxazole 




Figure 7.7. Proposed biosynthetic route to the 3-HAA oxazole dimer (2) 
catalysed by AjiA1 and AjiH.  
 
Formation of 3-HAA oxazole dimer-6-MSA trimer and AJI9561  
The 3-HAA oxazole dimer (2) was isolated and used as a substrate for downstream 
reactions. AjiG, the 3-oxoacyl-ACP synthase, catalysed the condensation between 
AjiP-6-MSA and the isolated 3-HAA oxazole dimer (2) to afford the 3-HAA oxazole 
dimer-6-MSA trimer (3). Step-wise addition of amidocyclase AjiH to the same 
enzymatic reaction lead to the cyclisation of the second oxazole ring to form the final 
product, the bis(benzoxazole) AJI9561 (Figure 7.8). Both reactions have a 
conversion rate of less than 5%. AJI9561 was also detected in a one-pot reaction 
containing 6-MSA, 3-HAA and all five Aji enzymes, though the efficiency of this 




Figure 7.8. Proposed biosynthetic route to the 3-HAA oxazole dimer-6-MSA 

























































7.1.4 Proposed biosynthetic pathway to AJI9561 
The proposal for the biosynthetic pathway to AJI9561 was based on bioinformatic 
analysis, the in vitro reconstitution of AJI9561 biosynthesis using purified Aji enzymes 
and structural elucidation of isolated pathway intermediates (Figure 7.9). It is unclear 
whether or not AJI9561 could arise from alternative intermediates, such as the 3-




Figure 7.9. Proposed biosynthetic pathway to AJI9561. 
 
7.1.5 Comparative sequence analysis of clusters governing AJI9561 and 
other (bis)benzoxazole natural products   
During the course of this project, the genetic studies of biosynthetic pathways 
governing three other (bis)benzoxazole natural products, nataxazole, A33853 and 
caboxamycin, were published by two independent groups (Cano-Prieto et al., 2015; 
Lv et al., 2015; Losada et al., 2017). Each gene in the AJI9561 biosynthetic gene 
cluster was aligned against these three clusters and several homologues were 
identified (Figure 7.10).  
Nataxazole is a methyl ester derivative of AJI9561, produced by 
Streptomyces sp. Tü 6176. Like AJI9561, the bis(benzoxazole) nataxazole is also 
assembled from two units of 3-HAA and a unit of 6-MSA. NatL2/S/L1/AC1/AM were 





















































Figure 7.10. Comparative sequence analysis of clusters governing 
(bis)benzoxazole natural products.   
 
identity (80-92%). Moreover, gene inactivation of natR3, encoding a TetR family 
transcriptional regulator, lead to an increase of nataxazole production (Cano-Prieto et 
al., 2015). As ajiR is highly similar to natR3, the biosynthesis of AJI9561 may be 
regulated in a similar fashion.    
A33853 is composed of two units of 3-HAA and one unit of 3-hydroxypicolinic 
acid (3-HPA), and contains one benzoxazole moiety formed between the two 3-HAA 
units. The gene cluster responsible for A33853 biosynthesis was identified in 
Streptomyces sp. NRRL 12068 (Lv et al., 2015). In addition to 3-HAA biosynthetic 
genes, genes responsible for 3-HPA biosynthesis are present. The AjiA1/G/A2/P/H 
homologues in this pathway, BomJKLMN, display lower levels of sequence identity 
(42-62%) to the AJI9561 equivalents than do those in the nataxazole pathway. The 
amide between 3-HAA and 3-HPA is not cyclised, potentially due to the inability of 
BomN to accommodate 3-HPA. The bomN deletion mutant produced the non-
cyclised 3-HAA dimer and 3HAA dimer-3HPA trimer, which is indicative of the role of 
BomN in oxazole ring formation and in accordance with our findings regarding AjiH in 
vitro.  
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Caboxamycin is produced by Streptomyces sp. NTK937 and its scaffold is 
formed from one unit of each of 3-HAA and salicylic acid (SA). Unlike 6-MSA, SA is 
not biosynthesised by a PKS but by a salicylate synthase which belongs to the 
superfamily of chorismate binding enzymes. The genes responsible for assembly and 
benzoxazole formation are also found in this gene cluster, with the homologue of 
AjiA1 missing as 3-HAA activation is not required in this pathway. It was shown that 
caboxamycin biosynthesis is positively regulated by CbxR, a SARP family 
transcriptional regulator (Losada et al., 2017).  
Comparative genome analysis revealed that homologues of the set of genes 
involved in benzoxazole formation in the AJI9561 pathway were found in all three 
other biosynthetic gene clusters, suggesting a common biosynthetic route is shared 
among members of this unique class of (bis)benzoxazole natural products. A second 
copy of ATP-depedent ligase responsible for the activation and dimerisation of 3-
HAA may or may not be present, depending on whether the final product is 
assembled from three or two precursor units.  
This chapter begins with a detailed study of the amidocyclase AjiH via 
phylogenetic analysis and in silico structural modelling, to explore the relationship 
between AjiH and other members of the metallo-amidohydrolase superfamily and to 
gain insight into its mechanism of oxazole ring cyclisation. Attempts to reconstitute 
the single cyclisation reaction on the isolated 3-HAA amide dimer (2) catalysed by 
AjiH, and to reconstitute AJI9561 biosynthesis using the isolated 3-HAA amide dimer 
(2) (instead of 3-HAA) are also described. Moreover, the investigation of alternative 
routes to AJI9561 biosynthesis via the formation of 3-HAA-6-MSA heterodimers or 3-





7.2 Results and discussion 
7.2.1 Phylogenetic analysis of AjiH 
As the metallo-amidohydrolase superfamily comprises a large set of evolutionarily-
related but highly divergent enzymes catalysing many different reactions, the 
Sturcture-Function Linkage Database (SFLD) was used to investigate the 
amidocyclase AjiH by comparison to/against other members of the superfamily 
(Akiva et al., 2014). SFLD utilises manually-curated multiple sequence alignment of 
protein superfamilies and their corresponding Hidden Markov model (HMM) to 
generate sequence alignments. The metal-binding His and Asp residues essential for 
the superfamily’s function were all identified in AjiH (Figure 7.11). Moreover, AjiH was 
shown to be the most closely related to the guanine deaminase, 
formimidoylglutamate deiminase and imidazolonepropionase protein families.  
 
3892028  AFNKPKVELHVHLDGAIKPET      LFPGHVEAYEGAVKNG-IHRTVHAGE-  // 
61229328 ISEAGFTLTHEHICG----SS      FQELVLKAAARASLATGVPVTTHTA--  // 
13194736 VVSPGFIDSHTHDDNYL----  //  STEEIIEVCRPLITHG-GVYATHMRD-  // 
137070  IVTAGGIDTHIHW--------      TPAAIDCALTVADEMD-IQVALHSDTL  // 
AjiH  MVLPGFVNAHWHEMFAM-GFT      TDELARGMADLVARHD-LPFATHVGA-  // 
 
3892028  L----K-------TERVGHGYH      TTHAVVRFKNDK-----ANYSLNTDDP  //   
61229328 F----ESEGLSPSRVCIGHSDD      WQTRALLIKALIDQGYMKQILVSNDWL / / 
13194736 GRELDV-------PVVISHHKV  //  EPDVQRILA--F-----GPTMIGSDGL / /  
137070  G----R-------TIHTFHTEG      TIAAEDVLHDLG-----AFSLTSSDSQ / / 
AjiH  ET--GT-------RRLAEHGLV      ETGVVPALRRAG-----LDVSLSTDAA  // 
 
Figure 7.11. Partial alignment of AjiH and members of the metallo-
amidohydrolase superfamily. The highly conserved metal-binding residues 
discussed in the text are highlighted in yellow. NCBI GI numbers of the enzymes are 
shown. The alignment was generated using the Structure-Function Linkage 
Database (SFLD) (Akiva et al., 2014). 
 
A phylogenetic tree comprising selected members of the superfamily 
including AjiH and its counterparts in the nataxazole (nat), A33853 (bom) and 
carboxamycin (cbx) pathways, was generated using MEGA7 (Kumar et al., 2016) 
(Figure 7.12). The amidocyclases involved in benzoxazole formation form a distinct 








Figure 7.12. Phylogenetic tree of members belonging to the metallo-
amidohydrolase superfamily. The evolutionary history was inferred using the 
maximum likelihood method (Jones et al., 1992). All positions containing gaps and 
missing data were eliminated. There were a total of 159 amino acids in the final 
dataset. The evolutionary analysis was conducted in MEGA7 (Kumar et al., 2016). 
  
7.2.2 In silico structural modelling of AjiH 
The structure of AjiH was modelled in silico using Phyre2 (Kelley et al., 2015).  
Multiple crystal structures of metallo-amidohydrolases were used as templates (Table 
7.2).  
 
Table 7.2. Alignment coverage, identify and confidence of templates used for 
the in silico structural modelling of AjiH.  
PDB ID Function % Alignment coverage  % Identity % Confidence 
4V1X Atrazine chlorohydrolase 97 22 100 
4DYK Adenosine deaminase 95 24 100 
4DZH Adenosine deaminase 95 22 100 
4F0R Adenosine deaminase 95 22 100 
3LNP  Adenosine deaminase 95 21 100 


























Although the amino acid sequence similarity is low within the superfamily, 
metallo-amidohydrolases shows a common overall three-dimensional structure, 
which was also observed for the structural model of AjiH. AjiH has a TIM barrel 
consisting eight alternating ß-sheets and α-helices, with the α-helices wrapped 
around the ß-barrel, and a smaller domain made of the N-terminus and C-terminus of 
the protein (Figure 7.13). Both domains are characteristic of the superfamily.  
Using RaptorX binding site prediction (Källberg et al., 2012), a putative active 
site pocket comprising His75, His77 Phe80, Asp108, Ile112, Thr115, Trp178, Ser226, 
His253, Ala256, Lys315, Asp345 and Leu349 was identified from the middle four ß-
sheets in the TIM barrel (Figure 7.14). AjiH likely constitutes a mononuclear divalent 
metal centre coordinated by the His and Asp residues in the active site, as the Lys or 
Glu residues required in the coordination of binuclear and multinuclear centres are 
absent. Above the metal binding site, a cavity potentially for substrate binding was 
observed. The aromatic residues, Phe80 and Trp178, on either side of the pocket 




Figure 7.13. Structural model of AjiH. (A) The TIM barrel (blue) and the smaller 
domain (purple) of AjiH. The N-terminus and C-terminus are indicated. Resides in the 
predicted active site pocket are shown as sticks. (B) AjiH (blue) overlaid with AtzA 
(PDB ID: 4V1X; green), an atrazine chlorohydrolase from Pseudomonas sp. DSM 
11735, and MtaD (PDB ID: 4F0R; light green), an adenosine deaminase from 









Figure 7.14. Predicted active site pocket of AjiH. The metal ion is shown as a grey 
sphere. 
 
7.2.3 Attempted in vitro reconstitution of the single cyclisation reaction 
catalysed by AjiH 
To confirm that the amidocyclase AjiH converts the 3-HAA amide dimer (1) to the 3-
HAA oxazole dimer (2) as well as to determine its co-factor requirement, the 
reconstitution of the single reaction catalysed by AjiH was attempted under various 
conditions. Protein expression constructs and strains described in this chapter were 
designed and generated by Dr. Qiulin Wu and Joachim Hug (Hug, 2015).  
 
Enzymatic synthesis of 3-HAA amide dimer 
The ATP-dependent ligase AjiA1 was expressed in Escherichia coli BL21(DE3) 
bearing pET-28a(+)-ajiA1 and purified using Ni2+ affinity chromatography (Figure 
7.15). The 3-HAA dimerisation reaction contained 0.5 mM 3-HAA, 5 µM purified 
AjiA1, 5 mM ATP and 10 mM MgCl2 in 25 mM HEPES buffer (pH 8.1). The reaction 
extract was subjected to analysis using LC-MS (Figure 7.16), and the eluate fraction 
containing the 3-HAA amide dimer (1) was collected.  
 
Attempted reconstitution of the AjiH-catalysed cyclisation reaction 
The amidocyclase AjiH was expressed in Streptomyces coelicolor CH999 bearing 
pCJW93-ajiH and purified using Ni2+ affinity chromatography (Figure 7.17). The AjiH 
reaction contained 0.25 mM 3-HAA amide dimer (1), 1 µM purified AjiH, 5 mM ATP 
























Figure 7.16. LC-MS analysis of the AjiA1 reaction. The reaction containing no 





















































analysed using LC-MS. Unexpectedly, the 3-HAA oxazole dimer (2) could not be 
detected and no obvious decrease of the 3-HAA amide dimer (1) was observed, 
despite the successful and efficient conversion of 3-HAA to the 3-HAA oxazole dimer 





Figure 7.18. LC-MS analysis of the AjiH reactions. The presence or absence of 
AjiH is indicated and the one-pot reaction containing 3-HAA, AjiA1 and AjiH (positive 
control) is shown for comparison.  
 
Various conditions were further tested in hope of enabling the cyclisation 
reaction to take place. At first, it was suspected that the interaction with protein 
partner(s) of AjiH (i.e. AjiA1 in this case) or the possible by-products of the AjiA1 
reaction may be required for the catalytic function of AjiH. So, AjiA1 and AMP were 
added individually to the reaction but none of them lead to the formation of the 3-HAA 
oxazole dimer (2). Furthermore, as it was reported that some members of the 
amidohydrolase superfamily favour the ring closing reactions at lower pH (Gojkovic et 
al., 2003; Porter et al., 2004; Hobbs et al., 2012; Grande-García et al., 2014), 25 mM 
MES buffer (pH 5.5), MOPS buffer (pH 6.5), HEPES buffer (pH 6.8), Tris-HCl buffer 
(pH 7.0 and 7.5) were used in place of 25 mM HEPES buffer (pH 8.1). However, the 
cyclisation still did not take place. The possibility of metal chelation by the aromatic 3-
HAA amide dimer (1) in preventing it from being processed by AjiH was also 
considered. However, the addition of ethylenediaminetetraacetic acid (EDTA) had no 

































Investigation of the true substrate of AjiH  
These results raised questions regarding the identity of the true substrate of AjiH. In 
addition to the 3-HAA amide dimer (1), two alternative substrates including the dimer 
adenylate and the 3-HAA ester dimer were considered as candidates.   
First, to investigate whether or not AjiA1 is capable of producing an adenylate 
form of the dimer, the ATP/3-HAA stoichiometry was determined using the 
EnzChek™ Pyrophosphate Assay Kit (Figure 7.19). As only one molecule of ATP 
appeared to be required for two molecules of 3-HAA to be dimerised, and since the 
3-HAA dimer adenylate was never observed from the AjiA1 reaction, it is unlikely that 




Figure 7.19. ATP/3-HAA stoichiometry of the AjiA1 reaction. 
 
On the other hand, members of the metallo-amidohydrolase family are known 
to act on amide and/or ester substrates (Seibert and Raushel, 2005). As an ester 
carbonyl is more electrophilic and theoretically more prone to a nucleophilic attack 
than an amide carbonyl, it is tempting to propose that an ester-linked 3-HAA dimer 
would serve as a more energetically-favourable substrate. Although the isolated, 15N-
labelled product of the AjiA1 reaction was determined by NMR analysis (Hug, 2015), 
the possibility of an ester-linked dimer being formed first and undergoing an acyl shift 
to form the more stable amide (during isolation) could not be ruled out.  
In silico docking of both the amide-linked and the ester-linked dimers to the 
AjiH model was attempted using SwissDock (Grosdidier et al., 2011a; 2011b), but 
was unsuccessful. The loops at the opening of the TIM barrel, were modelled at a 
relatively low level of confidence, and could possibly be restricting access of the 

































To examine the potential of AjiA1 in ester formation, AjiA1 reactions were 
carried out with two alternative substrates, 3-hydroxybenozic acid (3-HBA) and 2,3-
aminomethylbenzoic acid (2,3-AMBA), respectively. A peak corresponding to a dimer 
product was observed in the reaction containing 3-HBA but not 2,3-AMBA (Figure 
7.20). The result demonstrates AjiA1’s ability to form an ester bond in the absence of 
the amine group. Nevertheless, it does not necessarily imply an ester instead of an 
amide is formed when the native substrate 3-HAA is used. Anthranilic acid would 
have been a more suitable substrate for testing than 2,3-AMBA, as the methyl group 
may cause steric clash in AjiA1. Unfortunately, anthranilic acid is a category 2 




Figure 7.20. LC-MS analysis of AjiA1 reactions with alternative substrates. (A) 
3-HBA. (B) 2,3-AMBA. The presence or absence of AjiA1 is indicated.  
 
7.2.4 In vitro reconstitution of AJI9561 biosynthesis using 3-HAA amide dimer 
Previously, the isolated 3-HAA oxazole dimer (2) was confirmed as a competent 
precursor to AJI9561 (Hug, 2015). A similar experiment was conducted with pre-
isolated 3-HAA amide dimer (1) instead, to check if it could be processed by 









































Aji enzymes in addition to AjiH would drive the overall reaction forward to yield 
AJI9561.  
 
Chemical synthesis of 6-MSA 
6-MSA was chemically synthesised from the commercially available ethyl-6-MSA, via 
alkaline hydrolysis of the ester, as described in Hug (2015) (Section 8.7.2).  
 
Optimisation of one-pot in vitro reconstitution to AJI9561 
As mentioned in Section 7.1.3, previous efforts on the in vitro reconstitution were 
frustrated by the incomplete conversion of intermediates to AJI9561 (<5% yield) 
(Hug, 2015). To enable the generation of a sufficient amount of products for further 
study of the pathway, various strategies were employed to optimise the yield of the 
reaction.  
AjiA2 and AjiG were expressed in E. coli BL21(DE3) bearing pET-28a(+)-
ajiA2 and pET-28a(+)-ajiG, respectively. AjiP was co-expressed with MtaA, a 
PPTase from Stigmatella aurantiaca DW4/3-1 to enable the conversion of apo-AjiP to 
its holo form in vivo, in E. coli BL21(DE3) bearing pET-28a(+)-ajiP and pSU-mtaA. 




Figure 7.21. SDS-PAGE analysis of purified AjiA2, AjiG and AjiP. 
 
LC-MS analysis of purified AjiP showed that although holo-AjiP was present, 
a significant proportion of the sample comprised of apo-AjiP which failed to be 
activated by the co-expressed MtaA in vivo. To activate the remaining apo-AjiP, Sfp 
was included in the in vitro reaction.  
To facilitate the adenylation and loading of 6-MSA, the precursor was pre-
incubated with AjiA2, AjiP, Sfp, CoA, ATP and MgCl2 for 60 minutes prior to the 



















Moreover, although AJI9561 is assembled from two units of 3-HAA and only 
one unit of 6-MSA, an equal concentration of 6-MSA and 3-HAA increased the yield 
and maximised the utilisation of both precursors. This is likely due to the requirement 
of 6-MSA to be both activated and loaded onto the holo-AjiP to serve as a substrate 
for AjiG. A 6-MSA/3-HAA ratio of 1:1 resulted in the near-complete conversion to 




Figure 7.22. Optimised one-pot enzymatic conversion to AJI9561. 
 
In vitro reconstitution of AJI9561 biosynthesis using the 3-HAA amide dimer 
and 6-MSA as substrates 
The isolated 3-HAA amide dimer (1) (0.25 mM) was incubated with 1 mM 6-MSA, 10 
µM AjiA2, 60 µM AjiP, 20 µM AjiG, 1 uM AjiH, 20 µM Sfp, 0.25 mM CoA, 5 mM ATP 
and 10 mM MgCl2 in 25 mM HEPES buffer (pH 8.1), in a total reaction volume of 100 
µL (as with the previous one-pot reactions) or 2 mL. A small amount of AJI9561 
could be detected by LC-MS in the upscaled reaction of 2 mL (Figure 7.23), but not in 
100 µL. Despite the near-complete conversion of 3-HAA and 6-MSA to AJI9561 in 
the one-pot reaction containing all five Aji enzymes (positive control), the efficiency 
was extremely low when the 3-HAA amide dimer (1) was used. Nevertheless, the 3-
HAA amide dimer (1) was demonstrated for the first time to be a competent substrate 
for AJI9561 biosynthesis. 
 
7.2.5 Investigation of alternative biosynthetic routes to AJI9561 
Although the 3-HAA oxazole dimer (Hug, 2015) and the 3-HAA amide dimer were 
confirmed to be competent for the enzymatic conversion to AJI9561, alternative 































Figure 7.23. LC-MS analysis of the in vitro one-pot reconstitution of AJI9561 
biosynthesis using the 3-HAA amide dimer and 6-MSA. A sample of the pre-
isolated 3-HAA amide dimer (1) with no Aji enzymes was used as a standard and the 
one-pot reaction containing 3-HAA, 6-MSA and all five Aji enzymes was used as a 
positive control.  
 
ruled out at this stage. For instance, the possibility of 3-HAA-6-MSA heterodimer 
formation and the heterodimer being the preferred dimer intermediate had not been 
assessed experimentally. Various combinations of Aji enzymes were incubated with 
3-HAA and 6-MSA to check for the biosynthesis of previously unseen products. 
Subsequent testing of the isolated products, as alternative substrates for Aji 
enzymes, was carried out to determine their competence as intermediates in the 
AJI9561 pathway. 
 
One-pot reaction with various combinations of Aji enzymes 
Three different combinations of enzymes were incubated with 6-MSA and 3-HAA in a 
one-pot manner: (i) AjiA2, AjiP and AjiG, (ii) AjiA2, AjiP, AjiG and AjiH and (iii) AjiA2, 
AjiP, AjiG and AjiA1 (Figure 7.23).  
Through the incubation of AjiA2, AjiP and AjiG with both precursors in 
reaction (i), m/z 310.07 which corresponds to the sodium adduct ion of the 3-HAA-6-
MSA heterodimer (4) with a retention time of 29.24 min was detected (Figures 7.24 



























+ no Aji enzymes
3-HAA + 6-MSA
+ all five Aji enzymes
3-HAA amide dimer (1) + 6-MSA




With the addition of AjiH in reaction (ii), m/z 292.06 which corresponds to the 
sodium adduct ions of the 3-HAA-6-MSA oxazole heterodimer (5) at 35.32 min and a 
characteristic UV spectrum were observed (Figures 7.24 and 7.26).   
In the absence of AjiH, the 3-HAA dimer (1) was the major product of reaction 
(iii) and m/z 445.10 which corresponds to the sodium adduct ion of the 3-HAA dimer-
6-MSA trimer (6), with neither of the oxazole rings closed, was detected at 30.73 min 
as a minor product (Figures 7.24 and 7.27). It is unclear whether the 3-HAA dimer (1) 
or the 3-HAA-6-MSA heterodimer (4) was the (preferred) precursor to the trimer (6).  
All three products (4-6) as well as AJI9561 were submitted for accurate mass 
analysis (Table 7.3). Unfortunately, the amounts were not sufficient for detailed 




Figure 7.24. LC-MS analysis of one-pot reaction with various combinations of 
Aji enzymes. LC-MS-UV chromatogram of (A-B) the negative and positive controls, 
(C) reaction (i), (D) reaction (ii) and (E) reaction (iii). The presence and/or absence of 
Aji enzymes in the reactions are indicated. 
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Figure 7.25. LC-MS analysis of 3-HAA-6-MSA heterodimer (4). (A) Selective ion 
monitoring, (B) UV spectrum and (C) MS/MS fragmentation of m/z [M+Na]+ 310.07. 
(D) Proposed biosynthetic route to the 3-HAA-6-MSA heterodimer (4) catalysed by 
AjiG.  
 
Notably, the detection of these three previously unseen products revealed the 
broad substrate specificity of AjiH and AjiG. Not only was AjiH capable of closing the 
oxazole ring in the 3-HAA dimer (1) and the benzoxazole trimer, but also in the 3-
HAA-6-MSA heterodimer (4), whereas AjiG catalyses the condensation between 
AjiP-6-MSA and any of: 3-HAA, the 3-HAA oxazole dimer (2) and the non-cyclised 3-
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Figure 7.26. LC-MS analysis of 3-HAA-6-MSA oxazole heterodimer (5). (A) 
Selective ion monitoring and (B) UV spectrum of m/z [M+Na]+ 292.06. (C) Proposed 
biosynthetic route to the 3-HAA-6-MSA oxazole heterodimer (5) catalysed by AjiG 
and AjiH. 
 
Biosynthetic competency of 3-HAA-6-MSA dimer, 3-HAA-6-MSA oxazole dimer 
and 3-HAA dimer-6-MSA trimer 
In light of the detection of previously unseen products, alternative biosynthetic routes 
to AJI9561 via a different order of precursor assembly were investigated.  
The 3-HAA-6-MSA heterodimer (4), the 3-HAA-6-MSA oxazole heterodimer 
(5) and the 3-HAA dimer-6-MSA trimer (6) were purified using LC-MS, and were 
incubated individually with downstream enzymes. None of them were competent for 
downstream processing to yield AJI9561, unlike the 3-HAA dimer (1) (discussed 
earlier in this section) and the 3-HAA oxazole dimer (2) (Hug, 2015), and were 
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Figure 7.27. LC-MS analysis of 3-HAA dimer-6-MSA trimer (6). (A) Selective ion 
monitoring, (B) UV spectrum and (C) MS/MS fragmentation of m/z [M+Na]+ 445.10. 
(C) Proposed biosynthetic route to the 3-HAA dimer-6-MSA trimer (6) catalysed by 
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Table 7.3. Accurate mass analyses of the 3-HAA-6-MSA heterodimer (4), the 3-
HAA-6-MSA oxazole heterodimer (5), the 3-HAA dimer-6-MSA trimer (6) and 
AJI9561.  






3-HAA-6-MSA heterodimer C15H13NO5 287.07937 287.0783 
3-HAA-6-MSA oxazole heterodimer C15H11NO4 269.06881 269.0682 
3-HAA dimer-6-MSA trimer  C22H18N2O7 422.11140 422.1101 





7.3 Concluding remarks and future work 
In this chapter, the biosynthetic route to AJI9561, a potent, bis(benzoxazole) 
antibiotic and anti-proliferative agent produced by Streptomyces sp. AJ9561, was 
investigated via an in vitro approach.  
A key enzyme in benzoxazole formation, the amidocyclase AjiH, was 
subjected to detailed study via phylogenetic analysis, structural modelling and in vitro 
reconstitution. AjiH and its counterparts in other (bis)benzoxazole antibiotic 
biosynthetic pathways form a distinct clade in the metallo-amidohydrolase 
superfamily.  AjiH and its counterparts in the nataxazole, A33853 and caboxamycin 
pathways represent a novel catalytic function in the evolutionarily-divergent metallo-
amidohydrolase superfamily. Unexpectedly, the cyclisation of the previously identified 
substrate 3-HAA amide dimer (1), proposed to be catalysed by AjiH, could not be 
reconstituted as a single reaction despite multiple attempts under different assay 
conditions. Two alternative candidates to the amide-linked 3-HAA dimer (1), the 3-
HAA dimer adenylate and the ester-linked 3-HAA dimer, were considered. The 
adenylate was ruled out as it is unlikely to be produced by AjiA1, the ATP-dependent 
ligase involved in the activation and dimerisation of 3-HAA, and was never observed 
in the enzymatic assays. However, as the amide-linked and ester-linked 3-HAA 
dimers share the same molecular weight and MS/MS fragmentation pattern, they 
could not be distinguished from each other using LC-MS. Although AjiA1 was shown 
to catalyse the dimerisation of 3-HBA (in the absence of a 2-substituted amine group) 
via an ester linkage, the same may or may not be applicable in the case of 3-HAA, 
and hence, the true identity of AjiH’s substrate for 3-HAA oxazole dimer (2) formation 
remains obscure.  
On the other hand, the one-pot reconstitution of AJI9561 biosynthesis, using 
3-HAA and 6-MSA as precursors, was successfully optimised with a yield 
improvement from <5% to more than 90%. This enabled the detection of the low 
amount of AJI9561 enzymatically-converted from the isolated 3-HAA amide dimer (1) 
and 6-MSA, demonstrating the competency of the amide as a substrate for AJI9561 
biosynthesis for the first time. Alternative biosynthetic routes to AJI9561 were also 
investigated (Figure 7.30). From one-pot reactions containing different combinations 
of Aji enzymes, the 3-HAA-6-MSA heterodimer (4), the 3-HAA-6-MSA oxazole 
heterodimer (5) and the 3-HAA dimer-6-MSA trimer (6) were isolated and assessed 
for their biosynthetic competency. They are likely shunt products (and not 
intermediates) of the AJI9561 pathway as none of them were suitable substrates for 




For further work, metal substitution and crystallographic studies of the 
amidocyclase AjiH could shed light on its enzymology and mechanism for catalysis. If 
chemically-synthesised amide-linked and ester-linked 3-HAA dimers are available, 
they could be tested directly with AjiH and used as a standard for the other assays. 
Moreover, AjiH and AjiG exhibited a relaxed substrate specificity. The Aji enzymes 
could potentially be used for the generation of new benzoxazole antibiotics, via the 
use of benzoic acid derivatives as precursors.  
Chapter 8 
 




8.1.1 Chemical and biological reagents  
All chemical and biological reagents used in this work were purchased from Sigma-
Aldrich, Thermo Fisher Scientific and New England Biolabs, unless stated otherwise.  
 
8.1.2 Culture media 
Culture media used in this work are shown in Table 8.1. 
 
Table 8.1. Culture media used in this work.  
Medium Composition 
2TY 
1.6% (w/v) tryptone; 1% (w/v) yeast extract; 0.5% (w/v) NaCl; with or without 2% (w/v) 
agar; in distilled H2O; pH 7.0 
LB 
1% (w/v) tryptone; 0.5% (w/v) yeast extract; 1% (w/v) NaCl; with or without 2% (w/v) agar; 
in distilled H2O; pH 7.0 
SFM 2% (w/v) soy flour; 2% (w/v) mannitol; with or without 2% (w/v) agar; in tap water 





0.3% (w/v) yeast extract; 0.5% (w/v) peptone; 1% (w/v) glucose; 0.3% (w/v) malt extract; 
34% (w/v) sucrose; 0.5% (w/v) glycine; 0.235% (w/v) MgCl2; 0.0075% (w/v) L-proline; 
0.0075% (w/v) L-arginine; 0.0075% (w/v) L-cysteine; 0.01% (w/v) L-histidine; 0.0015% 
(w/v) uracil; distilled H2O 
 
8.1.3 Antibiotics 





Table 8.2. Antibiotics used in this work. 




Apramycin  H2O 50 50 
Carbenicillin  H2O 50 50 
Chloramphenicol  Ethanol 25 25 
Kanamycin  H2O 50 50 
Nalidixic acid  H2O 25 25 
Thiostrepton  Ethanol/DMSO 1:1 (v/v) 10 10 
 
8.1.4 Bacterial strains 
All bacterial strains were handled with aseptic techniques in laminar flow hoods. 
Streptomyces sp. OM-5714 and Streptomyces sp. KO-7888 were kind gifts from 
Professor Satoshi Omura (Kitasato Institute, Japan). Bacterial strains used in this 
work are listed in Table 8.3. 
 
Table 8.3. Bacterial strains used in this work. Strains generated by previous group 
members and deposited in the PFL strain collection are indicated with an asterisk.  
Strains Genotype/Features Reference 
Escherichia coli strains   
DH10B F- mcrA Δ(mrr- hsd RMS- mcrBC) Φ80lacZ ΔM15 ΔlacX74 
recA1 endA1 araD139 Δ (ara leu)7697 galU galK rpsL nupG λ-
. Host for cloning.  
Invitrogen 
ET12567/pUZ8002 F- dam- 13::Tn9 dcm- 6 hsdM hsdR recF143 zjj-202::Tn10 
galK2 galT22 ara14 pacY1 xyl-5 leuB6 thi-1. Donor strain for 
DNA conjugation into Streptomyces.  
MacNeil 
(1992) 
BL21(DE3) F- ompT hsdSB(rB–, mB–) gal dcm (DE3). Host for protein 
expression. 
Novagen 
BL21(DE3)/pET28a-ajiA1 E. coli BL21(DE3) bearing the protein expression construct 
pET-28a(+) containing ajiA1 with an N-terminal His6-tag.  
* 
BL21(DE3)/pET28a-ajiA2 E. coli BL21(DE3) bearing the protein expression construct 
pET-28a(+) containing ajiA2 with an N-terminal His6-tag.  
* 
BL21(DE3)/pET28a-ajiG E. coli BL21(DE3) bearing the protein expression construct 




E. coli BL21(DE3) bearing the protein expression constructs 
pET-28a(+) containing ajiP with an N-terminal His6-tag and 





Streptomyces strains   
Streptomyces sp. OM-
5714 




Phthoxazolins producer.  Shiomi et al. 
(1995) 
S. conglobatus ATCC 
31005 
Conglobatin producer. For PCR amplification of congE.  Westley et 
al. (1979) 
ΔACP13-S1676A Streptomyces sp. KO-7888 with a point mutation of the 
catalytic Ser1676 to Ala in ACP13 of PhoxR.  
This work 
ΔACP15-S4259A Streptomyces sp. KO-7888 with a point mutation of the 
catalytic Ser4259 to Ala in ACP15 of PhoxR.  
This work 
ΔACP16-S5512A Streptomyces sp. KO-7888 with a point mutation of the 
catalytic Ser5512 to Ala in ACP16 of PhoxR. 
This work 
ΔavaR3 Streptomyces sp. KO-7888 with avaR3 (outside of phox 
cluster) deleted in-frame.  
This work 
 
Δorf+5 Streptomyces sp. KO-7888 with orf+5 deleted in-frame.  This work 
Δorf0034 Streptomyces sp. KO-7888 with orf0034 (outside of phox 
cluster) deleted in-frame.  
This work 
Δorf3515 Streptomyces sp. KO-7888 with orf3515 (outside of phox 
cluster) deleted in-frame. 
This work 
 
ΔPCP14-S2778A Streptomyces sp. KO-7888 with a point mutation of the 
catalytic Ser2778 to Ala in PCP14 of PhoxR. 
This work 
ΔphoxE Streptomyces sp. KO-7888 with phoxE deleted in-frame.  This work 
ΔphoxF Streptomyces sp. KO-7888 with phoxF deleted in-frame.  This work 
ΔphoxG Streptomyces sp. KO-7888 with phoxG deleted in-frame.  This work 
ΔphoxI Streptomyces sp. KO-7888 with phoxI deleted in-frame.  This work 
ΔphoxJ Streptomyces sp. KO-7888 with phoxJ deleted in-frame.  This work 
ΔphoxK Streptomyces sp. KO-7888 with phoxK deleted in-frame.  This work 
ΔphoxP Streptomyces sp. KO-7888 with phoxP deleted in-frame.  This work 
ΔphoxP::phoxP Streptomyces sp. KO-7888 with phoxP deleted in-frame and 
phoxP genomically integrated at phiC31 attB site.  
This work 
ΔphoxP::phoxP-OM Streptomyces sp. KO-7888 with phoxP deleted in-frame and 
phoxP from Streptomyces sp. OM-5714 genomically 
integrated at phiC31 attB site.  
This work 
ΔphoxP::ozmP Streptomyces sp. KO-7888 with phoxP deleted in-frame and 
ozmP genomically integrated at phiC31 attB site.  
This work 
ΔphoxP::congE Streptomyces sp. KO-7888 with phoxP deleted in-frame and 





ΔphoxR Streptomyces sp. KO-7888 with phoxR deleted in-frame.  This work 
ΔphoxU Streptomyces sp. KO-7888 with phoxU deleted in-frame.  This work 
ΔphoxV Streptomyces sp. KO-7888 with phoxV deleted in-frame.  This work 
WT::orf+10  Streptomyces sp. KO-7888 with an additional copy of orf+10 
genomically integrated at phiC31 attB site. 
This work 
WT::orf+11 Streptomyces sp. KO-7888 with an additional copy of orf+11 
genomically integrated at phiC31 attB site. 
This work 
WT::phoxC Streptomyces sp. KO-7888 with an additional copy of phoxC 
genomically integrated at phiC31 attB site. 
This work 
WT::phoxT Streptomyces sp. KO-7888 with an additional copy of phoxT 




S. coelicolor CH999 bearing the protein expression construct 
pCJW93 containing ajiH between NdeI and EcoRI with an N-
terminal His6-tag. For thiostrepton-inducible expression of AjiH 
under the tipA promoter.  
Hug (2015) 
 
8.1.5 Plasmid constructs  
All plasmid constructs were stored in MQ H2O at -20 °C. Plasmid constructs used in 
this work are listed in Table 8.4. 
 
Table 8.4. Plasmid constructs used in this work. Plasmid constructs generated by 
previous group members and deposited in the PFL strain collection are indicated with 
an asterisk. 
Plasmid Features Reference 
For in-frame deletions 
pYH7 Amp, aac(3)IV, tsr, cos, oriT, PT7, PT3, oripIJ101, oriColE1, E. coli-
Streptomyces shuttle vector 
Sun (2009) 
pYH7-avaR3 Construct for in-frame deletion of avaR3 with arms of homology 
flanking avaR3 inserted at NdeI of pYH7.  
This work 
pYH7-orf+5 Construct for in-frame deletion of orf+5 with arms of homology 
flanking phoxAA inserted at NdeI of pYH7.  
This work 
pYH7-orf0034 Construct for in-frame deletion of orf0034 with arms of 
homology flanking asnS inserted at NdeI of pYH7.  
This work 
pYH7-orf3515 Construct for in-frame deletion of orf3515 with arms of 
homology flanking orf3515 inserted at NdeI of pYH7.  
This work 
pYH7-phoxE Construct for in-frame deletion of phoxE with arms of homology 





pYH7-phoxF Construct for in-frame deletion of phoxF with arms of homology 
flanking phoxF inserted at NdeI of pYH7.  
This work 
pYH7-phoxG Construct for in-frame deletion of phoxG with arms of homology 
flanking phoxG inserted at NdeI of pYH7.  
This work 
pYH7-phoxI Construct for in-frame deletion of phoxI with arms of homology 
flanking phoxI inserted at NdeI of pYH7.  
This work 
pYH7-phoxJ Construct for in-frame deletion of phoxJ with arms of homology 
flanking phoxJ inserted at NdeI of pYH7.  
This work 
pYH7-phoxP Construct for in-frame deletion of phoxP with arms of homology 
flanking phoxP inserted at NdeI of pYH7.  
This work 
pYH7-phoxR Construct for in-frame deletion of phoxR with arms of homology 
flanking phoxR inserted at NdeI of pYH7.  
This work 
pYH7-phoxU Construct for in-frame deletion of phoxU with arms of homology 
flanking phoxU inserted at NdeI of pYH7.  
This work 
pYH7-phoxV Construct for in-frame deletion of phoxV with arms of homology 
flanking phoxV inserted at NdeI of pYH7.  
This work 
For point mutagenesis 
pYH7-ACP13 Construct for inactivation of ACP13 in PhoxR with arms of 
homology containing the Ser1676 to Ala point mutation inserted 
at NdeI of pYH7.  
This work 
pYH7-ACP15 Construct for inactivation of ACP15 in PhoxR with arms of 
homology containing the Ser4259 to Ala point mutation inserted 
at NdeI of pYH7.  
This work 
pYH7-ACP16 Construct for inactivation of ACP16 in PhoxR with arms of 
homology containing the Ser5512 to Ala point mutation inserted 
at NdeI of pYH7.  
This work 
pYH7-PCP14 Construct for inactivation of PCP14 in PhoxR with arms of 
homology containing the Ser2278 to Ala point mutation inserted 
at NdeI of pYH7.  
This work 
For complementation of in-frame deletions 
pIB139 aac(3)IV, oriT, attP(ΦC31), int, PermE*, oripUC, ΦC31 site 
integrative vector with ermE* promoter. 
Wilkinson (2002) 
pIB139-phoxP Complementation construct containing phoxP between NdeI 




Complementation construct containing phoxP from 
Streptomyces sp. OM-5714 between NdeI and XbaI of pIB139. 
This work 
pIB139-ozmP Complementation construct containing ozmP from pYJ55 
between NdeI and XbaI of pIB139. 
This work 




Streptomyces conglobatus between NdeI and XbaI of pIB139. 
For overexpression of  
(putative) regulatory genes 
pIB139-orf+10 Overexpression construct containing orf+10 between NdeI and 
XbaI of pIB139.  
This work 
pIB139-orf+11 Overexpression construct containing orf+11 between NdeI and 
XbaI of pIB139.  
This work 
pIB139-phoxC Overexpression construct containing phoxC between NdeI and 
XbaI of pIB139.  
This work 
pIB139-phoxT Overexpression construct containing phoxT between NdeI and 
XbaI of pIB139.  
This work 
For protein expression 
pET-28a(+) kan, lacI, PT7, oripBR322, oriF1, N-terminal and C-terminal His6-tag. 
For protein expression. 
Novagen 
pET28a-folD Protein expression construct containing folD from E. coli DH10B 
between NdeI and XhoI of pET-28a(+) with an N-terminal His6-
tag. 
This work 
pET28a-phoxO Protein expression construct containing phoxO between NdeI 




Protein expression construct containing the first 4452 bp of 
phoxN (encoding Val1-Gly1483) between NdeI and HindIII of 
pET-28a(+) with an N-terminal His6-tag. 
This work 
pET28a-phoxS A protein expression construct containing phoxS between NdeI 
and XhoI of pET-28a(+) with an N-terminal His6-tag. 
This work 
pET28a-sfp Protein expression construct containing sfp between NdeI and 
XhoI of pET-28a(+) with an N-terminal His6-tag. 
* 
pET-29b(+) kan, lacI, PT7, oripBR322, oriF1, N-terminal S-tag, C-terminal His6-
tag. For protein expression. 
Novagen 
pET29b-phoxP Protein expression construct containing phoxP between NdeI 
and XhoI of pET-29b(+) with an N-terminal His6-tag. 
This work 
pET29b-phoxQ Protein expression construct containing phoxQ between NdeI 
and HindIII of pET-29b(+) with an N-terminal His6-tag. 
This work 
For amplification of ozmP 
pYJ55 Protein expression construct containing ozmP from S. albus 
JA3453 between NdeI and XhoI of pET-29b(+) with an N-






8.1.6 Oligonucleotides  
All DNA oligonucleotides were purchased from Eurofins and Sigma-Aldrich in 
lyophilised form. Diluted stocks (10 µM) were stored at -20 °C. DNA oligonucleotides 
used in this work are listed in Table 8.5.  
 
Table 8.5. DNA oligonucleotides used in this work. Restriction sites are 
underlined. F, forward primer; R, reverse primer; U, for upstream flanking region; D, 
for downstream flanking region.  
Primer Sequence (5'-3') 





pYH7_orf+5_UF TGATCAAGGCGAATACTTCATATG CCGCTGCCGTGACCGTCAC 
pYH7_orf+5_UR GATCGCCAGGGTGCCGCCCCAGGTCATGGCCTGCCGGTA 
pYH7_orf+5_DF TACCGGCAGGCCATGACCTGGGGCGGCACCCTGGCGATC 









pYH7_phoxB_UF TGATCAAGGCGAATACTTCATATG CCAGCGGTCCGGTCGCTC 
pYH7_phoxB_UR CGGTCCGTGCCCTCGCCGAGTCGCGCTGTCGCTGGTGG 
pYH7_phoxB_DF CCACCAGCGACAGCGCGACTCGGCGAGGGCACGGACCG 
pYH7_phoxB_DR CCGCGCGGTCGATCCCCGCATATG GCGATGACGCCGCGCGAG 
pYH7_phoxF_UF TGATCAAGGCGAATACTTCATATGCATGTTCCACCGCCGGTCTCACAG 
pYH7_phoxF_UR GCAAGCGCATGA GATGACACCACGACCGCTCTTTGC 





pYH7_phoxG_UF TGATCAAGGCGAATACTTCATATG GGAGAGCGATGGCTGTCAGGATGA 
pYH7_phoxG_UR GTTTCATGCGCT CATCGGTGTCCG TCCCAGAAAGAG 
pYH7_phoxG_DF CGGACACCGATG AGCGCATGAAAC CCACCACCGACA 
pYH7_phoxG_DR CCGCGCGGTCGATCCCCGCATATG CGAGACGCTCGCTTCGACGATCTT 
pYH7_phoxI_UF TGATCAAGGCGAATACTTCATATG ATTCACAAATGGCAGCGCACGGTT 
pYH7_phoxI_UR CCCTCTGCCTCA GGTCATCGTTTT TCCGTCCCAAGA 
pYH7_phoxI_DF AAAACGATGACC TGAGGCAGAGGG ACGACGATGGGC 
pYH7_phoxI_DR CCGCGCGGTCGATCCCCGCATATG TCGGGGTGCAGGACGAGCAGGTGC 
pYH7_phoxJ_UF TGATCAAGGCGAATACTTCATATG CCGTGGACAGCATGTGCACCTCCT 
pYH7_phoxJ_UR CGAAGGGATTGG CGTCGTCCCTCT GCCTCAGCTCTC 
pYH7_phoxJ_DF AGAGGGACGACG CCAATCCCTTCG ACCGACCGGACA 
pYH7_phoxJ_DR CCGCGCGGTCGATCCCCGCATATG TCACCACCGCGAATTCCTTGTGCA 
pYH7_phoxK_UF TGATCAAGGCGAATACTTCATATG AGCTTCCGCTCCAGCTGATCTTCA 
pYH7_phoxK_UR CCCGTTCGGTCA GTTGGTGTCTCT CCTTTTGCTGCG  
pYH7_phoxK_DF AGAGACACCAAC TGACCGAACGGG CGGCACTCATTT 
pYH7_phoxK_DR CCGCGCGGTCGATCCCCGCATATG CGATCATGATGATGTTGGCGTCCT 
pYH7_phoxP_UF TGATCAAGGCGAATACTTCATATGACCGCCGACCTGCTCGTACCCGAG 
pYH7_phoxP_UR CTGCTCGGTGTC TCATGGGCGCCGCCCCCTGCGGTC 
pYH7_phoxP_DF CGGCGCCCATGA GACACCGAGCAGGAGAACCCACAC 
pYH7_phoxP_DR CCGCGCGGTCGATCCCCGCATATGGGCGAGGGCGTACTCGTGGCAGCA 
pYH7_phoxR_UF TGATCAAGGCGAATACTTCATATG CGCCGGAGCGGTCGTCCTC 
pYH7_phoxR_UR GTGCGTCGGGCGCATCGGAGGCCAGCAGGTCCAGCAGCAG 
pYH7_phoxR_DF CTGCTGCTGGACCTGCTGGCCTCCGATGCGCCCGACGCAC 
pYH7_phoxR_DR CCGCGCGGTCGATCCCCGCATATG GCTCGACGGGCCGCTCCTC 
pYH7_phoxV_UF TGATCAAGGCGAATACTTCATATG GGCTCGCTCGCCGAGCTG 
pYH7_phoxV_UR CGTCGTGCGCGGTGCTGGGCAGGCGGCGGGCCTGCC 
pYH7_phoxV_DF CGGCAGGCCCGCCGCCTGCCCAGCACCGCGCACGACG 
pYH7_phoxV_DR CCGCGCGGTCGATCCCCGCATATG AGGCGGGTGTCGCCGGAGG 




























































8.2 Microbiological methods 
8.2.1 Growth and maintenance of E. coli strains 
All E. coli strains were grown on solid or in liquid 2TY or LB medium at 37 ºC, with 
antibiotics where appropriate. Liquid cultures were aerated by shaking at 220 RPM. 
For long-term storage, liquid cultures suspended in 25 % (v/v) glycerol were kept at  
-80 ºC.  
 
8.2.2 Growth and maintenance of Streptomyces strains 
All Streptomyces strains were grown in liquid TSBY, on solid or in liquid SFM at 30 
ºC, with antibiotics where appropriate. Liquid cultures were aerated in baffled flasks 
or flasks containing a coiled spring and by shaking at 220 RPM. For long-term 





8.3 Molecular biology methods 
8.3.1 Isolation of genomic DNA from Streptomyces strains 
The Streptomyces strains were cultured for 2 days for the isolation of genomic DNA. 
The cells from 500 µL of culture were harvested by centrifugation at 10,000 xg for 10 
minutes. The cell pellets were suspended in 500 µL of SET buffer (75 mM NaCl; 25 
mM EDTA, pH 8.0; 20 mM Tris-HCl; in MQ H2O; pH 7.5), added with 0.5 mg of 
lysozyme and incubated at 37 °C for 30 minutes. The mixtures were added with 0.2 
mg of proteinase K and 60 µL of 10 % SDS and incubated at 55 °C for 2 hours. After 
cooling down the mixtures to room temperature (21 °C), 200 µL of 5 M NaCl was 
added and the mixtures were mixed by inversion. Subsequently, 500 µL of 
chloroform was added and the mixtures were again mixed by inversion, followed by 
centrifugation at 10,000 xg for 10 minutes. The upper phase was transferred to fresh 
Eppendorf tubes, added with 600 µL of isopropanol and mixed by inversion. The 
mixtures were centrifuged at 10,000 xg for 10 minutes. The resulting pellets of 
genomic DNA were washed with 200 µL of ethanol twice and dried at 37 °C. The 
dried pellets were left to dissolve in 200 µL of MQ H2O at 4 °C overnight.  
 
8.3.2 Isolation of plasmid DNA from E. coli  
Plasmid DNA was isolated from overnight E. coli liquid cultures using the GeneJET 
Plasmid Midiprep Kit and eluted in MQ H2O.  
 
8.3.3 Polymerase chain reaction (PCR) 
PCR amplifications were performed using the Geneamp 9700 PCR thermal cycler 
(Applied Biosystems). For cloning, the reactions contained 10 µL of 5X Q5 Reaction 
Buffer, 10 µL of 5X Q5 High GC Enhancer, 2.5 µL of 10 mM dNTPs, 2.5 µL of each 
10 µM primer stock solution, 1 µL of DNA template, 0.5 µL of Q5® High-Fidelity DNA 
Polymerase and MQ H2O to adjust to a final volume of 50 µL. For screening, the 
reactions contained 10 µL of MyTaq™ Red Mix, 1 µL of each 10 µM primer stock 
solution, 1 µL of DMSO, 1 µL of DNA template and MQ H2O to adjust to a final 
volume of 50 µL. Thermocycling conditions are shown in Table 8.6.  
 
Table 8.6. Thermocycling conditions for PCR amplifications. 
Step Temperature Time   














Final extension 72 °C 2 minutes  
Hold 4 °C   
 
8.3.4 Agarose gel electrophoresis  
Agarose gels were prepared with 0.8 to 1.2 % (w/v) agarose in TAE buffer (0.45 M 
Tris, 0.45 M acetic acid, 0.1 M EDTA, pH 8.0; in MQ H2O) containing 2.5 % (v/v) of 
SYBR® Safe DNA Gel Stain (Invitrogen). DNA samples were mixed with 6X DNA 
Loading Dye and loaded to the agrose gels. The GeneRuler 1 kb Plus DNA Ladder 
was used as a molecular size marker. The gels were run at 120 to 150 V for 20 to 60 
minutes. DNA was visualised under a UV illuminator at 254 nm and purified using the 
GeneJET Gel Extraction Kit and the DNA Clean & Concentrator-5 Kit (Zymo 
Research).  
 
8.3.5 Restriction cloning  
Restriction enzyme reactions contained 2 µL of 10X FastDigest (Green) Buffer, 1 µL 
of (each) restriction enzyme, up to 1 µg of DNA and MQ H2O to adjust to a final 
volume of 20 µL. The reactions were incubated at 37 °C for 1 hour and subsequently 
heat-inactivated. To prevent the self-ligation of linearised plasmids, 1 µL of shrimp 
alkaline phosphatase was added directly to the completed digestion reactions and 
incubated further for 30 minutes prior to heat-inactivation at 65 °C or 80 °C. The 
reactions were then subjected to DNA separation by agarose gel electrophoresis or 
direct DNA purification using the DNA Clean & Concentrator-5 Kit (Zymo Research).  
DNA ligation reactions contained 50 ng linearised and dephosphorylated 
plasmid with two- to five-fold excess of (each) DNA insert, 2 µL of 10X T4 DNA 
Ligase Buffer, 1 µL of T4 DNA Ligase and MQ H2O to adjust to a final volume of 20 
µL. Following incubation at 16 °C overnight, the reactions were heat-inactivated at 65 
°C and desalted by micro-dialysis using mixed cellulose esters membranes 
(0.025 µm pore size) (MF-Millipore™) prior to transformation of chemically-competent 
E. coli DH10B cells with the entire reaction volume.  
  
8.3.6 Isothermal DNA assembly  




Isothermal assembly reactions were prepared on ice, and contained 50 ng of 
linearised and dephosphorylated plasmid with three-fold excess of each DNA insert, 
10 µL of 2X NEBuilder® HiFi DNA Assembly Master Mix and MQ H2O to adjust to a 
final volume of 20 µL. The reactions were incubated at 50 °C for 60 minutes and 
subsequently desalted by micro-dialysis using mixed cellulose esters membranes 
(0.025 µm pore size) (MF-Millipore™) prior to transformation of chemically-
competent E. coli DH10B cells with the entire reaction volume.  
 
8.3.7 Preparation and transformation of chemically-competent E. coli cells 
For the preparation of chemically-competent E. coli cells, glycerol stocks were 
streaked on 2TY agar and incubated at 37 °C overnight. A single colony was 
inoculated into 5 mL of 2TY and incubated at 37 °C overnight. In 250 mL flasks, 1 mL 
of overnight culture was inoculated into 25 mL of 2TY and incubated at 37 °C until 
the cultures reached an OD600 of 0.3 to 0.5. The cells were harvested by 
centrifugation at 4 °C, 4,000 xg for 10 minutes. The cell pellets were resuspended 
with 50 mL of ice-cold buffer (50 mM CaCl2, 10 mM KAc, in MQ H2O; pH 6.2) and 
incubated on ice with occasional agitation for 1 hour. The cells were centrifuged at 4 
°C, 4,000 xg for 10 minutes. The cell pellets were resuspended in 2 mL of ice-cold 
buffer (50 mM CaCl2, 10 mM KAc, 20 % (v/v) glycerol; in MQ H2O; pH 6.2). Aliquots 
of the cell suspensions were snap-frozen with dry ice and stored at -80 °C.  
For transformation of chemically-competent E. coli cells, aliquots of the cells 
were thawed in ice slurry and added with either 100 ng of purified plasmid or the 
entire volume of a micro-dialysed DNA assembly reaction. The mixtures were 
incubated on ice for 30 minutes, then heat-shocked at 42 °C for 1 minute and 
incubated on ice again for 2 minutes. The mixtures were added with 500 µL of 2TY 
and incubated at 37 °C for 1 hour. The cultures were plated on LB agar containing 
appropriate antibiotics and incubated at 37 °C overnight.  
 
8.3.8 DNA conjugation into Streptomyces sp. KO-7888 
Streptomyces sp. KO-7888 was inoculated in 25 mL of TSBY in 250 mL flasks 
containing a coiled spring and incubated at 30 °C for 2 days. The cells were 
harvested by centrifugation at 4 °C, 4,000 xg for 10 minutes. The cell pellets were 
resuspended in 20 mL of 2TY and centrifuged at 4 °C, 4,000 xg for 10 minutes. The 
final cell pellets were resuspended in 1 mL of 2TY and kept on ice. A single colony of 




plasmid was inoculated into 5 mL of 2TY with the appropriate antibiotics and 
incubated at 37 °C overnight. In 50 mL Falcon tubes, 500 µL of overnight cultures 
were inoculated into 10 mL of 2TY with antibiotics at half of the usual working 
concentrations and incubated at 37 °C until the cultures reached an OD600 of 0.3 – 
0.5. The cells were harvested by centrifugation 4 °C, 4,000 x g for 10 minutes. The 
cell pellets were resuspended in 20 mL of 2TY and centrifuged at 4 °C, 4,000 x g for 
10 minutes. This resuspension and centrifugation step was repeated for three times. 
The final cell pellets were resuspended in 500 µL of 2TY and kept on ice. For 
conjugation, 100 µL of Streptomyces sp. KO-7888 suspension and 100 µL of E. coli 
suspension were mixed, plated on 15 mL of SFM agar containing 10 mM MgCl2 and 
incubated at 30 °C for 15 to 20 hours.  
Following 15 to 20 hours of incubation, each plate was flooded with 2 mL of 
antibiotic solution containing 0.75 mg of Apr and 0.375 mg of Nal in autoclaved, MQ 
H2O and incubated at 30 °C for 7 days for exconjugants to emerge. To confirm the 
presence of the plasmid, exconjugants were streaked on SFM agar with antibiotics. 
To obtain deletion mutants, antibiotic-resistant exconjugants were subject to two to 
four rounds of growth on SFM agar without antibiotics, to facilitate the double 
crossover via homologous recombination and the subsequent loss of the pYH7 
deletion plasmid. Genomic DNA of antibiotic-sensitive colonies was extracted, 
screened by PCR and confirmed by DNA sequencing.  
 
8.3.9 DNA sequencing 
Sanger DNA sequencing and whole-genome sequencing were carried out using the 
3730xl DNA Analyser (Applied Biosystems) and the MiSeq system (Illumina) 





8.4 Protein expression and purification methods 
8.4.1 Protein expression in E. coli BL21(DE3) 
Protein expression constructs were introduced to E. coli BL21(DE3) by heat shock 
transformation. To prepare starter cultures, single colonies were inoculated to 10 mL 
LB medium with appropriate antibiotics in 50 mL Falcon tubes and incubated at 37 ºC 
220 RPM overnight. The entire starter cultures were inoculated to 400 mL LB with 
appropriate antibiotics in 2 L conical flasks and incubated at 37 ºC 220 RPM until 
OD600 reached 0.8 to 1.0. Protein expression was induced by the addition of isopropyl 
β-D-1-thiogalactopyranoside (IPTG) to the cultures at a final concentration of 0.5 mM. 
Following incubation at 16 ºC for another 16 hours, the cultures were centrifuged at 
4,000 xg for 10 minutes. The cell pellets were suspended in 20 mL 1X binding buffer 
(0.5 M NaCl, 20 mM Tris-HCl; in MQ H2O; pH 7.9) and sonicated on ice slurry, 
pulsed on for 2 seconds and off for 5.9 seconds, for a total sonication time of 4 
minutes using the Vibra-CellTM system (Sonics & Materials Inc.). Cell lysate was 
centrifuged at 18000 xg for 30 minutes and the supernatant containing soluble 
proteins was subjected to purification by nickel affinity chromatography.  
 
8.4.2 Protein expression in S. coelicolor CH999  
To prepare starter cultures, 100 µL of mycelia suspension from glycerol stocks of S. 
coelicolor CH999 bearing the expression construct pCJW93-ajiH was inoculated to 
30 mL of TSBY medium with appropriate antibiotics in 250 mL conical flasks and 
incubated at 28 ºC 220 RPM for 4 days. Two millilitres of starter culture were 
inoculated to 100 mL Super YEME medium with appropriate antibiotics in 500 mL 
conical flasks with a coil spring and incubated at 28 ºC 220 RPM for 2 days. Protein 
expression was induced by the addition of thiostrepton to the cultures at a final 
concentration of 5 µg mL-1. Following incubation for another two days, the cultures 
were centrifuged at 18,000 xg for 30 minutes. The cell pellets were suspended in 50 
mL of 1X binding buffer (0.5 M NaCl, 20 mM Tris-HCl; in MQ H2O; pH 7.9) and 
sonicated on ice slurry, pulsed on for 5.9 seconds and off for 5.9 seconds, for a total 
sonication time of 4 minutes using the Vibra-CellTM system (Sonics & Materials Inc.). 
Cell lysate was centrifuged at 18,000 xg for 30 minutes at 4 ºC and the supernatant 
containing soluble proteins was subjected to purification by nickel affinity 
chromatography.  
 




The supernatant of cell lysate was loaded to columns containing 500 µL bed volume 
of His-bind resin (Bio-Rad) charged with 5 mL 50 mM NiCl2 and equilibrated with one 
column volume of 1X binding buffer. After the supernatant passed through, the 
column was washed with 10 mL 1X binding buffer. Proteins were eluted with 1X 
elution buffer (1X binding buffer containing 10 to 300 mM imidazole), 2 to 4 mL of 
buffer at each concentration. Elution fractions containing the protein of interest were 
combined and concentrated using the Amicon® Ultra 4 mL Centrifugal Filter Units 
(Millipore) with a molecular weight cut-off of 3, 10, 30 or 100 kDa. Buffer exchange 
was performed in the filter units with 1X binding buffer until the estimated imidazole 
concentration fell below 0.1 mM. All protein purification steps were carried out at 4 
ºC. Purified proteins were stored in 20 % (v/v) glycerol and stored at 4 ºC.   
 
8.4.4 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)  
Protein samples (7.5 µL) mixed with 2.5 µL of NuPAGE® 4X LDS Sample buffer 
were loaded to NuPAGE® Novex® 4 – 12 % Bis-Tris gels. The Precision Plus 
Protein™ Dual Color Standards (Bio-Rad) were used as a molecular weight marker. 
The gels were run in 1X NuPAGE® MES Buffer at 200 V for 40 minutes. Proteins 






8.5 Enzymatic assay methods 
8.5.1 In vitro reconstitution of the early steps of phthoxazolin biosynthesis 
All in vitro enzymatic reactions were performed in 25 mM Tris-HCl buffer (pH 7.5) 
with a total volume of 500 µL. All reactions contained 5 mM ATP, 10 mM MgCl2, 20 
µM Sfp, 0.25 CoA, 0.25 mM malonyl-CoA, 0.5 mM NADPH, 1 mM Gly or Ser, purified 
or cell lysate containing PhoxO (2 µM), PhoxQ (5 µM), PhoxN (Val1-Gly1483) (1 µM), 
PhoxS (1 µM) and PhoxP (1 µM) and 25 % (v/v) of the N10-fH4F chemoenzymatic 
synthesis reaction (see Section 8.6.1). Following incubation at 25 °C for 1 hour, the 
proteins were precipitated by the addition of 4.5 mL of 10 % (v/v) TFA. The 
precipitated reactions were centrifuged at 4000 xg at 4 °C and the pellets were 
washed with 2 mL 3:1 (v/v) diethyl ether/ethanol. The solvent was dried at 30 °C 
using the Eppendorf™ Vacufuge™ Concentrator. Thioester cleavage was carried 
out by the addition of 500 µL of 0.1 M KOH. The reactions were incubated at 70 °C 
for 15 minutes, subsequently mixed with 2 mL of methanol and centrifuged at 4000 
xg. The supernatant was dried at 45 °C using the Eppendorf™ Vacufuge™ 
Concentrator and subjected to liquid chromatography-mass spectrometry (LC-MS) 
analysis. Reactions that did not contain amino acids or PhoxP were used as negative 
controls. All reactions were performed in duplicate.  
 
8.5.2 In vitro AjiA1 reactions 
All in vitro AjiA1 reactions were performed in 25 mM HEPES buffer (pH 8.1). For the 
isolation of the 3-HAA amide dimer, the reactions contained 10 µM AjiA1, 5 mM ATP, 
10 mM MgCl2, 0.25 mM 3-hydroxyanthranilic acid (3-HAA) and MQ H2O to adjust to a 
final volume of 1 to 4 mL. For the testing of alternative substrates, the reactions 
contained 10 µM AjiA1, 5 mM ATP, 10 mM MgCl2, either 0.25 mM 3-hydroxybenzoic 
acid or 0.25 mM 2-amino-3-methylbenzoic acid and MQ H2O to adjust to a final 
volume of 100 µL. Following incubation at 21 °C overnight, the reactions were 
inactivated by the addition of TFA to a final concentration of 0.5 % (v/v) and 
subjected to extraction and analysis. Reactions which did not contain AjiA1 were 
used as negative controls. All reactions were performed in duplicate.  
 
8.5.3 In vitro reconstitution of (individual steps of) AJI9561 biosynthesis 
All in vitro enzymatic reactions were performed in 25 mM HEPES buffer (pH 8.1) with 
a total reaction volume of 100 µL, unless stated otherwise. All reactions contained 5 




methylsalicylic acid (6-MSA), and one or more of 20 µM AjiA2, 60 µM AjiP, 10 µM 
AjiA1, 1 µM AjiH and 20 µM AjiG. Following incubation at 21 °C overnight, the 
reactions were inactivated by the addition of TFA to a final concentration of 0.5 % 
(v/v), then subjected to extraction and analysis. Reactions which did not contain the 






8.6 Extraction methods 
8.6.1 Extraction of Streptomyces spp. liquid cultures or agar plates 
Liquid cultures of Streptomyces spp. were extracted twice with equal volume of ethyl 
acetate. Agar plates (5 mL) of Streptomyces spp. were cut into pieces (1 cm x 1 cm) 
and incubated in 15 mL of ethyl acetate for 1 hour. The organic phases were dried 
and subjected to LC-MS analysis.   
 
8.6.2 Extraction of in vitro enzymatic reactions 
All in vitro enzymatic reactions were extracted twice with equal volume of ethyl 





8.7 Chemoenzymatic and chemical synthesis methods 
8.7.1 Chemoenzymatic synthesis of N10-formyltetrahydrofolate (N10-fH4F) 
The N10-fH4F chemoenzymatic synthesis reaction contained 20 µM FolD, 500 µM 
H4F, 8 mM NAD+ and 2 mM HCHO in potassium phosphate buffer (120 mM K3PO4, 
50 mM β-mercaptoethanol; in MQ H2O; pH 6.0), as described in Schönafinger et al. 
(2006). A reaction which did not contain FolD was used as the negative control. The 
reactions were monitored by UV spectroscopy at 340 nm.  
 
8.7.2 Chemical synthesis of 6-MSA 
Ethyl-6-MSA (300 mg) was refluxed at 120 °C in 15 mL of 1 M NaOH for 2 hours. 
The reaction was analysed by thin-layer chromatography (TLC) using 1:1 (v/v) 
THF/isopropanol as the liquid solvent phase and potassium permanganate solution 
for staining, and visualised under a UV illuminator at 254 nm. The completed reaction 
was incubated on ice and added with sulphuric acid to a final concentration of 10% 
(v/v). The precipitated product was filtered, dried by lyophilisation and dissolved in 





8.8 Analytical methods 
8.8.1 Liquid chromatography-mass spectrometry (LC-MS) 
LC-MS analysis was performed using the Agilent 1200 Series LC system and the 
MAT LTQ mass spectrometer (Thermo/Finnigan) fitted with an electrospray ionisation 
source, at the positive ionisation mode. The system was fitted with a Prodigy® C18 
Column (4.6 x 250 mm, 5 µm) (Phenomenex) and a Jupiter® C4 Column (4.6 x 250 
mm, 5 µm) (Phenomenex) for the analysis of extracts and protein samples, 
respectively.  
For the analysis of Streptomyces spp. extracts and in vitro enzymatic 
reactions regarding phthoxazolin biosynthesis, a solvent system containing MQ H2O 
with 0.1 % (v/v) formic acid (FA) and acetonitrile with 0.1 % (v/v) formic acid, with a 
linear gradient of 95 to 5 % MQ H2O with 0.1 % (v/v) FA at a flow rate of 0.7 mL min-1 
over 30 minutes, was used. M/z values ranging from 100 to 1000 were scanned and 
m/z values of interest were subjected to MS/MS fragmentation at a normalised 
collision energy of 30 %. UV absorption was also monitored.  
For the analysis of in vitro enzymatic reactions regarding AJI9561 
biosynthesis, a solvent system containing MQ H2O with 0.1 % (v/v) TFA and 
acetonitrile with 0.1 % (v/v) TFA, with a linear gradient of 95 to 5 % MQ H2O with 0.1 
% (v/v) TFA at a flow rate of 0.7 mL min-1 over 45 minutes, was used. M/z values 
ranging from 100 to 1000 were scanned and m/z values of interest were subjected to 
MS/MS fragmentation at a normalised collision energy of 30 %. UV absorption was 
also monitored.  
LC-MS and LC-MS/MS data was processed (and deconvoluted) using 
Xcalibur (Thermo/Finnigan).  
 
8.8.2 Accurate mass analysis  
Accurate mass analysis was performed using Vion IMS-MS-QTOF in the positive 





8.9 Bioinformatic methods 
8.9.1 Genome annotation 
Genome sequences were visualised and annotated using Artemis 16.0 (Rutherford et 
al., 2000). AntiSMASH 4.0 was used to detect biosynthetic gene clusters and PKS 
and NRPS enzymatic domains (Blin et al., 2017). Putative function of gene products 
was predicted using protein-BLAST (Altschul et al., 1990).  
 
8.9.2 Multiple sequence alignments   
Multiple protein sequence alignments were performed using Clustal Omega (Sievers 
et al., 2011), unless stated otherwise.   
 
8.9.3 Phylogenetic analysis 
DNA or protein sequences were aligned with MUSLE (Edgar, 2004) and the 
phylogenetic trees were created by the Maximum-likelihood Method using MEGA7 
(Kumar et al., 2016).  
 
8.9.4 In silico modelling of protein structures  
In silico modelling of protein structures and prediction of active site pocket were 
performed using Phyre2 and RaptorX (Kelley et al., 2015; Källberg et al., 2012). Edu 




Table S1. Properties of genes encoded within cluster 1 (coelichelin) in 
Streptomyces sp. OM-5714.  












0132R   451 98/99 Streptomyces 
coelicoflavus 
L-ornithine mono-
oxygenase CchB  
EHN77998.1 


























0126R 3672 96/97 Streptomyces 
coelicoflavus 
NRPS (L-fh-Orn, 
hOrn, L-Thr) CchH 
EHN78004.1 











Table S2. Properties of genes encoded within cluster 2 (bacteriocin) in 
Streptomyces sp. OM-5714.  







0394   819 98/98 Streptomyces sp. 
NRRL WC-3753 
PAS regulator KPC76431.1 
0395   408 98/99 Streptomyces sp. 
NRRL WC-3753 
proteinase KPC76432.1 
0396   168 — — — — 
0397     71 — — — — 
0398   268 85/92 Streptomyces 
azureus 




0399   720 99/99 Streptomyces 
coelicoflavus 
ABC transporter EHN78272.1 
0400   937 99/99 Streptomyces 
coelicoflavus 
ABC transporter  EHN78271.1 
 
 
Table S3. Properties of genes encoded within cluster 3 (hopene/ATBH) in 
Streptomyces sp. OM-5714.  

















0723R   204 99/99 Streptomyces sp. 
NRRL WC-3753 
Xre regulator KPC72756.1 
0724R   461 99/100 Streptomyces 
coelicoflavus 
aminotransfer-ase EHN78561.1 
0725R   650 98/99 Streptomyces 
coelicoflavus 
DXP synthase EHN78560.1 







0727R   340 99/99 Streptomyces sp. 
FXJ7.023 
radical SAM 
protein HpnH  
WP_037772613 




























0733R   300 99/99 Streptomyces 
coelicoflavus 





Table S4. Properties of genes encoded within cluster 5a (butyrolactone) in 
Streptomyces sp. OM-5714.  














Table S5. Properties of genes encoded within cluster 6b (NIS) in Streptomyces 
sp. OM-5714.  







1205   126 — — — — 






1207   516 94/96 Streptomyces sp. 
NRRL WC-3753 
iron transporter KPC87684.1 
1208   421 94/96 Streptomyces sp. 
NRRL WC-3753 
Von Willebrand 
Factor type A 
protein 
KPC87685.1 
1209   262 77/87 Streptomyces 
sviceus 
secreted protein EDY55527.1 
1210R   218 92/94 Streptomyces 
lividans 
HxlR regulator EOY51317.1 
1211   402 99/99 Streptomyces 
coelicolflavus 
aminotransfer-ase  EHN77626.1 





1213   220 — — — — 
 
Table S6. Properties of genes encoded within cluster 7 (geosmin) in 
Streptomyces sp. OM-5714.  












1390R   193 95/96 Streptomyces sp. 
NRRL WC-3753 
membrane protein KPC71996.1 
1391R   740 97/98 Streptomyces sp. 
NRRL WC-3753 
geosmin synthase KPC71995.1 





1393R   215 99/99 Streptomyces sp. 
NRRL WC-3753 
A-factor receptor KPC71993.1 





1395   340 95/96 Streptomyces sp. 
NRRL WC-3753 
histidine kinase  KPC71991.1 
 
Table S7. Properties of genes encoded within cluster 8 (bacteriocin) in 
Streptomyces sp. OM-5714.  



















1414     75 - - - - 
1415R   224 98/98 Streptomyces sp. 
NRRL WC-3753 
ABC transporter KPC71969.1 
1416R   284 97/97 Streptomyces  
coelicoflavus 
ABC transporter EHN75332.1 









1419   265 93/93 Streptomyces sp. 
NRRL WC-3753 
membrane protein KPC71965.1 
 
1420   535 98/98 Streptomyces sp. 
NRRL WC-3753 
proteinase KPC71964.1 














Table S8. Properties of genes encoded within cluster 9a (isorenieratene) in 












NRRL WC-3753 diphosphate 
synthase 










1663 261 93/95 Streptomyces 
violaceorubidus 
2Fe-2S ferredoxin WP_030182286 





1665R 244 86/90 Streptomyces 
lividans 
methyltransfer-ase EFD65917.1 
1666R 394 80/86 Streptomyces sp. 
NRRL WC-3753 
lycopene cyclase KPC71991.1 






Table S9. Properties of genes encoded within cluster 9b (undecylprodigiosin) 
in Streptomyces sp. OM-5714.  







1677R   295 98/99 Streptomyces sp. 
NRRL WC-3753 
acyltransferase KPC71499.1 
1678R   226 33/58 Kibdelosporang-
ium aridum 
membrane protein WP_033381793 











1681R   362 95/99 Streptomyces 
coelicoflavus 
methyltransfer-ase EHN75476.1 
1682R   280 95/96 Streptomyces sp. 
NRRL WC-3753 
thioesterase II KPC71504.1 
1683R   347 95/96 Streptomyces sp. 
NRRL WC-3753 
oxidoreductase  KPC71505.1 





1685R 1882 85/88 Streptomyces 
coelicolor 
modular PKS CAA16183.1 
1686R   532 96/98 Streptomyces sp. 
NRRL WC-3753 
NRPS (MarM-like) KPC87186.1 




NRRL WC-3753 nonanoate 
synthase 
1688R     97 73/85 Streptomyces 
peruviensis 
ACP/PCP WP_030050065 





1690     81 97/98 Streptomyces 
coelicoflavus 
ACP EHN75488.1 





1692   146 47/60 Streptomyces 
katrae 
phosphoester-ase WP_030293828 
1693   296 64/75 Streptomyces sp. 
CNQ-617 
?MarT-like protein AHF22847.1 











1696   197 58/67 Streptomyces 
coelicoflavus 
LuxR regulator EHN75482.1 
1697R   106 98/98 Streptomyces 
coelicoflavus 
RedY protein EHN75490.1 





1699R 1086 94/95 Streptomyces sp. 
NRRL WC-3753 
RedX PKS KPC87173.1 
1700R   268 98/99 Streptomyces 
coelicoflavus 
RedD regulator EHN79898.1 
 
Table S10. Properties of genes encoded within cluster 10 (NIS) in Streptomyces 
sp. OM-5714.  













1769R   610 83/87 Streptomyces sp. 
NRRL WC-3753 
iron transporter WP_030184400 





















1774R   721 96/98 Streptomyces sp. 
NRRL WC-3753 
ppGpp synthetase KPC87189.1 
 
Table S11. Properties of genes encoded within cluster 11 (spore pigment) in 
Streptomyces sp. OM-5714.  












2228   405 98/98 Streptomyces sp. 
NRRL WC-3753 
protein in whiE 
locus 
WP_030184400 
2229   158 99/99 Streptomyces 
aureofaciens 
small protein in 
whiE locus 
WP_052840703 
2230   423 99/99 Streptomyces sp. 
NRRL WC-3753 
PKS KSalpha KPC88984.1 
2231   424 98/99 Streptomyces sp. 
NRRL WC-3753 
PKS KSbeta KPC88985.1 
2232     89 100/100 Streptomyces 
coelicoflavus 
ACP EHN75822.1 
2233   159 98/98 Streptomyces sp. 
NRRL WC-3753 
polyketide cyclase KPC88987.1 
2234   111 100/100 Streptomyces 
coelicoflavus 
WhiE VII EHN75820.1 
2235   299 98/99 Streptomyces 
coelicoflavus 
membrane protein EHN75819.1 
 
Table S12. Properties of genes encoded within cluster 12 (albaflavenone) in 
Streptomyces sp. OM-5714.  







2315   322 90/92 Streptomyces 
coelicoflavus 
AraC regulator EHN75894.1 












Table S13. Properties of genes encoded within cluster 13 (lipopeptide) in 
Streptomyces sp. OM-5714.  







3202   168 94/95 Streptomyces sp. 
NRRL WC-3753 
membrane protein KPC77435.1 





3204   253 98/99 Streptomyces sp. 
NRRL WC-3753 
Clp proteinase KPC77437.1 
3205   563 97/98 Streptomyces sp. 
NRRL WC-3753 
3'-5'-exo nuclease KPC77438.1 





















3210     72 99/99 Streptomyces 
coelicoflavus 
MbtH-like protein EHN72129.1 
3211   597 99/99 Streptomyces 
coelicoflavus 
SARP regulator EHN72128.1 






3213R   305 96/98 Streptomyces 
coelicoflavus 
SyrP-like protein EHN78774.1 





3215R   339 82/86 Streptomyces 
griseoruber 
ACP KEG39421.1 
3216R     59 — — — — 
3217R     72 47/60 Streptomyces sp. 
NRRL WC-3753 
MbtH-like protein KPC77449.1 
3218R     93 97/97 Streptomyces sp. 
NRRL WC-3753 
PCP KPC77450.1 















3222R   227 98/98 Streptomyces 
coelicoflavus 
RedY protein EHN75490.1 





3224R   256 94/95 Streptomyces sp. 
NRRL WC-3753 
RedX PKS KPC87173.1 
3225   405 99/99 Streptomyces sp. 
NRRL WC-3753 
histidine kinase KPC77455.1 
3226   202 99/99 Streptomyces sp. 
NRRL WC-3753 
LuxR regulator KPC77472.1 
3227R   314 99/99 Streptomyces 
coelicoflavus 
SyrP-like protein EHN72123.1 
3228R   346 100/100 Streptomyces 
coelicoflavus 
monooxygenase EHN72122.1 
3229R   427 98/98 Streptomyces 
coelicoflavus 
MFS transporter EHN72121.1 
























3234R   217 95/98 S. aureofaciens LuxR regulator WP_052836389 





3236R   409 — — — — 
 
Table S14. Properties of genes encoded within cluster 14 (NIS) in Streptomyces 
sp. OM-5714.  












4616R     85 — — — — 

















4620R   182 98/99 Streptomyces 
coelicoflavus 
acetyltransfer-ase EHN73011.1 






4622R   480 99/99 Streptomyces sp. 
NRRL WC-3753 
decarboxylase KPC85283.1 





4624R   350 99/99 Streptomyces 
coelicoflavus 
ABC transporter EHN73007.1 
 
Table S15. Properties of genes encoded within cluster 15 (melanin) in 
Streptomyces sp. OM-5714.  



























4702   254 44/53 Streptomyces 
sviceus 
secreted protein EDY61093.1 
4703   100 67/73 Streptomyces 
scabiei 
secreted protein CBG72938.1 
4704   171 42/56 Streptomyces 
venezuelae 
secreted protein WP_015035837 
4705   210 94/94 Streptomyces sp. 
NRRL WC-3753 
tyrosinase  KPC85870.1 
4706   288 100/100 Streptomyces sp. 
NRRL WC-3753 
tyrosinase KPC85358.1 





4708   211 83/88 Streptomyces 
lividans 
secreted protein EOY47759.1 
 


















Table S16. Properties of genes encoded within cluster 16 (ectoine) in 
Streptomyces sp. OM-5714.  
































































NRRL WC-3753 aminotransferase 
5571   176 50/62 Streptomyces 
mirabilis 
 
membrane protein WP_037710600 




Table S17. Properties of genes encoded within cluster 17 (bacteriocin) in 
Streptomyces sp. OM-5714.  












6089   301 97/98 Streptomyces sp. 
NRRL WC-3753 
oxidoreductase  EHN74213.1 
6090R   524 97/97 Streptomyces 
violaceorubidus 
acyltransferase WP_030189328 




6092R     59 - - - - 














6095R     42 - - - 
 
- 
6096R   606 96/97 Streptomyces 
ambofaciens 
 
putative peptidase CAK50898.1 


















Table S18. Properties of genes encoded within cluster 18 (flaviolin) in 
Streptomyces sp. OM-5714.  







6205R   177 96/98 Streptomyces 
violaceoruber 
cupin WP_032866113 
6206R   395 96/98 Streptomyces sp. 
NRRL F-5650 
cytochrome P450 WP_031033656 
6207R   357 98/99 Streptomyces 
coelicoflavus 
RppA type III PKS EHN79529.1 
 
Table S19. Properties of genes encoded within cluster 19 (isorenieratene) in 
Streptomyces sp. OM-5714.  
































6713R   493 98/99 Streptomyces sp. 
NRRL WC-3753 
lycopene cyclase KPC75212.1 











6716R   340 97/98 Streptomyces sp. 
NRRL WC-3753 
2Fe-2S ferredoxin KPC75089.1 
 
Table S20. Properties of genes encoded within cluster 20 (indole) in 
Streptomyces sp. OM-5714.  







6796   449 99/99 Streptomyces 
coelicoflavus 













Table S21. Properties of genes encoded within cluster 21 (2-methylisoborneol) 
in Streptomyces sp. OM-5714.  







6966R   291 98/100 Streptomyces 
coelicoflavus 
methyltransferase EHN74708.1 





6968R   458 97/98 Streptomyces 
coelicoflavus 
Crp/Fnr regulator EHN74706.1 
 
Table S22. Properties of genes encoded within cluster 22 (PKS-NRPS) in 
Streptomyces sp. OM-5714.  












0156R   420 86/91 Streptomyces sp. 
NRRL WC-3753 
cytochrome P450 KPC76453.1 
0157R     99 98/99 Kibdelospor-
angium sp. 
PCP/ACP CEL23081.1 





0159R   532 97/98 Kibdelospor-
angium sp. 
NRPS A (Pro) 
domain 
CTQ90221.1 
0160R   466 97/98 Streptomyces sp. 
NRRL WC-3753 
CFA ligase (Cfa5)  WP_053745359 















0164R   150 42/52 Streptomyces 
celluloflavus 
thioesterase II WP_052860305 















0168   439 42/60 Verrucosispora 
maris 
MFS transporter AEB46034.1 
0169R 1090 72/81 Nonomuraea 
candida 
NRPS C-A(?)-T WP_052422987 
putative 
ORF   
    70   possible MbtH 
protein? 
 
0170R 1738 76/83 Nonomuraea 
candida 
NRPS C-A(cys)-T-











(the active site of 
the AT is mutated 
Ser to Gly) 
ADD43707.1 




Table S23. Properties of genes encoded within cluster 23 (PUFA-related) in 
Streptomyces sp. OM-5714.  







0312   404 69/81 Glaciibacter sp. ROK regulator WP_022884622 

















0315R   778 53/62 Saccharopoly-
spora erythraea 
KR-DH domains CAL99375.1 
0316R 1271 59/71 Saccharopoly-
spora erythraea 




0317R   239 50/63 Streptomyces sp. 
SPB74 
thioesterase  EFG64483.1 





Table S24. Properties of genes encoded within cluster 24 (lomaiviticin-like) in 
Streptomyces sp. OM-5714.  





























































































     
start of 
contig 
  nuclease 
 
  
0001   471 51/59 Streptomyces sp. 
NRRL S-646 
 
lycopene cyclase WP_037884983 
 
0002     67 - - - - 














0005R     87 - - - - 















































































































































0025R   407 37/49 Streptomyces 
olindensis 
 
protein kinase KDN77276.1 
 














































































0039   156 96/98 Streptomyces sp. 
NRRL WC-3753 
AraC regulator KPC71358.1 
 












0042   113 - - - - 
 




0044R   132 94/97 Streptomyces sp. 
NRRL            F-
5008 
HxlR regulator KPC71361.1 
 











0047R   262 100/100 Streptomyces sp. 
NRRL WC-3753 
AraC regulator KPC71390.1 
 






0049R   138 90/98 Streptomyces            
griseoflavus 
 
toxin RelE  EFL40766.1 
































0055R   462 99/99 Streptomyces 
coelicoflavus 
amidase Lom33 EHN77687.1 
 


































0062R   261 100/100 Streptomyces 
coelicoflavus 
ketoacyl reductase EHN77677.1 
 
0063R     91 100/100 Streptomyces 
coelicoflavus 
ACP act-like EHN77678.1 
 
0064R   109 100/100 Streptomyces 
coelicoflavus 
polyketide cyclase EHN77679.1 
 
0065R   231 98/99 Streptomyces sp. 
NRRL WC-3753 
anthrone oxidase KPC71343.1 
 




































0071   422 96/97 Streptomyces sp. 
NRRL WC-3753 
MFS transporter KPC71339.1 
 
0072     74 - - - - 







0074R   276 80/88 Streptomyces 
azureus 
 
SARP regulator GAP47966.1 
 
0075R   208 96/97 Streptomyces 
coelicoflavus 
 
TetR regulator EHN80235.1 
 









0077R     59 - - - - 





































Table S25. Properties of genes encoded within cluster 1 (coelichelin) in 
Streptomyces sp. KO-7888.  












0134R   451 98/99 Streptomyces sp. 
NRRL WC-3753 
L-ornithine mono-
oxygenase CchB  
KPC76206.1 


























0128R 3672 96/97 Streptomyces 
coelicoflavus 
NRPS (L-fh-Orn, 
hOrn, L-Thr) CchH 
EHN78004.1 











Table S26.  Properties of genes encoded within cluster 2 (bacteriocin) in 
Streptomyces sp. KO-7888.  







0396R   828 98/99 Streptomyces sp. 
NRRL WC-3753 
PAS regulator KPC76431.1 
0397R   408 98/99 Streptomyces sp. 
NRRL WC-3753 
proteinase KPC76432.1 
0398   168 — — — — 
0399     71 — — — — 
0400   268 85/92 Streptomyces 
azureus 
secreted protein GAP45380.1 
0401   720 99/99 Streptomyces 
coelicoflavus 
ABC transporter EHN78272.1 
0402   937 99/99 Streptomyces 
coelicoflavus 





Table S27.  Properties of genes encoded within cluster 3 (hopene/ATBH) in 
Streptomyces sp. KO-7888.  

















0725R   204 99/100 Streptomyces 
coelicoflavus 
Xre regulator EHN78562.1 
0726R   461 99/99 Streptomyces 
coelicoflavus 
aminotransfer-ase EHN78561.1 
0727R   650 98/99 Streptomyces 
coelicoflavus 
DXP synthase EHN78560.1 







0729R   340 99/99 Streptomyces sp. 
FXJ7.023 
radical SAM 
protein HpnH  
WP_037772613 




























0735R   300 98/98 Streptomyces 
coelicoflavus 
squalene synthase KPC72746.1 
 
Table S28.  Properties of genes encoded within cluster 5b (arsenolipid) in 
Streptomyces sp. KO-7888.  






















1164R     91 44/55 Streptomyces 
bingcheng-gensis 
histidine kinase ADI11540.1 
1165R   111 97/98 Streptomyces 
coelicolor 
ArsR repressor CAB71918.1 
1166   196 97/98 Streptomyces 
coelicolor 
oxidoreductase CAB71917.1 
1167R   493 99/99 Streptomyces 
coelicolor 
flavoprotein CAB71916.1 
1168 2358 97/97 Streptomyces 
coelicoflavus 
PKS EHN74897.1 
1169   346 45/61 Streptomyces 
avermitilis 
FabH BAC71233.1 
1170   223 97/99 Streptomyces 
coelicoflavus 
membrane protein EHN74895.1 






1172R   133 99/99 Streptomyces 
lividans 
ArsR regulator EOY45801.1 





1174   240 90/93 Streptomyces 
griseorubens 
CTP synthase  KEG37908.1 
1175   745 98/99 Streptomyces 
coelicolor 
oxidoreductase CAB71267.1 






































1182R     92 100/100 Streptomyces 
coelicolor 
ArsR regulator CAB71260.1 
1183   429 97/98 Streptomyces 
coelicolor 
secreted protein CAB71258.1 
1184   152 94/96 Streptomyces 
coelicolor 
glyoxalase CAB71257.1 
1185   409 97/97 Streptomyces 
coelicolor 
MFS transporter CAB71256.1 
1186   120 99/100 Streptomyces 
coelicoflavus 
ArsR regulator EHN74882.1 
1187R   352 97/98 Streptomyces 
coelicoflavus 
mono-oxygenase EHN74294.1 
1188R     65 — — — — 






1190R   102 100/100 Streptomyces 
coelicoflavus 
ArsR regulator EHN74921.1 















Table S29.  Properties of genes encoded within cluster 6a (NRPS) in 
Streptomyces sp. KO-7888.  







1556R   304 79/84 Streptomyces 
viridosporus 
aminotransfer-ase WP_016823965 
1557R   233 100/100 Streptomyces 
coelicoflavus 
LuxR regulator EHN79569.1 
1558R   113 99/99 Streptomyces 
coelicoflavus 
MbtH-like EHN79570.1 
1559R     61 100/100 Streptomyces 
coelicoflavus 
MbtH-like EHN79571.1 




























1565R   432 99/99 Streptomyces 
coelicoflavus 
esterase EHN79577.1 










1568   152 - - - - 
1569   398 98/99 Streptomyces 
coelicoflavus 
peptidase M23  EHN75119.1 
1570R   235 99/100 Streptomyces 
coelicoflavus 
ABC transporter EHN75124.1 
1571R   325 100/100 Streptomyces 
coelicoflavus 
ABC transporter EHN75123.1 
1572R   381 99/99 Streptomyces 
coelicoflavus 
peptidase EHN75122.1 







  199 100/100 Streptomyces 
coelicoflavus 
LuxR regulator EHN75120.1 
1575R   936 33/45 Streptomyces sp. 
MBT28 
LuxR regulator WP_046251400 





1577   841 30/40 Streptomyces sp. 
PRh5 
LuxR regulator EXU65116.1 
 
Table S30. Properties of genes encoded within cluster 6b (butyrolactone) in 
Streptomyces sp. KO-7888.  













1588   516 94/96 Streptomyces sp. 
NRRL WC-3753 
iron transporter KPC87684.1 
1589   421 94/96 Streptomyces sp. 
NRRL WC-3753 
Von Willebrand 






1590   262 77/87 Streptomyces 
sviceus 
secreted protein EDY55527.1 
1591R   218 92/94 Streptomyces 
lividans 
HxlR regulator EOY51317.1 
1592   402 99/99 Streptomyces 
coelicolflavus 
aminotransferase  EHN77626.1 





1594   216 — — — — 
1595   132 91/96 Streptomyces sp. thioesterase WP_030403422 
 
Table S31. Properties of genes encoded within cluster 7 (geosmin) in 
Streptomyces sp. KO-7888.  







1771R   193 95/96 Streptomyces sp. 
NRRL WC-3753 
membrane protein KPC71996.1 
1772R   740 98/99 Streptomyces sp. 
NRRL WC-3753 
geosmin synthase KPC71995.1 
1773R   405 75/83 Streptomyces 
azureus 
oxidoreductase GAP48695.1 
1774R   215 99/99 Streptomyces sp. 
NRRL WC-3753 
A-factor receptor KPC71993.1 





1776   860 94/96 Streptomyces sp. 
NRRL WC-3753 
histidine kinase  KPC71991.1 
 
Table S32. Properties of genes encoded within cluster 8 (bacteriocin) in 
Streptomyces sp. KO-7888.  


















1796     75 - - - - 
1797R   224 98/98 Streptomyces sp. 
NRRL WC-3753 
ABC transporter KPC71969.1 














1801 265 93/93 Streptomyces sp. 
NRRL WC-3753 
membrane protein KPC71965.1 
 
1802 535 96/97 Streptomyces sp. 
NRRL WC-3753 
proteinase KPC71964.1 













Table S33. Properties of genes encoded within cluster 9b (undecylprodigiosin) 
in Streptomyces sp. KO-7888.  







1972R   295 98/99 Streptomyces sp. 
NRRL WC-3753 
acyltransferase KPC71499.1 
1973R   226 33/58 Kibdelosporang-
ium aridum 
membrane protein WP_033381793 











1976R   362 99/99 Streptomyces 
coelicoflavus 
methyltransfer-ase EHN75476.1 
1977R   280 96/97 Streptomyces sp. 
NRRL WC-3753 
thioesterase II EHN75475.1 
1978R   347 98/99 Streptomyces sp. 
NRRL WC-3753 
oxidoreductase  EHN75474.1 





1980R 1885 85/89 Streptomyces 
coelicolor 
modular PKS CAA16183.1 
1981R   532 96/97 Streptomyces sp. 
NRRL WC-3753 
NRPS (MarM-like) KPC87186.1 









1983R     97 73/85 Streptomyces 
peruviensis 
ACP/PCP WP_030050065 





1985     81 98/98 Streptomyces 
coelicoflavus 
ACP EHN75488.1 





1987   146 47/60 Streptomyces 
katrae 
phosphoester-ase WP_030293828 
1988   296 64/75 Streptomyces sp. 
CNQ-617 
?MarT-like protein AHF22847.1 











1991   197 98/99 Streptomyces 
coelicoflavus 
LuxR regulator EHN75482.1 
1992R   106 98/98 Streptomyces 
coelicoflavus 
RedY protein EHN75490.1 





1994R 1071 94/95 Streptomyces sp. 
NRRL WC-3753 
RedX PKS KPC87173.1 
1995R   268 98/99 Streptomyces 
coelicoflavus 
RedD regulator EHN79898.1 
 
Table S34. Properties of genes encoded within cluster 10 (NIS) in Streptomyces 
sp. KO-7888.  













1769R   673 79/82 Streptomyces 
violaceorubidis 
iron transporter WP_030184400 






1771   408 80/89 Streptomyces 
davawensis 
secreted protein CCK27029.1 










1774R   721 96/98 Streptomyces sp. 
NRRL WC-3753 
ppGpp synthetase KPC87189.1 
 
Table S35. Properties of genes encoded within cluster 11 (spore pigment) in 
Streptomyces sp. KO-7888.  












2530   405 98/98 Streptomyces sp. 
NRRL WC-3753 
protein in whiE 
locus 
KPC89504.1 
2531   158 99/99 Streptomyces 
aureofaciens 
small protein in 
whiE locus 
WP_052840703 
2532   423 99/99 Streptomyces sp. 
NRRL WC-3753 
PKS KSalpha KPC88984.1 
2533   424 98/99 Streptomyces sp. 
NRRL WC-3753 
PKS KSbeta KPC88985.1 
2534     89 100/100 Streptomyces 
coelicoflavus 
ACP EHN75822.1 
2535   159 98/98 Streptomyces sp. 
NRRL WC-3753 
polyketide cyclase KPC88987.1 
2536   111 100/100 Streptomyces 
coelicoflavus 
WhiE VII EHN75820.1 
2537   299 98/99 Streptomyces 
coelicoflavus 
membrane protein EHN75819.1 
 
Table S36. Properties of genes encoded within cluster 12 (albaflavenone) in 
Streptomyces sp. KO-7888.  







2632   322 99/100 Streptomyces 
coelicoflavus 
AraC regulator EHN75894.1 














Table S37. Properties of genes encoded within cluster 13 (lipopeptide) in 
Streptomyces sp. KO-7888.  







3489   172 96/97 Streptomyces sp. 
NRRL WC-3753 
membrane protein KPC77435.1 





3491   253 98/99 Streptomyces sp. 
NRRL WC-3753 
Clp proteinase KPC77437.1 
3492   563 97/98 Streptomyces sp. 
NRRL WC-3753 
3'-5'-exo nuclease KPC77438.1 





















3497     72 99/99 Streptomyces sp. 
NRRL WC-3753 
MbtH-like protein KPC77443.1 
3498   597 97/98 Streptomyces 
coelicoflavus 
SARP regulator EHN72128.1 





3500R   305 96/98 Streptomyces 
coelicoflavus 
SyrP-like protein EHN78774.1 





3502R   339 82/86 Streptomyces 
griseoruber 
ACP KEG39421.1 
3503R     59 — — — — 
3504     72 98/100 Streptomyces 
coelicoflavus 
MbtH-like protein EHN77811.1 
3505R     93 97/97 Streptomyces 
coelicoflavus 
PCP EHN77810.1 


















3509R   227 98/98 Streptomyces sp. 
NRRL WC-3753 
RedY protein KPC77452.1 





3511R   256 94/95 Streptomyces sp. 
NRRL WC-3753 
RedX PKS KPC77454.1 
3512   405 99/99 Streptomyces sp. 
NRRL WC-3753 
histidine kinase KPC77455.1 
3513   202 99/99 Streptomyces sp. 
NRRL WC-3753 
LuxR regulator KPC77456.1 
3514R   314 99/99 Streptomyces sp. 
NRRL WC-3753 
SyrP-like protein KPC77457.1 
3515R   346 100/100 Streptomyces sp. 
NRRL WC-3753 
monooxygenase KPC77458.1 
3516R   427 98/98 Streptomyces sp. 
NRRL WC-3753 
MFS transporter KPC77459.1 
3517R 3867 50/62 S. sp. 769 NRPS (CAT-CAT-
CAMT-Te) 
AJC59844.1 

















3521R   217 95/97 S. aureofaciens LuxR regulator WP_052836389 





3523R   400 35/49 Prauserella sp. Clp proteinase KID29624.1 
 
Table S38. Properties of genes encoded within cluster 14 (NIS) in Streptomyces 
sp. KO-7888.  












4857R     85 — — — — 




















4861R   182 98/99 Streptomyces 
coelicoflavus 
acetyltransferase EHN73011.1 






4863R   480 99/99 Streptomyces sp. 
NRRL WC-3753 
decarboxylase KPC85283.1 





4865R   350 99/99 Streptomyces 
coelicoflavus 
ABC transporter EHN73007.1 






Table S39. Properties of genes encoded within cluster 15 (melanin) in 
Streptomyces sp. KO-7888.  


























4943   259 44/53 Streptomyces 
sviceus 
secreted protein EDY61093.1 
4944   100 67/73 Streptomyces 
scabiei 
secreted protein CBG72938.1 
4945   171 42/56 Streptomyces 
venezuelae 
secreted protein WP_015035837 
4946   210 93/95 Streptomyces sp. 
NRRL WC-3753 
tyrosinase  KPC85870.1 
4947   288 99/100 Streptomyces sp. 
NRRL WC-3753 
tyrosinase KPC85358.1 





4949   211 83/88 Streptomyces 
lividans 
secreted protein EOY47759.1 
 


















Table S40. Properties of genes encoded within cluster 16 (ectoine) in 
Streptomyces sp. KO-7888.  




































5779R   132 99/100 Streptomyces sp. 
NRRL F-5650 
 
























NRRL WC-3753 aminotransferase 
5783   176 50/62 Streptomyces 
mirabilis 
 
membrane protein WP_037710600 




Table S41. Properties of genes encoded within cluster 17 (bacteriocin) in 
Streptomyces sp. KO-7888.  












6295   301 97/98 Streptomyces sp. 
NRRL WC-3753 
oxidoreductase  EHN74213.1 
6296R   524 97/97 Streptomyces 
violaceorubidus 
acyltransferase WP_030189328 




6298R     59 - - - - 














6301R     42 - - - 
 
- 
6302R   606 96/97 Streptomyces 
ambofaciens 
 
putative peptidase CAK50898.1 







6304R     33 - - - - 








Table S42. Properties of genes encoded within cluster 18 (flaviolin) in 
















6413R   395 96/98 Streptomyces sp. 
NRRL F-5650 
cytochrome P450  WP_031633656 
6414R   357 98/99 Streptomyces 
coelicoflavus 




Table S43. Properties of genes encoded within cluster 19 (isorenieratene) in 
Streptomyces sp. KO-7888.  






























6892R   493 98/98 Streptomyces sp. 
NRRL WC-3753 
lycopene cyclase KPC75212.1 











6895R   340 97/98 Streptomyces sp. 
NRRL WC-3753 
2Fe-2S ferredoxin KPC75089.1 
 
Table S44. Properties of genes encoded within cluster 20 (indole) in 
Streptomyces sp. KO-7888.  






















Table S45. Properties of genes encoded within cluster 21 (MIB) in 
Streptomyces sp. KO-7888.  







7138R   291 98/100 Streptomyces sp. 
WC-3753 
methyltransferase KPC86710.1 





7140R   458 97/98 Streptomyces 
coelicoflavus 
Crp/Fnr regulator EHN74706.1 
 
Table S46. Properties of genes encoded within cluster 24 (lomaiviticin-like) in 
Streptomyces sp. KO-7888.  











0016R   421 100/100 Streptomyces 
coelicoflavus 
 
KSα  EHN77732.1 
 











































































0027     67 - - - - 














0030R     87 - - - - 















































































































































0050R   407 37/49 Streptomyces 
olindensis 
 
protein kinase KDN77276.1 
 















































































0063   156 96/98 Streptomyces sp. 
NRRL WC-3753 
AraC regulator KPC71358.1 
 


















































0071R   462 99/99 Streptomyces 
coelicoflavus 
amidase Lom33 EHN77687.1 
 


































0078R   261 100/100 Streptomyces 
coelicoflavus 
ketoacyl reductase EHN77677.1 
 
0079R     91 100/100 Streptomyces 
coelicoflavus 
ACP act-like EHN77678.1 
 
0080R   109 100/100 Streptomyces 
coelicoflavus 
polyketide cyclase EHN77679.1 
 
0081R   231 98/99 Streptomyces sp. 
NRRL WC-3753 
anthrone oxidase KPC71343.1 
 






































0087   418 96/97 Streptomyces sp. 
NRRL WC-3753 
MFS transporter KPC71339.1 
 
0088     74 - - - - 







0090R   276 80/88 Streptomyces 
azureus 
 
SARP regulator GAP47966.1 
 
0091R   208 96/97 Streptomyces 
coelicoflavus 
 
TetR regulator EHN80235.1 
 









0093R     69 - - - - 



































Abraham, E.P., and Chain, E. (1940). An enzyme from bacteria able to destroy 
penicillin. Nature 146, 837. 
Abraham, E.P., Chain, E., Fletcher, C.M., Florey, H.W., Gardner, A.D., Heatley, 
N.G., and Jennings, M.A. (1941). Further observations on penicillin. Lancet 238, 
177–189, 
Achkar, J., Xian, M., Zhao, H., and Frost, J. (2005). Biosynthesis of 
phloroglucinol. J. Am. Chem. Soc. 127, 5332–5333. 
Aggarwal, R., Caffrey, P., Leadlay, P.F, Smith, C.J., and Staunton, J. (1995). The 
thioesterase of the erythromycin-producing polyketide synthase: mechanistic 
studies in vitro to investigate its mode of action and substrate specificity J. Chem. 
Soc., Chem. Commun. 15, 1519–1520.  
Akiva, E., Brown, S., Almonacid, D.E., Barber, A.E. 2nd, Custer, A.F., Hicks, M.A., 
Huang, C.C., Lauck, F., Mashiyama, S.T., Meng, E.C., Mischel, D., Morris, J.H., 
Ojha, S., Schnoes, A.M., Stryke, D., Yunes, J.M., Ferrin, T.E., Holliday, G.L., and 
Babbitt, P.C. (2014). The Structure-Function Linkage Database. Nucl. Acids Res. 
42, D521–D530.  
Akiyama, T., Harada, S., Kojima, F., Takahashi, Y., Imada, C., Okami, Y., 
Muraoka, Y., Aoyagi, T., and Takeuchi, T. (1998). Fluostatins A and B, new 
inhibitors of dipeptidyl peptidase III, produced by Streptomyces sp. TA-3391. I. 
Taxonomy of producing strain, production, isolation, physico-chemical properties 
and biological properties. J. Antibiot. 51, 553–559. 
Alekseyev, V.Y., Liu, C.W., Cane, D.E., Puglisi, J.D., and Khosla, C. (2007). 
Solution structure and proposed domain domain recognition interface of an acyl 
carrier protein domain from a modular polyketide synthase. Protein Sci. 16, 2093–
2107. 
Alhamadsheh, M.M., Palaniappan, N., Daschouduri, S., and Reynolds, K.A. (2007). 
Modular polyketide synthases and cis double bond formation: establishment of 
activated cis-3-cyclohexylpropenoic acid as the diketide intermediate in 
phoslactomycin biosynthesis. J. Am. Chem. Soc. 129, 1910–1911. 




local alignment search tool. J. Mol. Biol. 215, 403–410. 
Ames, B.D., Korman, T.P., Zhang, W., Smith, P., Vu, T., Tang, Y., and Tsai, S.C. 
(2008). Crystal structure and functional analysis of tetracenomycin ARO/CYC: 
implications for cyclization specificity of aromatic polyketides. Proc. Natl. Acad. Sci. 
U.S.A. 105, 5349–5354. 
AMR Review (Review on Antimicrobial Resistance). (2016). Tackling drug-resistant 
infections globally:  Final report and recommendations. London: Review on 
Antimicrobial Resistance. 
Angert, E.R. (2005). Alternatives to binary fission in bacteria. Nat. Rev. Microbiol. 
3, 214–224. 
Arakawa, K., Sugino, F., Kodama, K., Ishii, T., and Kinashi, H. (2005). Cyclization 
mechanism for the synthesis of macrocyclic antibiotic lankacidin in Streptomyces 
rochei. Chem. Biol. 12, 249–256. 
Aravind, L., Anantharaman, V., and Koonin, E.V. (2002). Monophyly of class I 
aminoacyl tRNA synthetase, USPA, ETFP, photolyase, and PP-ATPase 
nucleotide-binding domains: implications for protein evolution in the RNA. Proteins 
48, 1–14. 
Auclair, K., Kennedy, J., Hutchinson, C.R., and Vederas, J.C. (2001). Conversion 
of cyclic nonaketides to lovastatin and compactin by a lovC deficient mutant of 
Aspergillus terreus. Bioorg. Med. Chem. Lett. 11, 1527–1531. 
Awodi, U.R., Ronan, J.L., Masschelein, J., de Los Santos, E.L.C., and Challis, G.L. 
(2017).  Thioester reduction and aldehyde transamination are universal steps in 
actinobacterial polyketide alkaloid biosynthesis. Chem. Sci. 8, 411–415. 
Baerga-Ortiz, A., Popovic, B., Siskos, A.P., O'Hare, H.M., Spiteller, D., Williams, 
M.G., Campillo, N., Spencer, J.B., and Leadlay, P.F. (2006). Directed mutagenesis 
alters the stereochemistry of catalysis by isolated ketoreductase domains from the 
erythromycin polyketide synthase. Chem. Biol. 13, 277–285. 
Bailey, A.M., Cox, R.J., Harley, K., Lazarus, C.M., Simpson, T.J., and Skellam, E. 
(2007). Characterisation of 3-methylorcinaldehyde synthase (MOS) in Acremonium 
strictum: first observation of a reductive release mechanism during polyketide 
biosynthesis. J. Chem. Soc., Chem. Commun. 39, 4053–4055. 




M.M., Fisher, A.J., and Rayment, I. (1995). Structure of bacterial luciferase. Curr. 
Opin. Struct. Biol. 5, 798–809. 
Balibar, C.J., and Walsh, C.T. (2006). GliP, a multimodular nonribosomal peptide 
synthetase in Aspergillus fumigatus, makes the diketopiperazine scaffold of 
gliotoxin. Biochemistry 45, 15029–15038. 
Baltz, R.H., and Seno, E.T. (1981). Properties of Streptomyces fradiae mutants 
blocked in biosynthesis of the macrolide antibiotic tylosin. Antimicrob. Agents 
Chemother. 20, 214–225. 
Barajas, J.F., Shakya, G., Moreno, G., Rivera, H. Jr., Jackson, D.R., Topper, C.L., 
Vagstad, A.L., La Clair, J.J., Townsend, C.A., Burkart, M.D., and Tsai, S.C. (2017). 
Polyketide mimetics yield structural and mechanistic insights into product template 
domain function in nonreducing polyketide synthases. Proc. Natl. Acad. Sci. U.S.A. 
114, E4142–E4148.  
Baur, S., Niehaus, J., Karagouni, A.D., Katsifas, E.A., Chalkou, K., Meintanis, C., 
Jones, A.L., Goodfellow, M., Ward, A.C., Beil, W., Schneider, K., Süssmuth, R.D., 
and Fiedler, H.P. (2006). Fluostatins C-E, novel members of the fluostatin family 
produced by Streptomyces strain Acta 1383. J. Antibiot. 59, 293–297. 
Bayer, A., Freund, S., and Jung, G. (1995). Post-translational heterocyclic 
backbone modifications in the 43-peptide antibiotic microcin B17. Structure 
elucidation and NMR study of a 13C,15N-labelled gyrase inhibitor. Eur. J. Biochem. 
234, 414–426. 
Beamer, L.J., and Pabo, C.O. (1992). Refined 1.8 Å crystal structure of the lambda 
repressor-operator complex. J. Mol. Biol. 227, 177–196. 
Belshaw, P.J., Walsh, C.T., and Stachelhaus, T. (1999). Aminoacyl-CoAs as 
probes of condensation domain selectivity in nonribosomal peptide synthesis. 
Science 284, 486–489. 
Bentley, S.D., Chater, K.F., Cerdeño-Tárraga, A.M., Challis, G.L., Thomson, N.R., 
James, K.D., Harris, D.E., Quail, M.A., Kieser, H., Harper, D., Bateman, A., Brown, 
S., Chandra, G., Chen, C.W., Collins, M., Cronin, A., Fraser, A., Goble, A., Hidalgo, 
J., Hornsby, T., Howarth, S., Huang, C.H., Kieser, T., Larke, L., Murphy, L., Oliver, 
K., O'Neil, S., Rabbinowitsch, E., Rajandream, M.A., Rutherford, K., Rutter, S., 
Seeger, K., Saunders, D., Sharp, S., Squares, R., Squares, S., Taylor, K., Warren, 




(2002). Complete genome sequence of the model actinomycete Streptomyces 
coelicolor A3(2). Nature 417, 141–147. 
Bérdy, J. (2005). Bioactive microbial metabolites. J. Antibiot. 58, 1–26. 
Betlach, M.C., Kealey, J.T., Ashley, G.W., and McDaniel, R. (1998). 
Characterization of the macrolide P-450 hydroxylase from Streptomyces 
venezuelae which converts narbomycin to picromycin. Biochemistry 37, 14937–
14942. 
Bignell, D.R., Seipke, R.F., Huguet-Tapia, J.C., Chambers, A.H., Parry, R.J., and 
Loria, R. (2010). Streptomyces scabies 87-22 contains a coronafacic acid-like 
biosynthetic cluster that contributes to plant-microbe interactions. Mol. Plant 
Microbe Interact. 23, 161–175. 
Bignell, D.R., Cheng, Z., and Bown, L. (2018). The coronafacoyl phytotoxins: 
structure, biosynthesis, regulation and biological activities. Antonie Van 
Leeuwenhoek 111, 649–666. 
Bindman, N.A., and Van Der Donk, W.A. ed., (2014). RiPPs: Ribosomally 
Synthesized and Posttranslationally Modified Peptides. In: Natural Products: 
Discourse, Diversity, and Design, first edition. Hoboken: John Wiley & Sons, Inc., 
197–218. 
Birch, A., Häusler, A., and Hütter, R. (1990). Genome rearrangement and genetic 
instability in Streptomyces spp. J. Bacteriol. 172, 4138–4142. 
Bisang, C., Long, P.F., Cortés, J., Westcott, J., Crosby, J., Matharu, A.L., Cox, 
R.J., Simpson, T.J., Staunton, J., and Leadlay, P.F. (1999). A chain initiation factor 
common to both modular and aromatic polyketide synthases. Nature 401, 502–
505. 
Blin K, Medema MH, Kottmann R, Lee SY, Weber T. (2017). The antiSMASH 
database, a comprehensive database of microbial secondary metabolite 
biosynthetic gene clusters. Nucl. Acids Res. 45, D555–D559. 
Bloudoff, K., and Schmeing, T.M. (2017). Structural and functional aspects of the 
nonribosomal peptide synthetase condensation domain superfamily: discovery, 
dissection and diversity. Biochim. Biophys. Acta. 1865, 1587–1604. 
Bode, H.B., Bethe, B., Höfs, R., and Zeeck, A. (2002). Big effects from small 





Boehlein, S.K., Schuster, S.M., and Richards, N.G. (1996). Glutamic acid gamma-
monohydroxamate and hydroxylamine are alternate substrates for Escherichia coli 
asparagine synthetase B. Biochemistry 35, 3031–3037. 
Brigham, R.B., and Pittenger, R.C. (1956). Streptomyces orientalis, n. sp., the 
source of vancomycin. Antibiot. Chemother. 6, 642–647. 
Brotzu, G. (1948). Ricerche su di un nuovo antibiotico. Lav. Ist. Ig. Cagliari, 1–11. 
Bruns, H., Crüsemann, M., Letzel, A.C., Alanjary, M., McInerney, J.O., Jensen, 
P.R., Schulz, S., Moore, B.S., and Ziemert, N. (2018). Function-related 
replacement of bacterial siderophore pathways. ISME J. 12, 320–329. 
Bunet, R., Song, L., Mendes, M.V., Corre, C., Hotel, L., Rouhier, N., Framboisier, 
X., Leblond, P., Challis, G.L., and Aigle, B. (2010). Characterization and 
manipulation of the pathway-specific late regulator AlpW reveals Streptomyces 
ambofaciens as a new producer of Kinamycins. J. Bacteriol. 193, 1142–1153. 
Butz D, Schmiederer T, Hadatsch B, Wohlleben W, Weber T, Süssmuth RD. 
(2008). Module extension of a non-ribosomal peptide synthetase of the 
glycopeptide antibiotic balhimycin produced by Amycolatopsis balhimycina. 
ChemBioChem 9, 1195–1200.  
Caffrey, P. (2003). Conserved amino acid residues correlating with ketoreductase 
stereospecificity in modular polyketide synthases. ChemBioChem 4, 654–657.  
Cane, D.E., and Watt, R.M. (2003). Expression and mechanistic analysis of a 
germacradienol synthase from Streptomyces coelicolor implicated in geosmin 
biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 100, 1547–1551.   
Cane, D.E., He, X., Kobayashi, S., Ōmura, S., and Ikeda, H. (2006). Geosmin 
Biosynthesis in Streptomyces avermitilis. Molecular Cloning, Expression, and 
Mechanistic Study of the Germacradienol/Geosmin Synthase J. Antibiot. 59, 471–
479. 
Cano-Prieto, C., García-Salcedo, R., Sánchez-Hidalgo, M., Braña, A.F., Fiedler, 
H.P., Méndez, C., Salas, J.A., and Olano, C. (2015). Genome Mining of 
Streptomyces sp. Tü 6176: Characterization of the Nataxazole Biosynthesis 
Pathway. ChemBioChem 16, 1461–1473.  




biosynthetic genes for disorazoles, potent cytotoxic compounds that disrupt 
microtubule formation. Gene 359, 91–98.  
Chain, E., Florey, H.W., Gardner, A.D., Heatley, N.G., Jennings, M.A., Orr-Ewing, 
J., and Sanders, A.G. (1940). Penicillin as a chemotherapeutic agent. Lancet 236, 
226–228. 
Challis, G.L., and Ravel, J. (2000). Coelichelin, a new peptide siderophore 
encoded by the Streptomyces coelicolor genome: structure prediction from the 
sequence of its non-ribosomal peptide synthetase. FEMS Microbiol. Lett. 187, 
111–114. 
Challis, G.L., Ravel, J., and Townsend, C.A. (2000). Predictive, structure-based 
model of amino acid recognition by nonribosomal peptide 
synthetase adenylation domains. Chem. Biol. 7, 211–224. 
Chang, Z., Sitachitta, N., Rossi, J.V., Roberts, M.A., Flatt, P.M., Jia, J., Sherman, 
D.H., and Gerwick, W.H. (2004). Biosynthetic pathway and gene cluster analysis of 
curacin A, an antitubulin natural product from the tropical marine cyanobacterium 
Lyngbya majuscula. J. Nat. Prod. 67, 1356–1367.  
Chater, K.F., and Bibb, M.J. (1997). Regulation of bacterial antibiotic production. In 
Biotechnology, Vol 7: Products of Secondary Metabolism. Kleinkauf, H., and Von 
Döhren, H., eds. Weinheim: Wiley-VCH, 57–105. 
Chen, D., Zhang, L., Pang, B., Chen, J., Xu, Z., Abe, I., and Liu, W. (2013). FK506 
maturation involves a cytochrome p450 protein-catalyzed four-electron C-9 
oxidation in parallel with a C-31 O-methylation. J. Bacteriol. 195, 1931–1919. 
Cheng, K., Rong, X., and Huang, Y. (2016). Widespread interspecies homologous 
recombination reveals reticulate evolution within the genus Streptomyces. Mol. 
Phylogenet. Evol. 102, 246–254. 
Cheng, Y.Q., Tang, G.L., and Shen, B. (2003). Type I polyketide synthase 
requiring a discrete acyltransferase for polyketide biosynthesis. Proc. Natl. Acad. 
Sci. U.S.A. 100, 3149–3154. 
Chevrette, M.G., Aicheler, F., Kohlbacher, O., Currie, C.R., and Medema, M.H. 
(2017). SANDPUMA: ensemble predictions of nonribosomal peptide chemistry 
reveal biosynthetic diversity across Actinobacteria. Bioinformatics 33, 3202–3210. 




Mavrommatis, K., Pati, A., Godfrey, P.A., Koehrsen, M., Clardy, J., Birren, B.W., 
Takano, E., Sali, A., Linington, R.G., and Fischbach, M.A. (2014). Insights into 
secondary metabolism from a global analysis of prokaryotic biosynthetic gene 
clusters. Cell 158, 412–421.  
Colis, L.C., Woo, C.M., Hegan, D.C., Li, Z., Glazer, P.M., and Herzon, S.B. (2014). 
The cytotoxicity of (-)-lomaiviticin A arises from induction of double-strand breaks in 
DNA. Nat. Chem. 6, 504–510. 
Conti, E., Stachelhaus, T., Marahiel, M.A., and Brick, P. (1997). Structural basis for 
the activation of phenylalanine in the non-ribosomal biosynthesis of gramicidin S. 
EMBO J. 16, 4174–4183. 
Coombs, J.T., and Franco, C.M. (2003). Visualization of an endophytic 
Streptomyces species in wheat seed. Appl. Environ. Microbiol. 69, 4260–4262. 
Cortés, J., Haydock, S.F., Roberts, G.A., Bevitt, D.J., and Leadlay, P.F. (1990). An 
unusually large multifunctional polypeptide in the erythromycin-
producing polyketide synthase of Saccharopolyspora erythraea. Nature 348, 176–
178. 
Cortés, J., Velasco, J., Foster, G., Blackaby, A.P., Rudd, B.A.M., and Wilkinson, B. 
(2002). Identification and cloning of a type III polyketide synthase required for 
diffusible pigment biosynthesis in Saccharopolyspora erythraea. Mol. Microbiol. 44, 
1213–1224. 
Cortes, J., Wiesmann, K.E., Roberts, G.A., Brown, M.J., Staunton, J., and 
Leadlay,P.F. (1995). Repositioning of a domain in a modular polyketide synthase 
to promote specific chain cleavage. Science 268, 1487–1489. 
Cruz-Morales, P., Kopp, J.F., Martínez-Guerrero, C., Yáñez-Guerra, L.A., Selem-
Mojica, N., Ramos-Aboites, H., Feldmann, J., and Barona-Gómez, F. (2016). 
Phylogenomic Analysis of Natural Products Biosynthetic Gene Clusters Allows 
Discovery of Arseno-Organic Metabolites in Model Streptomycetes. Genome Biol. 
Evol. 8, 1906–1916. 
Currie, C.R., Scott, J.A., Summerbell, R.C., and Malloch, D. (1999). Fungus-
growing ants use antibiotic-producing bacteria to control garden parasites. Nature 
398, 701–704. 




and Weissman, K.J. (2014). Insights into the function of trans-acyl transferase 
polyketide synthases from the SAXS structure of a complete module Chem. Sci. 5, 
3081–3095  
Decker, H., and Haag, S. (1995). Cloning and characterization of a polyketide 
synthase gene from Streptomyces fradiae Tü2717, which carries the genes for 
biosynthesis of the angucycline antibiotic urdamycin A and a gene probably 
involved in its oxygenation. J. Bacteriol. 177, 6126–6136. 
Del Vecchio, F., Petkovic, H., Kendrew, S.G., Low, L., Wilkinson, B., Lill, R., 
Cortés, J., Rudd, B.A., Staunton, J., and Leadlay, P.F. (2003). Active-site residue, 
domain and module swaps in modular polyketide synthases. J. Ind. Microbiol. 
Biotechnol. 30, 489–494. 
Deluca, M.R., and Kerwin, S.M. (1997). Total synthesis of UK-1. Tetrahedron 
Lett. 38, 199–202.  
Demmer, C.S., and Bunch, L. (2015). Benzoxazoles and oxazolopyridines in 
medicinal chemistry studies. Eur. J. Med. Chem. 97, 778–785. 
Di Giambattista, M., Chinali, G., and Cocito, C. (1989). The molecular basis of the 
inhibitory activities of type A and type B synergimycins and related antibiotics on 
ribosomes. J. Antimicrob. Chemother. 24, 485–507. 
Ding, Y., Yu, Y., Pan, H., Guo, H., Li, Y., and Liu, W. (2010). Moving 
posttranslational modifications forward to biosynthesize the glycosylated 
thiopeptide nocathiacin I in Nocardia sp. ATCC202099. Mol. Biosyst. 6, 1180–
1185. 
Dixon, J.M. (1968). Group A Streptococcus resistant to erythromycin and 
lincomycin. Can. Med. Assoc. J. 99, 1093–1094. 
Donadio, S., Staver, M.J., McAlpine, J.B., Swanson, S.J., and Katz, L. (1991). 
Modular organization of genes required for complex polyketide biosynthesis. 
Science 252, 675–679.  
Drake, E.J., Miller, B.R., Shi, C., Tarrasch, J.T., Sundlov, J.A., Allen, C.L., 
Skiniotis, G., Aldrich, C.C., and Gulick, A.M. (2016). 
Structures of two distinct conformations of holo-nonribosomal peptide synthetases. 
Nature 529, 235–238.  




Preparation of the agent. Its activity in vitro. J. Exp. Med. 70, 1–10. 
Dubos, R.J., and Hotchkiss, R.D. (1941). The production of bactericidal substances 
by aerobic sporulating Bacilli. J. Exp. Med. 73, 629–640. 
Duggar, B.M. (1948). Aureomycin-a New Antibiotic. Ann. N. Y. Acad. Sci. 51, 177–
342.  
Dunbar, K.L., Chekan, J.R., Cox, C.L., Burkhart, B.J., Nair, S.K., and Mitchell, D.A. 
(2014). Discovery of a new ATP-binding motif involved in peptidic azoline 
biosynthesis. Nat. Chem. Biol. 10, 823–829. 
Dunbar, K.L., Melby, J.O., and Mitchell, D.A. (2012). YcaO domains use ATP to 
activate amide backbones during peptide cyclodehydrations. Nat. Chem. Biol. 8, 
569–575. 
Duquesne, S., Destoumieux-Garzón, D., Zirah, S., Goulard, C., Peduzzi, J., and 
Rebuffat, S. (2007). Two enzymes catalyze the maturation of a lasso peptide in 
Escherichia coli. Chem. Biol. 14, 793–803. 
Dutta, S., Whicher, J.R., Hansen, D.A., Hale, W.A., Chemler, J.A., Congdon, G.R., 
Narayan, A.R., Håkansson, K., Sherman, D.H., Smith, J.L., and Skiniotis, G. 
(2014). Structure of a modular polyketide synthase. Nature 510, 512–517.  
Edgar, R.C. (2004). MUSCLE: multiple sequence alignment with high accuracy and 
high throughput. Nucl. Acids Res. 32, 1792–1797. 
Edwards, A.L., Matsui, T., Weiss, T.M., and Khosla, C. (2014). Architectures of 
whole-module and bimodular proteins from the 6-deoxyerythronolide B synthase. J. 
Mol. Biol. 426, 2229–2245. 
Ehmann, D.E., Trauger, J.W., Stachelhaus, T., and Walsh, C.T. (2000). Aminoacyl-
SNACs as small-molecule substrates for the condensation domains of 
nonribosomal peptide synthetases. Chem. Biol. 7, 765–772. 
Ehrlich, J., Bartz, Q.R., Smith, R.M., Joslyn, D.A., and Burkholder, P.R. (1947). 
Chloromycetin, a New Antibiotic From a Soil Actinomycete. Science 106, 417. 
Feitelson, J.S., Malpartida, F., and Hopwood, D.A. (1985). Genetic and 
biochemical characterization of the red gene cluster of Streptomyces coelicolor 
A3(2). J. Gen. Microbiol. 131, 2431–2441. 




F. (1992). Nucleotide sequence and deduced functions of a set of cotranscribed 
genes of Streptomyces coelicolor A3(2) including the polyketide synthase for the 
antibiotic actinorhodin. J. Biol. Chem. 267, 19278–19290. 
Firn, R.D., and Jones, C.G. (2000). The evolution of secondary metabolism - a 
unifying model. Mol. Microbiol. 37, 989–994. 
Flärdh, K, and Buttner MJ. (2009). Streptomyces morphogenetics: dissecting 
differentiation in a filamentous bacterium. Nat. Rev. Microbiol. 7, 36–49. 
Fleming, A. (1929). On the antibacterial action of cultures of a Penicillium, with 
special reference to their use in the isolation of B. influenzæ. Br. J. Exp. Pathol. 10, 
226–236. 
Floriano, B., and Bibb, M. (1996). AfsR is a pleiotropic but conditionally required 
regulatory gene for antibiotic production in Streptomyces coelicolor A3(2). Mol. 
Microbiol. 21, 385–396. 
Forsman, M., Häggström, B., Lindgren, L., and Jaurin, B. (1990). Molecular 
analysis of β-lactamases from four species of Streptomyces: comparison of amino 
acid sequences with those of other β-clactamases. J. Gen. Microbiol. 136, 589–
598. 
Frank, B., Wenzel, S.C., Bode, H.B., Scharfe, M., Blöcker, H., and Müller, R. 
(2007). From genetic diversity to metabolic unity: studies on the biosynthesis of 
aurafurones and aurafuron-like structures in myxobacteria and streptomycetes. J. 
Mol. Biol. 374, 24–38.  
Gaisser, S., Bohm, G.A., Doumith, M., Raynal, M.C., Dhillon, N., Cortés, J., and 
Leadlay, P.F. (1998). Analysis of eryBI, eryBIII and eryBVII from the erythromycin 
biosynthetic gene cluster in Saccharopolyspora erythraea. Mol. Gen. Genet. 258, 
78–88. 
Gaitatzis, N., Kunze, B., and Müller, R. (2001). In vitro reconstitution of the 
myxochelin biosynthetic machinery of Stigmatella aurantiaca Sg a15: Biochemical 
characterization of a reductive release mechanism from nonribosomal peptide 
synthetases. Proc. Natl. Acad. Sci. U.S.A. 98, 11136–11141. 
Gallimore, A.R., Stark, C.B., Bhatt, A., Harvey, B.M., Demydchuk, Y., Bolanos-
Garcia, V., Fowler, D.J., Staunton, J., Leadlay, P.F., and Spencer, J.B. (2006). 




monensin biosynthesis. Chem. Biol. 13, 453–460. 
Gardner, A.D. (1940). Morphological effects of penicillin on bacteria. Nature 146, 
837–838. 
Gatzeva-Topalova, P.Z., May, A.P., and Sousa, M.C. (2005). Crystal structure and 
mechanism of the Escherichia coli ArnA (PmrI) transformylase domain. An enzyme 
for lipid A modification with 4-amino-4-deoxy-L-arabinose and polymyxin 
resistance. Biochemistry 44, 5328–5338. 
Gavrish, E., Sit, C.S., Cao, S., Kandror, O., Spoering, A., Peoples, A., Ling, 
L., Fetterman, A., Hughes, D., Bissell, A., Torrey, H., Akopian, T., Mueller, 
A., Epstein, S., Goldberg, A., Clardy, J., and Lewis, K. (2014). Lassomycin, a 
ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by 
targeting the ATP-dependent protease ClpC1P1P2. Chem. Biol. 21, 509–518. 
Gay, D.C., Gay, G., Axelrod, A.J., Jenner, M., Kohlhaas, C., Kampa, A., Oldham, 
N.J., Piel, J., and Keatinge-Clay, A.T. (2014). A close look at a ketosynthase from 
a trans-acyltransferase modular polyketide synthase. Structure 22, 444–451. 
Geng, P., Bai, G., Shi, Q., Zhang, L., Gao, Z., and Zhang, Q. (2009). Taxonomy of 
the Streptomyces strain ZG0656 that produces acarviostatin alpha-amylase 
inhibitors and analysis of their effects on blood glucose levels in mammalian 
systems. J. Appl. Microbiol. 106, 525–533. 
Ghimire, G.P., Oh, T.J., Lee, H.C., and Sohng, J.K. (2009). Squalene-hopene 
cyclase (Spterp25) from Streptomyces peucetius: sequence analysis, expression 
and functional characterization. Biotechnol. Lett. 31, 565–569. 
Gish, W., and States, D.J. (1993). Identification of protein coding regions by 
database similarity search. Nat. Genet. 3, 266–272. 
Gojkovic, Z., Rislund, L., Andersen, B., Sandrini, M.P., Cook, P.F., Schnackerz, 
K.D., and Piskur, J. (2003). Dihydropyrimidine amidohydrolases and 
dihydroorotases share the same origin and several enzymatic properties. Nucl. 
Acids Res. 31, 1683–1692. 
Gokhale, R.S., Tsuji, S.Y., Cane, D.E., and Khosla, C. (1999). Dissecting and 
exploiting intermodular communication in polyketide synthases. Science 284, 482–
485. 




of actinobacteria for the discovery of novel natural products. Mar. Drugs. 14, 78. 
Gomez-Escribano, J.P., and Bibb, M.J. (2011). Engineering Streptomyces 
coelicolor for heterologous expression of secondary metabolite gene clusters. 
Microb. Biotechnol. 4, 207–215.  
Gomez-Escribano, J.P., and Bibb, M.J. (2014). Heterologous expression of natural 
product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining 
to manipulation of biosynthetic pathways. J. Ind. Microbiol. Biotechnol. 41, 425–
431.  
Goodwin, C.R., Covington, B.C., Derewacz, D.K., McNees, C.R., Wikswo, J.P., 
McLean, J.A., and Bachmann, B.O. (2015). Structuring microbial metabolic 
responses to multiplexed stimuli via self-organizing metabolomics maps. Chem. 
Biol. 22, 661–670. 
Gould, S.J., Hong, S.T., and Carney, J.R. (1998). Cloning and heterologous 
expression of genes from the kinamycin biosynthetic pathway of Streptomyces 
murayamaensis. J. Antibiot. 51, 50–57. 
Gould, S.J., Melville, C.R., Cone, M.C., Chen, J., and Carney, J.R. (1997). 
Kinamycin biosynthesis. Synthesis, isolation, and incorporation of stealthin C, an 
aminobenzo[b]fluorene. J. Org. Chem. 62, 320–324. 
Graham, M.Y., and Weisblum, B. (1979). Altered methylation of adenine in 23 S 
ribosomal RNA associated with erythromycin resistance in Streptomyces erythreus 
and Streptococcus faecalis. Contrib. Microbiol. Immunol. 6, 159–164. 
Grande-García, A., Lallous, N., Díaz-Tejada, C., and Ramón-Maiques, S. (2014). 
Structure, functional characterization, and evolution of the dihydroorotase domain 
of human CAD. Structure 22, 185–198.  
Griffiths, G.L., Sigel, S.P., Payne, S.M., and Neilands, J.B. (1984). Vibriobactin, a 
siderophore from Vibrio cholerae. J. Biol. Chem. 259, 383–385. 
Grosdidier, A., Zoete, V., and Michielin, O. (2011a). Fast docking using the 
CHARMM force field with EADock DSS. J. Comput. Chem. 32, 2149–2159.  
Grosdidier, A., Zoete, V., and Michielin, O. (2011b). SwissDock, a protein-small 
molecule docking web service based on EADock DSS. Nucl. Acids Res. 39, 
W270–W277. 




Streptomyces griseus 16S rRNA gene clade: use of multilocus sequence analysis 
for streptomycete systematics. Int. J. Syst. Evol. Microbiol. 58, 149–159. 
Haeder, S., Wirth, R., Herz, H., and Spiteller, D. (2009). Candicidin-producing 
Streptomyces support leaf-cutting ants to protect their fungus garden against the 
pathogenic fungus Escovopsis. Proc. Natl. Acad. Sci. U.S.A. 106, 4742–4746. 
Hale, K.J., Hatakeyama, S., Urabe, F., Ishihara, J., Manaviazar, S., Grabski, M., 
and Maczka, M. (2014). The absolute configuration for inthomycin C: revision of 
previously published work with a reinstatement of the (3R)-configuration for (−)-
inthomycin C. Org. Lett. 16, 3536–3539. 
Han, J.W., Kim, E.Y., Lee, J.M., Kim, Y.S., Bang, E., and Kim, B.S. (2012). Site-
directed modification of the adenylation domain of the fusaricidin nonribosomal 
peptide synthetase for enhanced production of fusaricidin analogs. Biotechnol. 
Lett. 34, 1327–1334. 
Harvey, B.M., Hong, H., Jones, M.A., Hughes-Thomas, Z.A., Goss, R.M., 
Heathcote, M.L., Bolanos-Garcia, V.M., Kroutil, W., Staunton, J., Leadlay, P.F., 
and Spencer, J.B. (2006) Evidence that a novel thioesterase is responsible for 
polyketide chain release during biosynthesis of the polyether ionophore monensin. 
ChemBioChem 7, 1435–1442.  
He, H., Ding, W.D., Bernan, V.S., Richardson, A.D., Ireland, C.M., Greenstein, M., 
Ellestad, G.A., and Carter, G.T. (2001). Lomaiviticins A and B, potent antitumor 
antibiotics from Micromonospora lomaivitiensis. J. Am. Chem. Soc. 123, 5362–
5363. 
Heath, R.J., and Rock, C.O. (2002). The Claisen condensation in biology. Nat. 
Prod. Rep. 19, 581–596. 
Heine, D., Bretschneider, T., Sundaram, S., and Hertweck, C. (2014). 
Enzymatic polyketide chain branching to give substituted lactone, lactam, and 
glutarimide heterocycles. Angew. Chem. Int. Ed. Engl. 53, 11645–11649. 
Hemmerling, F., and Hahn, F. (2016). Biosynthesis of oxygen and nitrogen-
containing heterocycles in polyketides. Beilstein. J. Org. Chem. 12, 1512–1250. 
Henkel, T., and Zeeck, A. (1991). Secondary metabolites by chemical screening, 
15. Structure and absolute configuration of naphthomevalin, a new dihydro-




Henkel, T., and Zeeck, A. (1991). Sekundärstoffe aus dem chemischen Screening, 
16. Inthomycine, neue oxazol-triene aus Streptomyces sp. Liebigs Ann. Chem. 
367–373. 
Ho, Y.T.C., Leng, D.J., Ghiringhelli F, Wilkening I, Bushell DP, Köstner O, Riva E, 
Havemann J, Passarella D, Tosin M. (2017). Novel chemical probes for the 
investigation of nonribosomal peptide assembly. J. Chem. Soc., Chem. Commun. 
53, 7088–7091.   
Hobbs, M.E., Malashkevich, V., Williams, H.J., Xu, C., Sauder, J.M., Burley, S.K., 
Almo, S.C., and Raushel, F.M. (2012). Structure and catalytic mechanism of LigI: 
insight into the amidohydrolase enzymes of cog3618 and lignin degradation. 
Biochemistry 51, 3497–3507.  
Hodgkin, D.C. (1949). The X-ray analysis of the structure of penicillin. Adv. Sci. 6, 
85–89. 
Holm, L., and Sander, C. (1997). An evolutionary treasure: unification of a broad 
set of amidohydrolases related to urease. Proteins 28, 72–82. 
Hood, D.W., Heidstra, R., Swoboda, U.K., and Hodgson, D.A. (1992). Molecular 
genetic analysis of proline and tryptophan biosynthesis in Streptomyces coelicolor 
A3(2): interaction between primary and secondary metabolism - a review. Gene 
115, 5–12. 
Horinouchi, S., and Beppu, T. (1994). A-factor as a microbial hormone that controls 
cellular differentiation and secondary metabolism in Streptomyces griseus. Mol. 
Microbiol. 12, 859–864. 
Horinouchi, S., and Beppu, T. (2007). Hormonal control by A-factor of 
morphological development and secondary metabolism in Streptomyces. Proc. 
Jpn. Acad. Ser. B. Phys. Biol. Sci. 83, 277–295. 
Hover, B.M., Kim, S.H., Katz, M., Charlop-Powers, Z., Owen, J.G., Ternei, M.A., 
Maniko, J., Estrela, A.B., Molina, H., Park, S., Perlin, D.S., and Brady, S.F. (2018). 
Culture-independent discovery of the malacidins as calcium-dependent antibiotics 
with activity against multidrug-resistant Gram-positive pathogens. Nat. 
Microbiol. 3, 415–422. 
Hug, J. (2015). Enzymatic logic in biosynthesis of benzoxazole antibiotics. Diplom-




Ikeda, H., Ishikawa, J., Hanamoto, A., Shinose, M., Kikuchi, H., Shiba, T., Sakaki, 
Y., Hattori, M., and Omura, S. (2003). Complete genome sequence and 
comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat. 
Biotechnol. 21, 526–531. 
Ikeda, H., Kazuo, S.Y., and Omura, S. (2014). Genome mining of the 
Streptomyces avermitilis genome and development of genome-minimized hosts for 
heterologous expression of biosynthetic gene clusters. J. Ind. Microbiol. 
Biotechnol. 41, 233–250. 
Iqbal, H.A., Low-Beinart, L., Obiajulu, J.U., and Brady, S.F. (2016). Natural product 
discovery through improved functional metagenomics in Streptomyces. J. Am. 
Chem. Soc. 138, 9341–9344. 
Itŏ, S., Matsuya, T., Ômura, S., Otani, M., and Nakagawa, A. (1970). A new 
antibiotic, kinamycin. J. Antibiot. 23, 315–317. 
Janso, J.E., Haltli, B.A., Eustáquio, A.S., Kulowski, K., Waldman, A.J., Zha, L., 
Nakamura, H., Bernan, V.S., He, H., Carter, G.T., Koehn, F.E., and Balskus, E.P. 
(2014). Discovery of the lomaiviticin biosynthetic gene cluster in Salinispora 
pacifica. Tetrahedron 70, 4156–4164. 
Jenke-Kodama, H., Sandmann, A., Müller, R., and Dittmann, E. (2005). 
Evolutionary implications of bacterial polyketide synthases. Mol. Biol. Evol. 22, 
2027–2039. 
Jensen K, Niederkrüger H, Zimmermann K, Vagstad AL, Moldenhauer J, Brendel 
N, Frank S, Pöplau P, Kohlhaas C, Townsend CA, Oldiges M, Hertweck C, Piel J. 
(2012). Polyketide proofreading by an acyltransferase-like enzyme. Chem. Biol. 19, 
329–339.  
Jevons, M.P., Coe, A.W., and Parker, M.T. (1963). Methicillin resistance in 
staphylococci. Lancet. 1, 904–907.  
Jiang, X., Zhang, Q., Zhu, Y., Nie, F., Wu, Z., Yang, C., Zhang, L., Tian, X., and 
Zhang, C. (2017). Isolation, structure elucidation and biosynthesis of 
benzo[b]fluorene nenestatin A from deep-sea derived Micromonospora 
echinospora SCSIO 04089. Tetrahedron 73, 3585–3590. 
Jones, D.T., Taylor, W.R., and Thornton, J.M. (1992). The rapid generation of 




Joule, J.A., and Mills, K. (2010). Heterocyclic Chemistry, fifth edition. Wiley, 2010. 
Oxford: Wiley-Blackwell. 
Kagan, R.M., and Clarke, S. (1994). Widespread occurrence of three sequence 
motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a 
common structure for these enzymes. Arch. Biochem. Biophys. 310, 417–427.  
Källberg, M., Wang, H., Wang, S., Peng, J., Wang, Y., Lu, H., and Xu, J. (2012). 
Template-based protein structure modeling using the RaptorX web server. Nat. 
Protoc. 7, 1511–1522. 
Kaltenpoth, M., Yildirim, E., Gürbüz, M.F., Herzner, G., and Strohm, E. (2012). 
Refining the roots of the beewolf-Streptomyces symbiosis: antennal symbionts in 
the rare genus Philanthinus (Hymenoptera, Crabronidae). Appl. Environ. Microbiol. 
78, 822–827. 
Kanzaki, H., Wada, K., Nitoda, T., and Kawazu, K. (1998). Novel bioactive 
oxazolomycin isomers produced by Streptomyces albus JA3453. Biosci. 
Biotechnol. Biochem. 62, 438–442. 
Kao, C.M., Luo, G., Katz, L., Cane, D.E., and Khosla, C. (1995). Manipulation of 
macrolide ring size by directed mutagenesis of a modular polyketide synthase. J. 
Am. Chem. Soc. 117, 9105–9106. 
Kaulmann, U., and Hertweck, C. (2002). Biosynthesis of polyunsaturated fatty 
acids by polyketide synthases. Angew. Chem. Int. Ed. Engl. 41, 1866–1869. 
Kawada, M., Inoue, H., Usami, I., and Ikeda, D. (2009). Phthoxazolin A inhibits 
prostate cancer growth by modulating tumor-stromal cell interactions. Cancer Sci. 
100, 150–157. 
Keatinge-Clay A. (2008). Crystal structure of the erythromycin polyketide synthase 
dehydratase. J. Mol. Biol. 384, 941–953. 
Keatinge-Clay, A.T. (2007). A tylosin ketoreductase reveals how chirality is 
determined in polyketides. Chem. Biol. 14, 898–908. 
Keatinge-Clay, A.T. (2016). Stereocontrol within polyketide assembly lines. Nat. 
Prod. Rep.  33, 141–149. 
Kelley, L.A., Mezulis, S., Yates, C.M., Wass, M.N., and Sternberg, M.J. (2015). The 





Kendrew, S.G., Petkovic, H., Gaisser, S., Ready, S.J., Gregory, M.A., Coates, 
N.J., Nur-E-Alam, M., Warneck, T., Suthar, D., Foster, T.A., McDonald, 
L., Schlingman, G., Koehn, F.E., Skotnicki, J.S., Carter, G.T., Moss, S.J., Zhang, 
M.Q., Martin, C.J., Sheridan, R.M., and Wilkinson, B. (2013). Recombinant strains 
for the enhanced production of bioengineered rapalogs. Metab. Eng.  15, 167–
4173. 
Kennedy, J., Auclair, K., Kendrew, S.G., Park, C., Vederas, J.C., and Hutchinson, 
C.R. (1999). Modulation of polyketide synthase activity by accessory proteins 
during lovastatin biosynthesis. Science 284, 1368–1372. 
Kersten, R.D., Lane, A.L., Nett, M., Richter, T.K., Duggan, B.M., Dorrestein, P.C., 
and Moore, B.S. (2013). Bioactivity-guided genome mining reveals the lomaiviticin 
biosynthetic gene cluster in Salinispora tropica. ChemBioChem 14, 955–962. 
Kessler, N., Schuhmann, H., Morneweg, S., Linne, U., and Marahiel, M.A. (2004). 
The linear pentadecapeptide gramicidin is assembled by four multimodular 
nonribosomal peptide synthetases that comprise 16 modules with 56 catalytic 
domains. J. Biol. Chem. 279, 7413–7419.  
Kevany, B.M., Rasko, D.A., and Thomas, M.G. (2009). Characterization of the 
complete zwittermicin A biosynthesis gene cluster from Bacillus cereus. Appl. 
Microbiol. Biotechnol. 75, 1144–1155 
Kim, K.R., Kim, T.J., and Suh, J.W. (2008). The gene cluster for spectinomycin 
biosynthesis and the aminoglycoside-resistance function of spcM in Streptomyces 
spectabilis. Curr. Microbiol. 57, 371–374. 
Kimura, M. (1980). A simple method for estimating evolutionary rate of base 
substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 
16, 111–120. 
Kislak, J.W., Razavi, L.M., Daly, A.K., Finland, M. (1965). Susceptibility of 
pneumococci to nine antibiotics. Am. J. Med. Sci. 250, 261–268. 
Kleigrewe, K., Almaliti, J., Tian, I.Y., Kinnel, R.B., Korobeynikov, A., Monroe, E.A., 
Duggan, B.M., Di Marzo, V., Sherman, D.H., Dorrestein, P.C., Gerwick, L., and 
Gerwick, W.H. (2015). Combining mass spectrometric metabolic profiling with 
genomic analysis: a powerful approach for discovering natural products from 




Knight, V., and Collins, H.S. (1955). A current view on the problem of drug resistant 
staphylococci and staphylococcal infection. Bull. N. Y. Acad. Med. 31, 549–568. 
Komatsu, M., Komatsu, K., Koiwai, H., Yamada, Y., Kozone, I., Izumikawa, M., 
Hashimoto, J., Takagi, M., Omura, S., Shin-Ya, K., Cane, D.E., and Ikeda, H. 
(2013). Engineered Streptomyces avermitilis host for heterologous expression of 
biosynthetic gene cluster for secondary metabolites. ACS Synth. Biol. 2, 384–396.  
Komatsu, M., Uchiyama, T., Omura, S., Cane, D.E., and Ikeda, H. (2010). 
Genome-minimized Streptomyces host for the heterologous expression of 
secondary metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 2646–2651  
Koumoutsi, A., Chen, X.H., Henne, A., Liesegang, H., Hitzeroth, G., Franke, 
P., Vater, J., and Borriss, R. (2004). Structural and functional characterization 
of gene clusters directing nonribosomal synthesis of bioactive cyclic lipopeptides in 
Bacillus amyloliquefaciens strain FZB42. J. Bacteriol. 186, 1084–1096. 
Krügel, H., Krubasik, P., Weber, K., Saluz, H.P., and Sandmann, G. (1999). 
Functional analysis of genes from Streptomyces griseus involved in the synthesis 
of isorenieratene, a carotenoid with aromatic end groups, revealed a novel type of 
carotenoid desaturase. Biochim. Biophys. Acta. 1439, 57–64. 
Kulowski, K., Pienkowski, E.W., Han, L., Yang, K.Q., Vining, L.C., and Hutchinson, 
C.R. (1999). Functional Characterization of the jadI Gene As a Cyclase Forming 
Angucyclinones. J. Am. Chem. Soc. 121, 1786–1794. 
Kumagai, T., Nakano, T., Maruyama, M., Mochizuki, H., and Sugiyama, M. (1999). 
Characterization of the bleomycin resistance determinant encoded on the 
transposon Tn5. FEBS Lett. 8, 34–38. 
Kumar, D., Jacob, M.R., Reynolds, M.B., and Kerwin, S.M. (2002). Synthesis and 
evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1. Bioorg. 
Med. Chem. 10, 3997–4004. 
Kumar, S., Stecher, G., and Tamura, K. (2016). MEGA7: Molecular Evolutionary 
Genetics Analysis version 7.0. Mol. Biol. Evol. 33, 1870–1874. 
Kurtz, S., Phillippy, A., Delcher, A.L., Smoot, M., Shumway, M., Antonescu, C., and 
Salzberg, S.L. (2004). Versatile and open software for comparing large genomes. 
Genome Biol. 5, R12. 




modular polyketide synthase enoylreductase domain reveals insights into catalysis 
and stereospecificity. ACS Chem. Biol. 5, 829–838. 
Labeda, D.P., Dunlap, C.A., Rong, X., Huang, Y., Doroghazi, J.R., Ju, K.S., and 
Metcalf, W. W. (2017). Phylogenetic relationships in the family Streptomycetaceae 
using multi-locus sequence analysis. Antonie van Leeuwenhoek 110, 563–583. 
Lambalot, R.H., Cane, D.E., Aparicio, J.J., and Katz, L. (1995). Overproduction and 
characterization of the erythromycin C-12 hydroxylase, EryK. Biochemistry 34, 
1858–1866. 
Larsen, T.M., Boehlein, S.K., Schuster, S.M., Richards, N.G., Thoden, J.B., 
Holden, H.M., and Rayment, I. (1999). Three-dimensional structure of Escherichia 
coli asparagine synthetase B: a short journey from substrate to product. 
Biochemistry 38, 16146–16157. 
Laskaris, P., Tolba, S., Calvo-Bado, L., and Wellington, E.M. (2010). Coevolution 
of antibiotic production and counter-resistance in soil bacteria. Environ. Microbiol. 
12, 783–796. 
Lau, J., Fu, H., Cane, D.E., and Khosla, C. (1999). Dissecting the role of 
acyltransferase domains of modular polyketide synthases in the choice and 
stereochemical fate of extender units. Biochemistry 38, 1643–1651. 
Lau, R.C., and Rinehart, K.L. (1994). Berninamycins B, C, and D, minor 
metabolites from Streptomyces bernensis. J. Antibiot. 47, 1466–1472. 
Lautru, S., Deeth, R.J., Bailey, L.M., and Challis, G.L. (2005). Discovery of a new 
peptide natural product by Streptomyces coelicolor genome mining. Nat. Chem. 
Biol. 1, 265–269. 
Lazos, O., Tosin, M., Slusarczyk, A.L., Boakes, S., Cortés, J., Sidebottom, P.J., 
and Leadlay, P.F. (2010) Biosynthesis of the putative siderophore erythrochelin 
requires unprecedented crosstalk between separate nonribomsal peptide gene 
clusters. Chem. Biol. 17, 160–173. 
Lee, M.Y., Ames, B.D., and Tsai, S.C. (2012). Insight into the molecular basis of 
aromatic polyketidecyclization: crystal structure and in vitro characterization of 
WhiE-ORFVI. Biochemistry 51, 3079–3091.  
Lee, S.W., Mitchell, D.A., Markley, A.L., Hensler, M.E., Gonzalez, D., Wohlrab, A., 




toxin biosynthetic gene cluster. Proc. Natl. Acad. Sci. U.S.A. 105, 5879–5884. 
Legendre, F., and Armau, E. (1989). Nouveaux composés herbicides, le CL22T et 
ses derivés, procédés de préparation de ces composés, composition les contenant 
et procédés de traitement du desherbage les utilisant. French Patent 89,08615, 
June 28, 1989. 
Legendre, F., Maturano, M.D., Etienne, G., Klaebe, A., and Tiraby, G. (1994). 
Synthesis and biological activity of the herbicidal metabolite CL22T (phthoxazolin) 
J. Antibiot. 48, 341–343. 
Lenfant, N., Hotelier, T., Bourne, Y., Marchot, P., and Chatonnet, A. (2013). 
Proteins with an alpha/beta hydrolase fold: Relationships between subfamilies in 
an ever-growing superfamily. Chem. Biol. Interact. 203, 266–268.  
Levy, S.B., and McMurry, L. (1974). Detection of an inducible membrane protein 
associated with R-factor-mediated tetracycline resistance. Biochem. Biophys. Res. 
Commun. 27, 1060–1068.   
Li, B., Yu, J.P., Brunzelle, J.S., Moll, G.N., Van Der Donk, W.A., and Nair, S.K. 
(2006). Structure and mechanism of the lantibiotic cyclase involved in nisin 
biosynthesis. Science 311, 1464–1467. 
Li, L., Deng, W., Song, J., Ding, W., Zhao, Q.F., Peng, C., Song, W.W., Tang, 
G.L., and Liu, W. (2007). Characterization of the saframycin A gene cluster from 
Streptomyces lavendulae NRRL 11002 revealing a nonribosomal peptide 
synthetase system for assembling the unusual tetrapeptidyl skeleton in an iterative 
manner. J. Bacteriol. 190, 251–263. 
Li, S., Guo, J., Reva, A., Huang, F., Xiong, B., Liu, Y., Deng, Z., Leadlay, P.F., and 
Sun, Y. (2018). Methyltransferases of gentamicin biosynthesis. Proc. Natl. Acad. 
Sci. U.S.A. 115, 1340–1345.  
Li, Y., Xu, W., and Tang, Y. (2010). Classification, prediction, and verification of the 
regioselectivity of fungal polyketide synthase product template domains. J. Biol. 
Chem. 285, 22764–22773.  
Li, Y.M., Milne, J.C., Madison, L.L., Kolter, R., and Walsh, C.T. (1996). From 
peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin 
B17 synthase. Science 274, 1188–1193. 




amidation way to process the C-terminally methylated peptide backbone. J. Am. 
Chem. Soc. 133, 2852–2855. 
Lin, L.S., Lanza, T.J. Jr., Castonguay, L.A., Kamenecka, T., McCauley, E., Van 
Riper, G., Egger, L.A., Mumford, R.A., Tong, X., MacCoss, M., Schmidt, J.A., and 
Hagmann, W.K. (2004). Bioisosteric replacement of anilide with benzoxazole: 
potent and orally bioavailable antagonists of VLA-4. Bioorg. Med. Chem. Lett. 14, 
2331–2334. 
Lin, X., Hopson, R., and Cane, D.E. (2006). Genome mining in Streptomyces 
coelicolor: molecular cloning and characterization of a new sesquiterpene 
synthase. J. Am. Chem. Soc. 128, 6022–6023.   
Lin, Y.S., Kieser, H.M., Hopwood, D.A., and Chen, C.W. (1993). The chromosomal 
DNA of Streptomyces lividans 66 is linear. Mol. Microbiol. 10, 923–33. 
Liu, F., Garneau, S., and Walsh, C.T. (2004). Hybrid nonribosomal peptide-
polyketide interfaces in epothilone biosynthesis: minimal requirements at N and C 
termini of EpoB for elongation. Chem. Biol. 11, 1533–1542. 
Liu, H.K., and Sadler, P.J. (2011). Metal complexes as DNA intercalators. Acc. 
Chem. Res. 44, 349–359. 
Liu, S., Guo, H., Zhang, T., Han, L., Yao, P., Zhang, Y., Rong, N., Yu, Y., Lan, W., 
Wang, C., Ding, J., Wang, R., Liu, W., and Cao, C. (2015). Structure-based 
mechanistic insights into terminal amide synthase in nosiheptide-represented 
thiopeptides biosynthesis. Sci. Rep. 5, 12744. 
Lohman, J.R., Ma, M., Osipiuk, J., Nocek, B., Kim Y, Chang, C., Cuff, M., Mack, J., 
Bigelow, L., Li, H., Endres, M., Babnigg, G., Joachimiak, A., Phillips, G.N. Jr., and 
Shen, B. (2015). Structural and evolutionary relationships of "AT-less" type 
I polyketide synthase ketosynthases. Proc. Natl. Acad. Sci. U.S.A. 112, 12693–
12698.  
Lomovskaya, N., Hong, S.K., Kim, S.U., Fonstein, L., Furuya, K., and Hutchinson, 
R.C. (1996). The Streptomyces peucetius drrC gene encodes a UvrA-like protein 
involved in daunorubicin resistance and production. J. Bacteriol. 178, 3238–3245. 
Lopanik, N.B., Shields, J.A., Buchholz, T.J., Rath, C.M., Hothersall, J., Haygood, 
M.G., Håkansson, K., Thomas, C.M., and Sherman, D.H. (2008). In vivo and in 




derived from an uncultured marine symbiont. Chem. Biol. 15, 1175–1186. 
Losada, A.A., Cano-Prieto, C., García-Salcedo, R., Braña, A.F., Méndez, C., 
Salas, J.A., and Olano, C. (2017). Caboxamycin biosynthesis pathway and 
identification of novel benzoxazoles produced by cross-talk in Streptomyces sp. 
NTK 937. Microb. Biotechnol. 10, 873–885. 
Lowry, B., Li, X., Robbins, T., Cane, D.E., and Khosla, C. (2016). A turnstile 
mechanism for the controlled growth of biosynthetic intermediates on assembly 
line polyketide synthases. ACS Cent. Sci. 2, 14–20.  
Lowry, B., Robbins, T., Weng, C.H., O’Brien, R.V., Cane, D.E., and Khosla, C. 
(2013). In vitro reconstitution and analysis of the 6-deoxyerythronolide B synthase. 
J. Am. Chem. Soc. 135, 16809–16812. 
Luo, L., Kohli, R.M., Onishi, M., Linne, U., Marahiel, M.A. and Walsh, C.T. (2002). 
Timing of epimerization and condensation reactions in nonribosomal peptide 
assembly lines:  kinetic analysis of phenylalanine activating elongation modules of 
tyrocidine synthetase B. Biochemistry 41, 9184–9196. 
Luo, Y., Ruan, L.F., Zhao, C.M., Wang, C.X., Peng, D.H., and Sun, M. (2011). 
Validation of the intact zwittermicin A biosynthetic gene cluster and discovery of a 
complementary resistance mechanism in Bacillus thuringiensis. Antimicrob. Agents 
Chemother. 55, 4161–4169. 
Luscombe, N.M., Austin, S.E., Berman, H.M., and Thornton, J.M. (2000). An 
overview of the structures of protein-DNA complexes. Genome Biol. 1, 
REVIEWS001. 
Lv, M., Zhao, J., Deng, Z., and Yu, Y. (2015). Characterization of the biosynthetic 
gene cluster for benzoxazole antibiotics A33853 reveals unusual assembly logic. 
Chem. Biol. 22, 1313–1324. 
MacNeil, D.J., Gewain, K.M., Ruby, C.L., Dezeny, B., Gibbons, P.H., and MacNeil, 
T. (1992). Analysis of Streptomyces avermitilis genes required for avermectin 
biosynthesis utilizing a novel integration vector. Gene 111, 61–68. 
Madigan, M.T., and Martinko, J.M. (2006). Brock Biology of Microorganisms, 
eleventh edition. New Jersey: Prentice Hall. 
Maier, T., Leibundgut, M., and Ban, N. (2008). The crystal structure of a 




Malcolmson, S.J., Young, T.S., Ruby, J.G., Skewes-Cox, P., and Walsh, C.T. 
(2013). The posttranslational modification cascade to the 
thiopeptide berninamycin generates linear forms and altered macrocyclic scaffolds. 
Proc. Natl. Acad. Sci. U.S.A. 110, 8483–8488. 
Malpartida, F., and Hopwood, D.A. (1986). Physical and genetic characterisation of 
the gene cluster for the antibiotic actinorhodin in Streptomyces coelicolor A3(2). 
Mol. Gen. Genet. 205, 66–73. 
Mao, Y., Varoglu, M., and Sherman, D.H. (1999). Molecular characterization and 
analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C 
from Streptomyces lawendulae NRRL 2564. Chem. Biol. 6, 251–263. 
Markowitz, V.M., Chen, I.M., Palaniappan, K., Chu, K., Szeto, E., Grechkin, Y., 
Ratner, A., Jacob, B., Huang, J., Williams, P., Huntemann, M., Anderson, I., 
Mavromatis, K., Ivanova, N.N., and Kyrpides, N.C. (2012). IMG: the Integrated 
Microbial Genomes database and comparative analysis system. Nucl. Acids Res. 
40, D115–D122. 
Marsden, A.F., Caffrey, P., Aparicio, J.F., Loughran, M.S., Staunton, J., and 
Leadlay, P.F. (1994). Stereospecific acyl transfers on the erythromycin-producing 
polyketide synthase. Science 263, 378–380. 
Masschelein, J., Clauwers, C., Awodi, U.R., Stalmans, K., Vermaelen, W., 
Lescrinier, E., Aertsen, A., Michiels, C., Challis, G.L., and Lavigne, R. (2015). A 
combination of polyunsaturated fatty acid, nonribosomal peptide 
and polyketide biosynthetic machinery is used to assemble the zeamine antibiotics. 
Chem. Sci. 6, 923–929.  
Masschelein, J., Mattheus, W., Gao, L.J., Moons, P., Van Houdt, R., Uytterhoeven, 
B., Lamberigts, C., Lescrinier, E., Rozenski, J., Herdewijn, P., Aertsen, A., 
Michiels, C., and Lavigne, R. (2013). A PKS/NRPS/FAS hybrid gene cluster from 
Serratia plymuthica RVH1 encoding the biosynthesis of three broad spectrum, 
zeamine-related antibiotics. PLoS One 8, E54143.  
McCafferty, D.G., Cudic, P., Frankel, B.A., Barkallah, S., Kruger, R.G., and Li, W. 
(2002). Chemistry and biology of the ramoplanin family of peptide antibiotics. 
Biopolymers 66, 261–284. 
McDonald, M., Mavrodi, D.V., Thomashow, L.S., and Floss, H.G. (2001). 




primary shikimate biosynthetic pathway and role of phenazine-1,6-dicarboxylic 
acid. J. Am. Chem. Soc. 123, 9459–9460. 
McGuire, J.M., Bunch, P.L., Anderson, R.C., Boaz, H.E., Flynn, E.H., Powell, E.H., 
and Smith, J.W. (1952). Ilotycin, a new antibiotic. Antibiot. Chemother. 2, 281–283. 
McKee, M.L., and Kerwin, S.M. (2008). Synthesis, metal ion binding, and biological 
evaluation of new anticancer 2-(2'-hydroxyphenyl)benzoxazole analogs of UK-1. 
Bioorg. Med. Chem. 16, 1775–1783. 
Medema, M.H., Cimermancic, P., Sali, A., Takano, E., and Fischbach, M.A. (2014). 
A systematic computational analysis of biosynthetic gene cluster evolution: lessons 
for engineering biosynthesis. PLoS Comput. Biol. 10, e1004016. 
Medema, M.H., Takano, E., and Breitling, R. (2013). Detecting sequence homology 
at the gene cluster level with MultiGeneBlast. Mol. Biol. Evol. 30, 1218–1223. 
Metz, J.G., Roessler, P., Facciotti, D., Levering, C., Dittrich, F., Lassner, 
M., Valentine, R., Lardizabal, K., Domergue, F., Yamada, A., Yazawa, K., Knauf, 
V., and Browse, J. (2001). Production of polyunsaturated fatty acids 
by polyketide synthases in both prokaryotes and eukaryotes. Science 293, 290–
293. 
Meurer, G., Gerlitz, M., Wendt-Pienkowski, E., Vining, L.C., Rohr, J., and 
Hutchinson, C.R. (1997). Iterative type II polyketide synthases, cyclases and 
ketoreductases exhibit context-dependent behavior in the biosynthesis of linear 
and angular decapolyketides. Chem. Biol. 4, 433–443. 
Meyer, S., Kehr, J.C., Mainz, A., Dehm, D., Petras, D., Süssmuth, R.D., and 
Dittmann, E. (2016). Biochemical dissection of the natural diversification of 
microcystin provides lessons for synthetic biology of NRPS. Cell Chem Biol. 23, 
462–471. 
Miao, V., Coëffet-Legal, M.F., Brian, P., Brost, R., Penn, J., Whiting, A., Martin, S., 
Ford, R., Parr, I., Bouchard, M., Silva, C.J., Wrigley, S.K., and Baltz, R.H. (2005). 
Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the 
gene cluster and revision of peptide stereochemistry. Microbiology 151, 1507–
1523. 
Miller, D.A., Luo, L., Hillson, N., Keating, T.A., and Walsh, C.T. (2002). 




nonribosomal peptide/polyketide hybrid siderophore of Yersinia pestis. Chem. 
Biol. 9, 333–344. 
Miller, D.J., Ouellette, N., Evdokimova, E., Savchenko, A., Edwards, A., and 
Anderson, W.F. (2003). Crystal complexes of a predicted S-adenosylmethionine-
dependent methyltransferase reveal a typical AdoMet binding domain and a 
substrate recognition domain. Protein Sci. 12, 1432–1442. 
Molnár, I., Schupp, T., Ono, M., Zirkle, R., Milnamow, M., Nowak-Thompson, 
B., Engel, N., Toupet, C., Stratmann, A., Cyr, D.D., Gorlach, J., Mayo, J.M., Hu, 
A., Goff, S., Schmid, J., and Ligon, J.M. (2000). The biosynthetic gene cluster for 
the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum 
So ce90. Chem. Biol. 7, 97–109. 
Molohon, K.J., Blair, P.M., Park, S., Doroghazi, J.R., Maxson, T., Hershfield, J.R., 
Flatt, K.M., Schroeder, N.E., Ha, T., and Mitchell, D.A. (2016). Plantazolicin is an 
ultra-narrow spectrum antibiotic that targets the Bacillus anthracis membrane. ACS 
Infect. Dis. 2, 207–220. 
Mootz, H.D., Kessler, N., Linne, U., Eppelmann, K., Schwarzer, D., and Marahiel, 
M.A. (2002). Decreasing the ring size of a cyclic nonribosomal peptide antibiotic by 
in-frame module deletion in the biosynthetic genes. J. Am. Chem. Soc. 124, 
10980–10981. 
Mori, T., Takahashi, K., Kashiwabara, M., Uemura, D., Katayama, C., Iwadare, S., 
Shizuri, Y., Mitomo, R., Nakano, F., and Matsuzaki, A. (1985). Structure of 
oxazolomycin, a novel β-lactone antibiotic. Tetrahedron Lett. 26, 1073-1076. 
Müller I, Weinig S, Steinmetz H, Kunze B, Veluthoor S, Mahmud T, Müller R. 
(2006). A unique mechanism for methyl ester formation via an amide intermediate 
found in myxobacteria. ChemBioChem 7, 1197–1205. 
Murphy, A.C., Hong, H., Vance, S., Broadhurst, R.W., and Leadlay, P.F. (2016). 
Broadening substrate specificity of a chain-extending ketosynthase through a 
single active-site mutation. J. Chem. Soc., Chem. Commun. 52, 8373–8376. 
Ng, B.G., Han, J.W., Lee, D.W., Choi, G.J., and Kim, B.S. (2018) The chejuenolide 
biosynthetic gene cluster harboring an iterative trans-AT PKS system in Hahella 
chejuensis strain MB-1084. J. Antibiot. 71, 495–505. 




Gavilan, R.G., Aparicio, M., Atencio, L., Jackson, C., Ballesteros, J., Sanchez, J., 
Watrous, J.D., Phelan, V.V., van de Wiel, C., Kersten, R.D., Mehnaz, S., De Mot, 
R., Shank, E.A., Charusanti, P., Nagarajan, H., Duggan, B.M., Moore, B.S., 
Bandeira, N., Palsson, B.Ø., Pogliano, K., Gutiérrez, M., and Dorrestein, P.C. 
(2013). MS/MS networking guided analysis of molecule and gene cluster families. 
Proc. Natl. Acad. Sci. U.S.A. 110, E2611–E2620. 
Nguyen, T., Ishida, K., Jenke-Kodama, H., Dittmann, E., Gurgui, C., Hochmuth, 
T., Taudien, S., Platzer, M., Hertweck, C., and Piel, J. (2008). Exploiting the 
mosaic structure of trans-acyltransferase polyketidesynthases for natural product 
discovery and pathway dissection. Nat. Biotechnol. 26, 225–233.  
Olano, C., Wilkinson, B., Sánchez, C., Moss, S.J., Sheridan, R., Math, V., Weston, 
A.J, Braña, A.F., Martin, C.J., Oliynyk, M., Méndez, C., Leadlay, P.F., and Salas, 
J.A. (2004). Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces 
parvulus Tü4055: cluster analysis and assignment of functions. Chem. Biol. 11, 
87–97. 
Olarte, J., and de la Torre, J.A. (1959). Resistance of Shigella flexneri to 
tetracyclines, chloramphenicol and streptomycin; a study of 131 freshly isolated 
strains. Am. J. Trop. Med. Hyg. 8, 324–326. 
Ômura, S., Tanaka, Y., Kanaya, I., Shinose, M., and Takahashi, Y. (1990). 
Phthoxazolin, a specific inhibitor of cellulose biosynthesis, produced by a strain of 
Streptomyces sp. J. Antibiot. 43, 1034-1036. 
Owen, J.G., Calcott, M.J., Robins, K.J., Ackerley, D.F. (2016). Generating 
functional recombinant NRPS enzymes in the laboratory setting via peptidyl carrier 
protein engineering. Cell Chem. Biol. 23, 1395–1406. 
Owen, J.G., Reddy, B.V., Ternei, M.A., Charlop-Powers, Z., Calle, P.Y., Kim, 
J.H., and Brady, S.F. (2013). Mapping gene clusters within arrayed metagenomic 
libraries to expand the structural diversity of biomedically relevant natural products. 
Proc. Natl. Acad. Sci. U.S.A. 110, 11797–11802.  
Parascandolo, J.S., Havemann, J., Potter, H.K., Huang, F., Riva, E., Connolly, J., 
Wilkening, I., Song, L., Leadlay, P.F., and Tosin, M. (2016). Insights into 6-
methylsalicylic acid bio-assembly by using chemical probes. Angew. Chem. INt. 
Ed. Engl. 55, 3463-3467. 




The action of the bacterial toxin, microcin B17, on DNA gyrase. Biochimie 89, 500–
507. 
Pasteur, L., and Joubert, J.F. (1877). Charbon et septicémie. C. R. Hebd. Séances 
Acad. Sci. 85, 101–115. 
Patel, H.M., Tao, J., and Walsh, C.T. (2003). Epimerization of an L-cysteinyl to a D-
cysteinyl residue during thiazoline ring formation in siderophore chain elongation 
by pyochelin synthetase from Pseudomonas aeruginosa. Biochemistry 42, 10514–
10527. 
Paulus, T.J., Tuan, J.S., Luebke, V.E., Maine, G.T., DeWitt, J.P., and Katz, L. 
(1990). Mutation and cloning of eryG, the structural gene for erythromycin O-
methyltransferase from Saccharopolyspora erythraea, and expression of eryG in 
Escherichia coli. J. Bacteriol. 172, 2541–2546. 
Penwell, W.F., Arivett, B.A., and Actis, L.A. (2012). The Acinetobacter baumannii 
entA gene located outside the acinetobactin cluster is critical for siderophore 
production, iron acquisition and virulence. PLoS One 7, e36493.  
Petersen, F., Zähner, H., Metzger, J.W., Freund, S., and Hummel, R.P. (1993). 
Germicidin, an autoregulative germination inhibitor of Streptomyces 
viridochromogenes NRRL B-1551. J. Antibiot. 46, 1126–1138. 
Pfeifer, B.A., Admiraal, S.J., Gramajo, H., Cane, D.E., and Khosla, C. (2001). 
Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. 
Science 291, 1790–1792.  
Pickens, L.B., and Tang, Y. (2010). Oxytetracycline biosynthesis. J. Biol. 
Chem. 285, 27509–27515. 
Poralla, K., Muth, G., and Härtner, T. (2000). Hopanoids are formed during 
transition from substrate to aerial hyphae in Streptomyces coelicolor A3(2). FEMS 
Microbiol. Lett. 189, 93–95. 
Porter, T.N., Li, Y., and Raushel, F.M. (2004). Mechanism of the dihydroorotase 
reaction. Biochemistry 43, 16285–16292. 
Poust, S., Phelan, R.M., Deng, K., Katz, L., Petzold, C.J., and Keasling, J.D. 
(2015). Divergent mechanistic routes for the formation of gem-dimethyl groups in 





Pozharskii, A.F., Soldatenkov, A.T., and Katritzky, A.R. (2011). Heterocycles in Life 
and Society: An Introduction to Heterocyclic Chemistry, Biochemistry and 
Applications, second edition. Hoboken: John Wiley & Sons, Ltd. 
Pulsawat, N., Kitani, S., and Nihira, T. (2007). Characterization of biosynthetic 
gene cluster for the production of virginiamycin M, a streptogramin type A 
antibiotic, in Streptomyces virginiae. Gene 393, 31–42. 
Rangaswamy, V., Mitchell, R., Ullrich, M., and Bender, C. (1998). Analysis of 
genes involved in biosynthesis of coronafacic acid, the polyketide component of 
the phytotoxin coronatine. J. Bacteriol. 180, 3330–3338. 
Read, J.A., and Walsh, C.T. (2007). The lyngbyatoxin biosynthetic assembly line: 
chain release by four-electron reduction of a dipeptidyl thioester to the 
corresponding alcohol. J. Am. Chem. Soc. 129, 15762–15763. 
Redshaw, P.A., McCann, P.A., Pentella, M.A., and Pogell, B.M. (1979). 
Simultaneous loss of multiple differentiated functions in aerial mycelium-negative 
isolates of streptomycetes. J. Bacteriol. 137, 891–899.  
Reeves, C.D., Murli, S., Ashley, G.W., Piagentini, M., Hutchinson, C.R., and 
McDaniel, R. (2001). Alteration of the substrate specificity of a 
modular polyketidesynthase acyltransferase domain through site-specific 
mutations. Biochemistry 40, 15464–15470. 
Reid, R., Piagentini, M., Rodriguez, E., Ashley, G., Viswanathan, N., Carney, J., 
Santi, D.V., Hutchinson, C.R., and McDaniel, R. (2003). A model of structure and 
catalysis for ketoreductase domains in modular polyketide synthases. Biochemistry 
42, 72–79. 
Richards, A.N. (1964). Production of penicillin in the United States (1941-1946). 
Nature 201, 441–445. 
Riva, E., Wilkening, I., Gazzola, S., Li, W.M., Smith, L., Leadlay, P.F., and Tosin, 
M. (2014). Chemical probes for the functionalization of polyketide intermediates. 
Angew. Chem. Int. Ed. Engl. 53, 11944–11949. 
Robbins, T., Kapilivsky, J., Cane, D.E., and Khosla, C. (2016). Roles of conserved 
active site residues in the ketosynthase domain of an assembly Line polyketide 
synthase. Biochemistry 55, 4476–4484.  




Escherichia coli of an intact multienzyme component of the erythromycin-producing 
polyketide synthase. Eur. J. Biochem. 214, 305–311. 
Rohmer, M., Seemann, M., Horbach, S., Bringer-Meyer, S., and Sahm, H. (1996). 
Glyceraldehyde 3-phosphate and pyruvate as precursors of isoprenic units in an 
alternative non-mevalonate pathway for terpenoid biosynthesis. J. Am. Chem. Soc. 
118, 2564–2566. 
Rong, X., and Huang, Y (2012). Taxonomic evaluation of the Streptomyces 
hygroscopicus clade using multi-locus sequence analysis and DNA-DNA 
hybridization, validating the MLSA scheme for the systematics of the whole genus. 
Syst. Appl. Microbiol. 35, 7–18. 
Rowe, C.J., Böhm, I.U., Thomas, I.P., Wilkinson, B., Rudd, B.A., Foster, 
G., Blackaby, A.P., Sidebottom, P.J., Roddis, Y., Buss, A.D., Staunton, J., and 
Leadlay, P.F. (2001). Engineering a polyketide with a longer chain by insertion of 
an extra module into the erythromycin-producing polyketide synthase. Chem. 
Biol. 8, 475–485. 
Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P., Rajandream, M.A., and 
Barrell, B. (2000). Artemis: sequence visualization and annotation. Bioinformatics 
16, 944–945. 
Saha, S., Zhang, W., Zhang, G., Zhu, Y., Chen, Y., Liu, W., Yuan, C., Zhang, Q., 
Zhang, H., Zhang, L., Zhang, W., and Zhang, C. (2017). Activation and 
characterization of a cryptic gene cluster reveals a cyclization cascade for 
polycyclic tetramate macrolactams. Chem. Sci. 8, 1607–1612. 
Salah-Bey, K., Doumith, M., Michel, J.M., Haydock, S., Cortés, J., Leadlay, P.F., 
and Raynal, M.C. (1998). Targeted gene inactivation for the elucidation of 
deoxysugar biosynthesis in the erythromycin producer Saccharopolyspora 
erythraea. Mol. Gen. Genet. 257, 542–553. 
Sato, S., Kajiura, T., Noguchi, M., Takehana, K., Kobayashi, T., and Tsuji, T. 
(2001). AJI9561, a new cytotoxic benzoxazole derivative produced by 
Streptomyces sp. J. Antibiot. 54, 102–104. 
Schatz, A., Bugle, E., and Waksman, S.A. (1944). Streptomycin, a substance 
exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. 




Scherlach, K., Partida-Martinez, L.P., Dahse, H.M., and Hertweck, C. (2006). 
Antimitotic rhizoxin derivatives from a cultured bacterial endosymbiont of the rice 
pathogenic fungus Rhizopus microsporus. J. Am. Chem. Soc. 128, 11529–11536. 
Schlumbohm, W., Stein, T., Ullrich, C., Vater, J., Krause, M., Marahiel, M.A., Kruft, 
V., and Wittmann-Liebold, B. (1991). An active serine is involved in covalent 
substrate amino acid binding at each reaction center of gramicidin S synthetase. J. 
Biol. Chem. 266, 23135–23141. 
Schmitt, E., Blanquet, S., and Mechulam, Y. (1996). Structure of crystalline 
Escherichia coli methionyl-tRNA(f)Met formyltransferase: comparison with 
glycinamide ribonucleotide formyltransferase. EMBO J. 15, 4749–4758. 
Schneider, R., and Hantke, K. (1993). Iron-hydroxamate uptake systems in Bacillus 
subtilis: identification of a lipoprotein as part of a binding protein-dependent 
transport system. Mol. Microbiol. 8, 111–121. 
Schnell, N., Entian, K.D., Schneider, U., Götz, F., Zähner, H., Kellner, R., and 
Jung, G. (1988). Prepeptide sequence of epidermin, a ribosomally synthesized 
antibiotic with four sulphide-rings. Nature 333, 276–278. 
Schönafinger, G., Schracke, N., Linne, U., and Marahiel, M.A. (2006). Formylation 
domain: an essential modifying enzyme for the nonribosomal biosynthesis of linear 
gramicidin. J. Am. Chem. Soc. 128, 7406–7407. 
Scotti, C., Piatti, M., Cuzzoni, A., Perani, P., Tognoni, A., Grandi, G., Galizzi, 
A., and Albertini, A.M. (1993). A Bacillus subtilis large ORF coding for a 
polypeptide highly similar to polyketide synthases. Gene 130, 65–71. 
Seibert, C.M., and Raushel, F.M. (2005). Structural and catalytic diversity within 
the amidohydrolase superfamily. Biochemistry 44, 6383–6391. 
Sekiguchi, J., and Shuman, S. (1997). Nick sensing by DNA ligase requires a 5′ 
phosphate at the nick and occupancy of the adenylate binding site on the enzyme. 
J. Virol. 71, 9679–9684. 
Shen, B., and Hutchinson, C.R. (1996). Deciphering the mechanism for the 
assembly of aromatic polyketides by a bacterial polyketide synthase. Proc. Natl. 
Acad. Sci. U.S.A. 93, 6600–6604. 
Shiomi, K., Arai, N., Shinose, M., Takahashi, Y., Yoshida, H., Iwabuchi, J., Tanaka, 




Streptomyces sp. KO-7888. J. Antibiot. 48, 714–719. 
Shulse, C.N., and Allen, E.E. (2011). Diversity and distribution of microbial long-
chain fatty acid biosynthetic genes in the marine environment. Environ. 
Microbiol. 13, 684–695.  
Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., 
McWilliam, H., Remmert, M., Söding, J., Thompson, J.D., and Higgins, D.G. 
(2011). Fast, scalable generation of high-quality protein multiple sequence 
alignments using Clustal Omega. Mol. Syst. Biol. 7, 539–544. 
Silakowski, B., Kunze, B., and Müller, R. (2000). Stigmatella aurantiaca Sg a15 
carries genes encoding type I and type II 3-deoxy-D-arabino-heptulosonate-7-
phosphate synthases: involvement of a type II synthase in aurachin biosynthesis. 
Arch. Microbiol. 173, 403–411. 
Silakowski, B., Schairer, H.U., Ehret, H., Kunze, B., Weinig, S., Nordsiek, G., 
Brandt, P., Blöcker, H., Höfle, G., Beyer, S., and Müller, R. (1999). New lessons for 
combinatorial biosynthesis from myxobacteria. The myxothiazol biosynthetic gene 
cluster of Stigmatella aurantiaca DW4/3-1. J. Biol. Chem. 274, 37391–37399. 
Skiba, M.A., Sikkema, A.P., Fiers, W.D., Gerwick, W.H., Sherman, D.H., Aldrich, 
C.C., and Smith, J.L. (2016). Domain organization and active site architecture of a 
polyketide synthase C-methyltransferase. ACS Chem. Biol. 11, 3319–3327. 
Stachelhaus, T., Mootz, H.D., and Marahiel, M.A. (1999). The specificity-conferring 
code of adenylation domains in nonribosomal peptide synthetases. Chem. Biol. 6, 
493–505. 
Stassi, D., Donadio, S., Staver, M.J., and Katz, L. (1993). Identification of a 
Saccharopolyspora erythraea gene required for the final hydroxylation step in 
erythromycin biosynthesis. J. Bacteriol. 175, 182–189. 
Staunton, J., and Weissman, K.J. (2001). Polyketide biosynthesis: a millennium 
review. Nat. Prod. Rep. 18, 380–416. 
Stindl, A., and Keller, U. (1994). Epimerization of the D-valine portion in the 
biosynthesis of actinomycin D. Biochemistry 33, 9358–9364. 
Storm, D.R., and Strominger, J.L. (1973). Complex formation between bacitracin 
peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide interactions. 




Sugiyama, M., Mochizuki, H., Nimi, O., and Nomi, R. (1981). Mechanism of 
protection of protein synthesis against streptomycin inhibition in a producing strain. 
J. Antibiot. 34, 1183–1188. 
Sugiyama, M., Paik, S.Y., Nomi, R. (1985). Mechanism of self-protection in a 
puromycin-producing micro-organism. J. Gen. Microbiol. 131, 1999–2005. 
Sugiyama, M., Takeda, A., Paik, S.Y., Nimi, O., and Nomi, R. (1986). Acetylation of 
blasticidin S by its producing actinomycetes. J. Antibiot. 39, 827–832. 
Summers, R.G., Donadio, S., Staever, M.J., Wendt-Pienkowski, E., Hutchinson, 
C.R., and Katz, L. (1997). Sequencing and mutagenesis of genes from the 
erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are 
involved in L-mycarose and D-desosamine production. Microbiology 143, 3251–
3262. 
Sun, Y., He, X., Liang, J., Zhou, X., and Deng, Z. (2009). Analysis of functions in 
plasmid pHZ1358 influencing its genetic and structural stability in Streptomyces 
lividans 1326. Appl. Microbiol. Biotechnol. 82, 303–310 
Suroto, D.A., Kitani, S., Miyamoto, K.T., Sakihama, Y., Arai, M., Ikeda, H., and 
Nihira, T. (2017). Activation of cryptic phthoxazolin A production in Streptomyces 
avermitilis by the disruption of autoregulator-receptor homologue AvaR3. J. Biosci. 
Bioeng. 124, 611–617.  
Taguchi, T., Ebihara. T., Furukawa, A., Hidaka, Y., Ariga, R., Okamoto, S., and 
Ichinose, K. (2012). Identification of the actinorhodin monomer and its related 
compound from a deletion mutant of the actVA-ORF4 gene of Streptomyces 
coelicolor A3(2). Bioorg. Med. Chem. Lett. 22, 5041–5045. 
Tahlan, K., Ahn, S.K., Sing, A., Bodnaruk, T.D., Willems, A.R., Davidson, A.R., and 
Nodwell, J.R. (2007). Initiation of actinorhodin export in Streptomyces coelicolor. 
Mol. Microbiol. 63, 951–961. 
Takano, H., Obitsu, S., Beppu, T., and Ueda, K. (2005). Light-induced 
carotenogenesis in Streptomyces coelicolor A3(2): identification of an 
extracytoplasmic function sigma factor that directs photodependent transcription of 
the carotenoid biosynthesis gene cluster. J. Bacteriol. 187, 1825–1832. 
Tanaka, Y., Kanaya, I., Takahashi, Y., Shinose, M., Tanaka, H., and Ômura, S. 




origin. I. Discovery, taxonomy of producing microorganism, fermentation, and 
biological activity. J. Antibiot. 46, 1208–1213. 
Tang, L., Shah, S., Chung, L., Carney, J., Katz, L., Khosla, C., and Julien, B. 
(2000). Cloning and heterologous expression of the epothilone gene cluster. 
Science 287, 640–642. 
Tang, Y., Lee, H.Y., Tang, Y., Kim, C.Y., Mathews, I., and Khosla, C. (2006). 
Structural and functional studies on SCO1815: a beta-ketoacyl-acyl carrier protein 
reductase from Streptomyces coelicolor A3(2). Biochemistry 45, 14085–14093. 
Tang, Y., Tsai, S.C., and Khosla, C. (2003). Polyketide chain length control by 
chain length factor. J. Am. Chem. Soc. 125, 12708–12709. 
Tao, W., Yurkovich, M.E., Wen, S., Lebe, K.E., Samborskyy, M., Liu, Y., Yang, 
A., Liu, Y., Ju, Y., Deng, Z., Tosin, M., Sun, Y., and Leadlay, P.F. (2016). A 
genomics-led approach to deciphering the mechanism of thiotetronate antibiotic 
biosynthesis. Chem. Sci. 7, 376–385. 
Tierno, M.B., Kitchens, C.A., Petrik, B., Graham, T.H., Wipf, P., Xu, F.L., Saunders, 
W.S., Raccor, B.S., Balachandran, R., Day, B.W., Stout, J.R., Walczak, C.E., 
Ducruet, A.P., Reese, C.E., and Lazo, J.S. (2009). Microtubule binding and 
disruption and induction of premature senescence by disorazole C. J. Pharmacol. 
Exp. Ther. 328, 715–722. 
Tocchetti, A., Maffioli, S., Iorio, M., Alt, S., Mazzei, E., Brunati, C., Sosio, M., and 
Donadio, S. (2013). Capturing linear intermediates and C-terminal variants during 
maturation of the thiopeptide GE2270. Chem. Biol. 20, 1067–1077. 
Traxler, M. F. and Kolter, R. (2015) Natural products in soil microbe interactions 
and evolution. Nat. Prod. Rep. 32, 956–970. 
Tsai, S.C., Lu, H., Cane, D.E., Khosla, C., and Stroud, R.M. (2002). Insights into 
channel architecture and substrate specificity from crystal structures of two 
macrocycle-forming thioesterases of modular polyketide synthases. Biochemistry 
41, 12598–12606. 
Umezawa, H., Ueda, M., Maeda, K., Yagishita, K., Kondo, S., Okami, Y., Utahara, 
R., Osato, Y., Nitta, K., and Takeuchi, T. (1957). Production and isolation of a new 
antibiotic: kanamycin. J. Antibiot. 10, 181–188.  




Broadhurst, W. Biochem. J. 473, 1097–1110.  
Velasco, A., Acebo, P., Gomez, A., Schleissner, C., Rodriguez, P., Aparicio, T., 
Conde, S., Munoz, R., De La Calle, F., Garcia, J.L., and Sanchez-Puelles, J.M. 
(2005). Molecular characterization of the safracin biosynthetic pathway from 
Pseudomonas fluorescens A2-2: designing new cytotoxic compounds. Mol. 
Microbiol. 56, 144–154. 
Vieweg, L., Reichau, S., Schobert, R., Leadlay, P.F., and Süssmuth, R.D. (2014) 
Recent advances in the field of bioactive tetronates. Nat. Prod. Rep. 31, 1554–
1584. 
Wagner, D.T., Zeng, J., Bailey, C.B., Gay, D.C., Yuan, F., Manion, H.R., and 
Keatinge-Clay, A.T. (2017). Structural and functional trends in dehydrating 
bimodules from trans-acyltransferase polyketide synthases. Structure 25, 1045– 
1055. 
Wakimoto, T., Egami, Y., Nakashima, Y., Wakimoto, Y., Mori, T., Awakawa, T., Ito, 
T., Kenmoku, H., Asakawa, Y., Piel, J., and Abe, I. (2014). Calyculin biogenesis 
from a pyrophosphate protoxin produced by a sponge symbiont. Nat. Chem. 
Biol. 10, 648–655. 
Waksman, S.A., and Henrici, A.T. (1943). The Nomenclature and Classification of 
the Actinomycetes. J. Bacteriol. 46, 337–341. 
Waksman, S.A., and Woodruff, H.B. (1940). The soil as a source of 
microorganisms antagonistic to disease-producing bacteria. J. Bacteriol. 40, 581–
600. 
Waksman, S.A., and Woodruff, H.B. (1942). Selective antibiotic action of various 
substances of microbial origin. J. Bacteriol. 44, 373–384. 
Walsh, C.T. (2016). Insights into the chemical logic and enzymatic machinery of 
NRPS assembly lines. Nat. Prod. Rep. 33, 127–135. 
Wang, B., Guo, F., Ren, J., Ai, G., Aigle, B., Fan, K., and Yang, K. (2015a). 
Identification of Alp1U and Lom6 as epoxy hydrolases and implications for 
kinamycin and lomaiviticin biosynthesis. Nat. Commun. 6, 7674. 
Wang, B., Ren, J., Li, L., Guo, F., Pan, G., Ai, G., Aigle, B., Fan, K., and Yang, K. 
(2015b). Kinamycin biosynthesis employs a conserved pair of oxidases for B-ring 




Wang, C.M., and Cane, D.E. (2008) Biochemistry and molecular genetics of the 
biosynthesis of the earthy odorant methylisoborneol in Streptomyces coelicolor. J. 
Am. Chem. Soc. 130, 8908–8909. 
Weber, G., Schörgendorfer, K., Schneider-Scherzer, E., and Leitner, E. (1994). 
The peptide synthetase catalyzing cyclosporine production in Tolypocladium 
niveum is encoded by a giant 45.8-kilobase open reading frame. Curr. Genet. 26, 
120–125. 
Weinig, S., Hecht, H.J., Mahmud, T., and Müller, R. (2003). Melithiazol 
biosynthesis: further insights into myxobacterial PKS/NRPS systems and evidence 
for a new subclass of methyl transferases. Chem. Biol. 10, 939–952. 
Weissman, K.J., Timoney, M., Bycroft, M., Grice, P., Hanefeld, U., Staunton, J., 
and Leadlay, P.F. (1997). The molecular basis of Celmer's rules: the 
stereochemistry of the condensation step in chain extension on the erythromycin 
polyketide synthase. Biochemistry 36, 13849–13855. 
Weitnauer, G., Mühlenweg, A., Trefzer, A., Hoffmeister, D., Süssmuth, R.D., Jung, 
G., Welzel, K., Vente, A., Girreser, U., and Bechthold, A. (2001). Biosynthesis of 
the orthosomycin antibiotic avilamycin A: deductions from the molecular analysis of 
the avi biosynthetic gene cluster of Streptomyces viridochromogenes Tü57 and 
production of new antibiotics. Chem. Biol. 8, 569–581. 
Westley, J.W., Liu, C.M., Evans, R.H., and Blount, J.F. (1979). Conglobatin, a 
novel macrolide dilactone from Streptomyces conglobatus ATCC 31005. J. 
Antibiot. 32, 874–877. 
Whicher, J.R., Dutta, S., Hansen, D.A., Hale, W.A., Chemler, J.A., Dosey, A.M., 
Narayan, A.R., Håkansson, K., Sherman, D.H., Smith, J.L., and Skiniotis, G. 
(2014). Structural rearrangements of a polyketide synthase module during its 
catalytic cycle. Nature 510, 560–564.  
Wilkinson C.J., Hughes-Thomas Z.A., Martin C.J., Bohm I., Mironenko T., Deacon 
M., Wheatcroft, M.P., Wirtz, G., Staunton, J., and Leadlay, P.F. (2002). Increasing 
the efficiency of heterologous promoters in actinomycetes. J. Mol. Microbiol. 
Biotechnol. 4, 417–426. 
Winkelman, G., and Drechsel, H. (1997). Microbial siderophores. In Biotechnology, 
Vol 7: Products of Secondary Metabolism. Kleinkauf, H., and von Döhren, H., eds. 




Wittmann, M., Linne, U., Pohlmann, V., and Marahiel, M.A. (2008). Role of DptE 
and DptF in the lipidation reaction of daptomycin. FEBS J. 275, 5343–5354. 
Woo, C.M., Beizer, N.E., Janso, J.E., and Herzon, S.B. (2012). Isolation of 
lomaiviticins C-E, transformation of lomaiviticin C to lomaiviticin A, complete 
structure elucidation of lomaiviticin A, and structure-activity analyses. J. Am. Chem. 
Soc. 134, 15285–15288. 
World Health Organization (WHO). (2015). Worldwide country situation analysis: 
response to antimicrobial resistance. Geneva: World Health Organization. 
Wu, Q., Liang, J., Lin, S., Zhou, X., Bai, L., Deng, Z., and Wang, Z. (2011). 
Characterization of the biosynthesis gene cluster for the pyrrole polyether antibiotic 
calcimycin (A23187) in Streptomyces chartreusis NRRL 3882. Antimicrob. Agents 
Chemother. 55, 974–982.  
Xie, L., Miller, L.M., Chatterjee, C., Averin, O., Kelleher, N.L., Van Der Donk, W.A. 
(2004). Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. 
Science 303, 679–681. 
Xie, X., Garg, A., Keatinge-Clay, A.T., Khosla, C., and Cane, D.E. (2016). 
Epimerase and reductase activities of polyketide synthase ketoreductase domains 
utilize the same conserved tyrosine and serine residues. Biochemistry 55, 1179–
1186. 
Yamanaka, K., Reynolds, K.A., Kersten, R.D., Ryan, K.S., Gonzalez, D.J., Nizet, 
V., Dorrestein, P.C., and Moore, B.S. (2014). Direct cloning and refactoring of a 
silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc. 
Natl. Acad. Sci. U.S.A. 111, 1957–1962. 
Yang, K., Han, L., Ayer, S.W., and Vining, L.C. (1996). Accumulation of the 
angucycline antibiotic rabelomycin after disruption of an oxygenase gene in the 
jadomycin B biosynthetic gene cluster of Streptomyces venezuelae. Microbiology 
142, 123–132. 
Yin, J., Hoffmann, M., Bian, X., Tu, Q., Yan, F., Xia, L., Ding, X., Stewart, 
A.F., Müller, R., Fu, J., and Zhang, Y. (2015). Direct cloning and heterologous 
expression of the salinomycin biosynthetic gene cluster from Streptomyces albus 
DSM41398 in Streptomyces coelicolor A3(2). Sci. Rep. 5, 15081.   




Streptomyces fungicidicus. Microbiology 152, 2969–2983. 
Yu, T.W., and Chen, C.W. (1993). The unstable melC operon of Streptomyces 
antibioticus is codeleted with a Tn4811-homologous locus. J. Bacteriol. 175, 1847–
1852. 
Yu, T.W., Shen, Y., Doi-Katayama, Y., Tang, L., Park, C., Moore, B.S., Hutchinson, 
C.R., and Floss, H.G. (1999). Direct evidence that 
the rifamycin polyketide synthase assembles polyketide chains processively. Proc. 
Natl. Acad. Sci. U.S.A. 96, 9051–9056. 
Yu, Y., Guo, H., Zhang, Q., Duan, L., Ding, Y., Liao, R., Lei, C., Shen, B., and 
Liu, W. (2010). NosA catalyzing carboxyl-terminal amide formation in nosiheptide 
maturation via an enamine dealkylation on the serine-extended precursor peptide. 
J. Am. Chem. Soc. 132, 16324–16326. 
Zalacain, M., and Cundliffe, E. (1989). Methylation of 23S rRNA caused by tlrA 
(ermSF), a tylosin resistance determinant from Streptomyces fradiae. J. Bacteriol. 
171, 4254–4260. 
Zawada, R.J., and Khosla, C. (1999). Heterologous expression, purification, 
reconstitution and kinetic analysis of an extended type II polyketide synthase. 
Chem. Biol. 6, 607–615. 
Zawada, R.J.X., and Khosla, C. (1997). Domain analysis of the molecular 
recognition features of aromatic polyketide synthase subunits. J. Biol. Chem. 272, 
16184–16188. 
Zhang ,W., Watanabe, K., Cai, X., Jung, M.E., Tang, Y., and Zhan, J. (2008). 
Identifying the minimal enzymes required for anhydrotetracycline biosynthesis. J. 
Am. Chem. Soc. 130, 6068–6069. 
Zhang, L., Hashimoto, T., Qin, B., Hashimoto, J., Kozone, I., Kawahara, T., Okada, 
M., Awakawa, T., Ito, T., Asakawa, Y., Ueki, M., Takahashi, S., Osada, H., 
Wakimoto, T., Ikeda, H., Shin-Ya, K., and Abe, I. (2017). Characterization of giant 
modular PKSs provides insight into genetic mechanism for structural diversification 
of aminopolyol polyketides. Angew. Chem. Int. Ed. Engl. 56, 1740–1745. 
Zhang, W., Watanabe, K., Wang, C.C., and Tang, Y. (2007). Investigation of early 





Zhao, C., Coughlin, J.M., Ju, J., Zhu, D., Wendt-Pienkowski, E., Zhou, X., Wang, 
Z., Shen, B., and Deng, Z. (2010). Oxazolomycin biosynthesis in Streptomyces 
albus JA3453 featuring an "acyltransferase-less" type I polyketide synthase that 
incorporates two distinct extender units. J. Biol. Chem. 285, 20097–20108. 
Zheng, J., Gay, D.C., Demeler, B., White, M.A., and Keatinge-Clay, A.T. (2012). 
Divergence of multimodular polyketide synthases revealed by a didomain structure. 
Nat. Chem. Biol. 8, 615–621. 
Zheng, J., Taylor, C.A., Piasecki, S.K., and Keatinge-Clay, A.T. (2010). Structural 
and functional analysis of A-type ketoreductases from the amphotericin 
modular polyketide synthase. Structure 18, 913–922.  
Zhou, Z., Xu, Q., Bu, Q., Guo, Y., Liu, S., Liu, Y., Du, Y., and Li, Y. (2015). 
Genome mining-directed activation of a silent angucycline biosynthetic gene 
cluster in Streptomyces chattanoogensis. ChemBioChem 16, 496–502. 
Ziemert, N., Lechner, A., Wietz, M., Millán-Aguiñaga, N., Chavarria, K.L., and 
Jensen, P.R. (2014). Diversity and evolution of secondary metabolism in the 
marine actinomycete genus Salinispora. Proc. Natl. Acad. Sci. U.S.A. 111, E1130–
E1139. 
Ziemert, N., Podell, S., Penn, K., Badger, J.H., Allen, E., and Jensen, P.R. (2012). 
The natural product domain seeker NaPDoS: a phylogeny based bioinformatic tool 
to classify secondary metabolite gene diversity. PLoS One 7, e34064. 
 
 
 
 
 
